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ABSTRACT 
 
Protein degradation is a vital process in cells for quality control and participation 
in regulatory pathways.  Intracellular ATP-dependent proteases are responsible for 
regulated degradation and are highly controlled in their function, especially with respect 
to substrate selectivity.  Adaptor proteins that can associate with the proteases add an 
additional layer of control to substrate selection.  Thus, understanding the mechanism and 
role of adaptor proteins is a critical component to understanding how proteases choose 
their substrates. 
In this thesis, I examine the role of the intracellular protease ClpAP and its 
adaptor ClpS in Escherichia coli.  ClpS binds to the N-terminal domain of ClpA and 
plays dual roles in ClpAP substrate selectivity: ClpS inhibits the degradation of some 
substrates such as ssrA-tagged proteins and enhances the degradation of other substrates 
such as N-end-rule proteins.  We wished to elucidate how ClpS influences ClpAP 
substrate selection, and found that the stoichiometry of ClpS binding to ClpA is one level 
of regulation.  Furthermore, we demonstrated that the N-terminal extension of ClpS is 
vital for the adaptor’s role in delivering N-end-rule substrates to ClpAP for degradation, 
but this extension is not required for inhibition of ssrA-tagged proteins.  Truncation 
studies of the ClpS N-terminal extension showed a dramatic length-dependence on N-
end-rule protein delivery, and the chemical composition of this portion of ClpS also 
affected the ability to degrade N-degron-bearing substrates.  Evidence suggests that ClpS 
allosterically affects the ClpA enzyme, causing a modulation in substrate specificity, and 
preliminary studies localized the point of contact by the ClpS N-terminal extension to the 
ClpA pore region.  ClpS therefore represents a new type of adaptor protein that 
modulates substrate selection allosterically, rather than simply recruiting and tethering 
substrates to the protease. 
To further understand the role of ClpS and ClpAP in the cell, we conducted a 
proteomic-based search for ClpS-dependent ClpAP substrates.  A list of putative 
substrates was generated from these experiments, and we believe that ClpAP plays a key 
role in quality control, perhaps through the degradation of N-end-rule substrates.  
Combined with mechanistic studies, these physiological studies aid in the understanding 
of how ClpS influences substrate recognition by ClpAP. 
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SIGNIFICANCE OF REGULATED PROTEOLYSIS 
 Proteins are involved in virtually every cellular function, and it is essential that 
the amount, folding, processing, and localization of proteins are exquisitely controlled.  
Numerous mechanisms regulate the protein levels in the cell, including transcription, 
translation, post-translational processing, and degradation.  Transcription is a critical step 
in the regulation of intracellular protein levels because control at this step determines 
which gene products are produced and how many copies are synthesized.  Once the cell 
decides to up-regulate a gene, transcription, RNA processing in eukaryotes, translation, 
and sometimes localization and post-translational processing events are necessary before 
attaining the functional protein.  Tuning down levels of protein expression typically 
involves alleviating the activation signal or inducing a repressor.  However, control at the 
step of transcription still allows existing RNA transcripts to be translated into protein.  
Therefore, if rapid down-regulation of a gene product is required, direct degradation of 
the existing protein is a convenient strategy often employed by cells. 
 One study showed that 2.7% of proteins are degraded per generation in 
Escherichia coli growing in logarithmic phase (Fox and Brown 1961).  There are many 
reasons why it would be advantageous for a cell to turn over a protein.  A cell assaulted 
by external stress needs to respond quickly in order to survive.  For example, degradation 
of a cellular regulator could result in transduction of a signal to activate stress-response 
genes.  Protein degradation is also involved in less life-and-death situations in which the 
cell adjusts its proteome while continuously sampling its environment, such as for 
nutrients or developmental cues.  It can sometimes be deleterious for too much of a 
particular protein to be present in the cell; proteins not wanted or required for active use 
can be degraded to provide building blocks for up-regulated gene products.  The ability to 
fine-tune the levels of proteins allows the adaptability to external stimuli as well as the 
progression of cellular programs.  Several examples illustrate the role of proteolysis in 
these functionalities.   
In eukaryotic cells, various cyclin-dependent kinases are responsible for carrying 
out cell cycle progression.  As their name implies, these kinases must bind to their partner 
cyclin protein for activity.  Cyclin levels oscillate with the cell cycle, and it was 
discovered that cyclins accumulate and then are specifically and periodically degraded, 
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thereby deactivating their partnered kinases at indicated times during the cell cycle.  
Different cyclins are degraded at different stages to allow cell cycle progression (Glotzer 
et al. 1991; Nigg 1995).  Thus, these precise proteolytic events are crucial in maintaining 
the cell cycle clock.   
 Another example of regulated proteolysis taken from eukaryotes is the response to 
ethylene by Arabidopsis.  Exogenous ethylene can result in a range of physiological and 
morphological changes in plants including leaf and flower senescence, fruit ripening, and 
adaptation to stress and pathogenic infections.  One study reports on the rapid 
accumulation of a nuclear signaling protein in Arabidopsis involved in the ethylene 
response pathway.  It was discovered that this protein, EIN3, is constitutively produced 
and degraded in the absence of ethylene.  The exposure to ethylene blocks EIN3 from 
being recognized for degradation through an undefined mechanism, thereby allowing the 
protein to accumulate and turn on its target genes for ethylene response (Guo and Ecker 
2003).  The employment of protein degradation in this mechanism allows the plant to 
rapidly respond to environmental signals. 
 Although protein degradation plays key roles in cellular function, regulated 
degradation is also essential for clearing aberrant or damaged protein products while 
ignoring functional ones.  The cell needs to prevent irreversibly-misfolded or otherwise 
damaged proteins from inducing uncontrolled aggregation and disrupting normal 
processes.  The challenge for this protein-clearance process is to determine which 
proteins should be degraded.  In general, the cell uses several strategies for discriminating 
proteins slated for degradation from stable proteins.  One common mechanism for this 
discrimination is the revealing of a latent degradation signal in the targeted protein.  This 
signal could be a stretch of hydrophobic residues that would normally be in the interior of 
a properly-folded protein, a degradation motif that is revealed after an upstream 
processing event, or a sequence in a protein that is hidden when associated with a partner 
protein (Gottesman and Maurizi 1992).  Degradation tags are discussed more thoroughly 
below. 
 Regulated proteolysis can broadly be defined as the process by which proteins are 
selectively degraded.  This degradation can be controlled temporally and spatially and is 
often a result from a physiological change or external stimulus such as a stress signal.  
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This regulated degradation is important not only for housekeeping functions such as 
providing new building blocks for synthesis and avoiding accumulation of abnormal 
proteins but also in reshaping the global proteomic composition of the cell.  It is therefore 
important to understand the various mechanisms that the cell uses to select substrates for 
degradation as well as the requirements for the proteolysis to be accomplished.   
 This remainder of this introduction provides an overview of the principal players 
in the pathway for energy-dependent proteolysis.   An emphasis is placed on control 
mechanisms in order to highlight the strategies the cell utilizes to regulate degradation at 
multiple steps.  In-depth coverage is provided for the protease ClpAP and its accessory 
protein ClpS, which are central to this thesis.  ClpAP and ClpS provide a system in which 
to study the mechanism underlying the complex role of proteases in the cell.      
 
KEY COMPONENTS OF PROTEIN DEGRADATION 
When regulated protein degradation is discussed, it is often in reference to the 
complete degradation of a protein substrate rather than a single cutting event or the 
cleavage of peptides, such as by amino- or carboxypeptidases.  Our focus is on complete 
protein processing through processive degradation carried out by energy-dependent 
proteolytic machines.  There are two principal components for protein degradation: the 
substrate to be eliminated and the complex that carries out the degradation.  Tertiary 
factors, such as adaptor proteins, often provide another layer of regulation to substrate 
selection and processing. 
 
Degradation Tags 
 Proteins that are slated for degradation must bear a specific signal that is distinct 
from stable proteins.  In bacteria, proteins recognized for degradation possess tags 
encoded in their primary structure on their N- and/or C-termini.  In eukaryotes, proteins 
intended for degradation are appended with a small modifier protein called ubiquitin.  
These tags or modifiers are recognized and bound either directly by the protease or by 
adaptor proteins which recruit the tagged substrate to the degradation machine.  Here, I 
will address several types of tags, with a broader focus on bacterial systems. 
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ssrA tags 
One type of degradation tag is the ssrA tag.  This tagging system, encoded by the 
ssrA RNA, is involved in protein quality control in all eubacteria (Karzai et al. 2000).  In 
the instance when an mRNA being translated lacks a proper stop codon, the ribosome 
stalls due to the absence of sufficient signals for release of the mRNA and the growing 
polypeptide chain.  The ssrA RNA can rescue the stalled ribosome through the action of 
its tmRNA features.  The tmRNA enters the A-site of the ribosome and directs the 
addition of an alanine to the existing polypeptide through the transpeptidation reaction.  
Subsequently, the tmRNA moves into the P-site of the ribosome and displaces the 
original mRNA message.  The tmRNA then guides the translation of the remainder of the 
ssrA protein tag onto the C-terminus of the nascent polypeptide until a stop codon is 
reached in the new RNA message.  The ribosome is now free to translate another mRNA, 
and the protein product is slated for degradation via the freshly-encoded ssrA tag (Keiler 
et al. 1996).  It is estimated that 0.5% of translations in Escherichia coli result in ssrA-
tagging, and proteins with the ssrA tag are degraded by intracellular ATP-dependent 
proteases (Gottesman et al. 1998; Lies and Maurizi 2008).  The role of the ssrA system in 
bacteria appears to be largely for quality control, as it prevents build-up of aberrant 
protein products and keeps the cellular translation machinery running smoothly.   
The sequence of the E. coli ssrA tag is AANDENYALAA-CO2-.  The various 
proteases and adaptor proteins known to interact with the ssrA tag recognize different 
features and regions of the tag sequence, and proteins that recognize overlapping 
sequences on the ssrA tag compete for binding.  The E. coli ATP-dependent protease 
ClpXP primarily recognizes the final LAA and the C-terminal carboxyl group of the ssrA 
tag (Flynn et al. 2003).  Interestingly, other proteins that are known to be turned over in 
this bacterium have a similar C-terminal di-alanine sequence to the ssrA tag, such as 
RecN, a protein involved in DNA double-stranded break repair that is rapidly turned over 
in the cell when not in use (Neher et al. 2006).  The di-alanine C-termini of these tags is a 
simple degradation motif recognized by intracellular proteases in bacteria, though other 
residues in the tag and in the overall protein may contribute to enhanced degradation 
and/or regulation. 
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Exposed substrate-specific tags 
 Like RecN, there are proteins in the cell that have a degradation tag encoded into 
its native sequence.  One example, also taken from bacteria, is Dps (DNA-binding protein 
in starved cells), which can form biocrystals with DNA, protecting it from stresses and 
damage (Nair and Finkel 2004).  Dps has a degradation tag encoded at its N-terminus and 
is degraded by ClpXP; Dps protein deleted in its first five residues is no longer degraded 
by ClpXP, and appending the first twelve residues onto a model protein causes that 
protein to be proteolyzed (Flynn et al. 2003).  Low levels of Dps exist during exponential 
phase of E. coli growth, presumably because degradation is occurring soon after the 
protein is translated.  However, Dps levels rise in stationary phase.  The mechanism for 
how Dps is stabilized in stationary phase is unknown, but the DNA-binding and 
protection functions of the protein necessitate abundant Dps levels in the cell (Almiron et 
al. 1992).  Thus, by constantly producing Dps, the cell is able to rapidly respond to stress 
and starvation conditions by halting degradation, leading to immediate accumulation of 
the protein.  This scenario exemplifies the use of proteins with degradation signals “hard-
wired” into their native sequence. 
 
Internal and revealed degradation tags 
 Degradation tags can also reside in the interior of a protein’s primary sequence.  
Some studies suggest that ATP-dependent proteases can directly recognize interior 
degradation sequences in model proteins (Hoskins et al. 2002).  However, some proteins 
bearing an interior degradation tag are internally cleaved, revealing a tag on the new N- 
or C-terminus.  The example of the RseA protein in E. coli illustrates this process well.  
RseA is an inner membrane-spanning protein.  The N-terminal portion of the portion 
extends into the cytoplasmic space of the cell and binds to sigmaE, the sigma factor 
involved in turning on genes involved in addressing extracytoplasmic stress.  RseA acts 
as an inhibitor of sigmaE activity because it sequesters sigmaE away from its respective 
promoters on the DNA.  When the cell experiences periplasmic stress by way of an 
accumulation of unfolded or misfolded outer membrane proteins, two site-specific 
cleavage events occur in the RseA protein, one of which liberates the N-terminal portion 
bound to sigmaE.  This cleavage reveals a degradation tag on the C-terminus of this N-
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terminal fragment, denoted NRseA, and this tag bears a C-terminal –VAA motif that is 
similar to the ssrA tag in E. coli.  Specific ATP-dependent proteases in the cytoplasm 
now recognize NRseA as a proteolytic substrate, releasing sigmaE to activate stress 
response genes (Flynn et al. 2004).  Therefore, the specific revelation of a degradation tag 
is another strategy employed by the cell in regulated protein degradation. 
 
Ubiquitin 
 In eukaryotes, the major degradation tag directly recognized for proteolysis is 
ubiquitin.  Instead of being encoded into the sequence of the protein being degraded, 
ubiquitin is a small protein that is post-translationally added to substrates for degradation 
by the proteasome (discussed below).  Multiple proteins are responsible for fusing the 
ubiquitin protein tag onto its substrate protein.  The first enzyme, E1, is the ATP-
dependent activating enzyme that renders the C-terminal amino acid of ubiquitin more 
reactive for subsequent steps through covalent binding to a cysteine residue in E1.  The 
ubiquitin protein is next transferred to E2, a ubiquitin-carrier protein.  Lastly, a ubiquitin 
ligase, E3, fuses the C-terminus of ubiquitin to a lysine residue on the substrate protein.  
The E2 and E3 steps occur in concert, and due to the need for substrate specificity in 
ubiquitin ligation and the subsequent degradation, there are many different types of E2 
and E3 enzymes in the cell dedicated towards specific substrates.   In some cases, adaptor 
proteins may assist E3 in the transfer of ubiquitin to substrates.  Typically, multiple 
ubiquitins in the form of a polyubiquitin chain are required for recognition of a substrate 
by the proteasome, in which the C-terminus of a monoubiquitin unit is covalently 
attached to a lysine residue of the preceding ubiquitin in the chain.  The proteasome 
directly recognizes the ubiquitin degradation tag, but the ubiquitin molecules are not 
degraded with the substrate protein (Hershko and Ciechanover 1998). 
 Because the ubiquitin molecule itself is not degraded, it can sometimes be 
considered an adaptor (discussed below) that delivers the actual substrates for 
degradation closer to the proteolytic machine.  Evidence suggests that once a protein is 
brought into close proximity to the proteasome, an unstructured and accessible region of 
the substrate is required for efficient initiation of unfolding and degradation (Prakash et 
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al. 2004; Inobe and Matouschek 2008).  In this light, the ubiquitin is simply the adaptor 
bringing in the unstructured portion towards the proteasome processing sites.   
 
Ubiquitin-dependent sequences 
Further complexity arises when one considers how the ubiquitination enzymes 
determine which proteins are slated for degradation.  Even though the polyubiquitin chain 
is the principle degradation tag recognized by the proteasome, certain sequence elements 
in the substrate proteins themselves are necessary for degradation.  One example is the 
recognition of PEST elements, regions in a substrate protein enriched in Pro, Glu, Ser, 
and/or Thr residues.  PEST elements possess phosphorylation sites that are in turn 
recognized by the ubiquitination enzymes.  The timing of some cyclins is regulated by 
key phosphorylation events at PEST elements (Hershko and Ciechanover 1998).  Thus, 
ubiquitin serves as a very important and versatile degradation tag for a wide variety of 
proteolytic substrates in eukaryotic cells. 
 
N-degrons 
 Another broad category of degradation tags that exists in eukaryotes as well as 
prokaryotes is the N-degron.  It was first reported in 1986 by the lab of Alexander 
Varshavsky that systematically changing the amino-terminal residue of a protein altered 
the protein’s half-life in the cell (Bachmair et al. 1986).  The N-end rule was developed, 
stating that the half-life of a protein is related to the identity of its N-terminal residue, 
with proteins commencing with large, bulky residues favored for degradation.  However, 
the N-end rule, a phenomenon that exists in all organisms studied, has different sequence 
specificities in different species (Fig. 1.1).  For example, Leu, Phe, Trp, and Tyr are 
primary destabilizing residues in E. coli.  Arg and Lys are considered secondary 
destabilizing residues because a Leu/Phe aminoacyl-transferase is required to append an 
additional N-terminal Leu to bear a primary destabilizing residue (Varshavsky 1995).  In 
E. coli, most N-degrons can be directly recognized by the protease ClpAP, but is assisted 
in recognition by the adaptor protein ClpS (Erbse et al. 2006).  In contrast, in the yeast 
Saccharomyces cerevisiae, the N-end rule is more complex.  More residues are 
considered primary destabilizing residues, and there are both secondary and tertiary 
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destabilizing residues that require one and two more processing steps, respectively, to 
become functional recognition signals.  Furthermore, unlike E. coli, in S. cerevisiae, the 
N-degron is not directly recognized by the protease.  Instead the N-degron is recognized 
by N-recognin – the general class of E3 ubiquitin ligases that recognize N-degrons, and 
the N-degron-containing substrate is processed along the ubiquitination pathway as 
described above (Varshavsky 1996; Hershko and Ciechanover 1998). 
 In S. cerevisiae, Varshavsky and colleagues discovered that a subunit of cohesin, 
the molecule that holds together sister chromatids during DNA replication, is an N-end 
rule substrate.  Before anaphase, the protease separase cleaves the subunit of cohesin, 
revealing an N-degron on the C-terminal fragment.  This fragment is degraded through 
the ubiquitin-proteasome pathway, and the destruction of the cohesin complex allows the 
separation of sister chromatids to their respective daughter cells during cell division (Rao 
et al. 2001).  In contrast to eukaryotic cells, no physiological N-end-rule substrates have 
been fully characterized in bacteria.  Because of the existence and conservation of N-
degron processing machinery in bacteria, N-degron substrates are likely to exist.  One 
theory for the conservation is that the degradation of N-end rule substrates in bacteria is a 
quality control mechanism.  In E. coli, for instance, the initiator methionine is cleaved 
from the amino-terminus of the newly translated protein only if the second residue is 
small (Hirel et al. 1989).  Thus, the primary and secondary destabilizing residues should 
never be revealed at the N-terminus of a protein after translation.  If one of these 
destabilizing residues is present at the N-terminus, that protein may be a damaged or 
aberrant protein that should be cleared from the cell.  Nevertheless, it is also possible that 
the N-end rule is conserved in bacteria for specific regulatory events involving post-
translational cleavage of a protein and uncovering of an N-degron, as exemplified in 
eukaryotes with cohesion.  Due to the lack of absolute sequence stringency other than the 
character of the N-terminal residue, N-degrons are potentially used in a wide range of 
regulatory and quality-control mechanisms in the cell.  A very recent study suggests that 
Dps and Putrescine-Aminotransferase (PATase) are processed by the N-end-rule pathway 
(Schmidt et al. 2009), and it will be interesting to follow-up on these substrates. 
 I have presented several classifications of degradation tags as well as examples 
illustrating their uses.  Understanding how substrate proteins are recognized for 
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degradation aids in the discovery of new substrates as well as the mechanisms underlying 
the proteolysis. 
 
 
 
Figure 1.1.  The N-end rule pathway. 
(a) The ubiquitin-pathway in Saccharomyces cerevisiae is shown, with tertiary residues 
in green, secondary residues in blue, and primary destabilizing residues in orange (Type 
1) and red (Type 2).  (b) The pathway in Escherichia coli with secondary destabilizing 
residues in blue and primary destabilizing residues in red. 
(Adapted from Varshavsky 1996) 
 
 
Proteolytic machines 
 A study examining proteolysis in yeast showed that energy was required for the 
breakdown of intracellular proteins (Halvorson 1958a; Halvorson 1958b).  The field now 
knows that ATP-dependent proteolytic machines are responsible for this degradation.  
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The archetypical ATP-dependent protease is a barrel-shaped complex with proteolytic 
active sites hidden in the inside chamber.  Substrates are recognized by ring-shaped 
regulatory components capping the ends of the barrel, unfolded through a pulling motion 
generated by ATP hydrolysis-induced conformational changes within the machine, and 
threaded through the pore of the barrel to the active sites where the substrate is degraded.  
The resultant peptides are then released into the milieu in a mechanism not thoroughly 
understood.   
 
Basic architecture 
 The core component of the proteolytic machine is the peptidase barrel.  In 
general, the proteolytic core’s barrel is comprised of stacked rings of identical or similar 
subunits.  The interior chamber contains the enzymatic active sites, and structural 
protrusions at the ends of the pore act as “gates” to the opening of the inner cavity, 
preventing entire proteins from diffusing inside (Bajorek and Glickman 2004; Jennings et 
al. 2008).  Thus, additional regulation is required to select which substrates are eligible 
for degradation. 
The protein-unfolding components that cap the ends of the core proteolytic 
components bear the ability to discriminate between substrates and to open the central 
pore allowing processing of larger polypeptides such as whole proteins.  These subunits 
belong to the AAA+ (ATPases associated with various cellular activities) family of 
proteins.  AAA+ proteins are characterized by ATP-binding motifs that have been 
conserved throughout evolution.  Proteins bearing these motifs have a AAA+ domain, 
and these domains typically multimerize to form hexameric rings.  Most rings of AAA+ 
proteins are able to bind and hydrolyze ATP, and the resultant conformational changes in 
the overall protein can exert mechanical force on other molecules.  Therefore AAA+ 
proteins are involved in a wide array of cellular functions requiring movement or the 
application of force (Fig. 1.2).  For example, AAA+ proteins are involved in cytoskeletal 
mobility, DNA replication, vesicle fusion, and a wide array of ubiquitin-mediated 
functions (Hanson and Whiteheart 2005).  Because AAA+ proteins participate in a 
multitude of functions, understanding the mechanisms behind regulated proteolysis by 
AAA+ proteases aids in the knowledge of this general class of proteins. 
 23
  
 
Figure 1.2.  Roles of AAA+ proteins. 
(a) In bacteria, the AAA+ enzyme ClpA in conjunction with the peptidase ClpP can 
unfold and degrade tagged protein substrates.  (b) The AAA+ unfoldase Hsp104/ClpB, 
with the assistance of co-chaperones Hsp70 and Hsp40, can unfold and resolubilize 
aggregated proteins.  (c) The AAA+ enzyme N-ethylmaleimide-sensitive factor (NSF) 
protein and its adaptor protein α-SNAP can disassemble SNARE proteins, allowing 
vesicle fusion in eukaryotes to proceed. 
(Hanson and Whiteheart 2005) 
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Figure 1.3.  The 26S proteasome in eukaryotes and ClpAP in bacteria. 
(a) Left, combined electromicrogram and crystal structure of the 19S regulatory particle 
and the 20S core particle.  Right, cartoon depiction of the major structural components of 
the proteasome.  (b) Left, combined electromicrogram and crystal structure of ClpAP.  
Right, cartoon depiction of the protease. 
(Zwickl et al. 2000; Schmidt et al. 2005) 
 
 
The proteasome 
The proteasome in archaea and eukaryotes and the various AAA+-proteases in 
bacteria bear much resemblance.  For simplicity, only the 26S eukaryotic proteasome will 
be described and used for comparison.  The 26S proteasome is comprised of a proteolytic 
core called the 20S subunit and a 19S regulatory subunit capping each end of the core.  
The 20S proteasome is composed of four seven-membered rings of alpha and beta 
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subunits (Fig. 1.3a).  In the eukaryotic 20S core particle, only three of the seven beta 
subunits in each ring have proteolytic activity; the alpha subunits lack protease active 
sites.  The proteasome typifies the canonical protease with its proteolytic active sites 
sequestered inside the chamber created by the stacked rings of alpha and beta subunits.  
The 19S regulatory particle is required for the specific degradation of substrate proteins 
by the proteasome and contains two major regions, the lid and the base.  The base is 
formed by six ATPase subunits and two non-ATPase subunits.  The base of the 19S 
particle directly contacts the 20S core and is responsible for the ATP-dependent 
unfolding of substrate proteins to be fed into the 20S particle.  The lid of the 19S particle 
is less well understood, but one component of the lid appears to be necessary for the 
deubiquitination of ubiquitinated substrates (Pickart and Cohen 2004). 
 
Bacterial proteases 
Bacterial AAA+-proteases are simpler than the 26S proteasome.  There are 
several different types of AAA+ proteases in bacteria.  E. coli has five distinct proteases 
with partially overlapping specificities: ClpAP, ClpXP, FtsH, HslUV, and Lon.  Using 
ClpXP, a well-studied bacterial protease, as an example, a similar proteolytic core and 
capping unfoldase architecture is observed.  ClpXP is comprised of the ClpP core 
peptidase flanked by one or two ClpX hexamer rings.  ClpP is a tetradecamer in which 
two identical seven-membered rings bind back-to-back (Gottesman 2003).  In the absence 
of an ATPase, ClpP is able to degrade peptides, preferentially cleaving after hydrophobic 
residues (Katayama-Fujimura et al. 1987; Woo et al. 1989).  As with the 26S proteasome, 
partnering of ClpP with an ATPase such as ClpX allows the regulated degradation of 
protein substrates.  ClpX is a homohexamer, in which each monomer has an N-terminal 
domain and a AAA+ domain.  The AAA+ domain of ClpX forms a hexameric ring as is 
the case with most AAA+ family members, with the ATP-binding site at the interface 
between subunits.   
The other AAA+ proteases in bacteria have a similar construction to ClpXP.  
ClpA is similar to ClpX in that it associates with ClpP, but ClpA has two AAA+ domains 
per monomer instead of one (Fig. 1.3b).  HslUV is another two-component protease in 
which an HslU hexamer is the AAA+ unfoldase and the HslV tetradecamer is the 
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peptidase.  In contrast, Lon and FtsH are both one-component proteases, with the ATPase 
domain and the proteolytic domain encoded in the same polypeptide per monomer.  FtsH 
is bound to the inner membrane and is the only AAA+ protease in E. coli that is essential 
(Gottesman 2003).   
Studying bacterial proteases has shed light on general mechanisms behind AAA+ 
enzymes.  One insight relates to the recognition of degradation tags.  Because the AAA+ 
subunits dictate which proteins are transferred to the proteolytic subunit, there must be 
recognition elements of substrate degradation motifs on the ATPase.  Several electron 
microscopy studies have shown that the regulatory subunits and the proteolytic subunits 
bind such that their central pores are aligned (Beuron et al. 1998; Ortega et al. 2000; 
Ishikawa et al. 2004).  Due to the fact that the proteolytic active sites are sequestered 
inside the enclosed chamber of the proteolytic subunit, the clearest path to the protease 
active sites is through the central pore.  The pore is lined with loops that protrude into the 
axial space (Wang 2001).  Mutation of pore loop residues in the AAA+ subunits of these 
proteolytic machines impair the function of their respective protease, demonstrating the 
importance of these residues in the recognition and processing of substrate proteins 
(Yamada-Inagawa et al. 2003; Siddiqui et al. 2004; Hinnerwisch et al. 2005a; Park et al. 
2005; Okuno et al. 2006; Farrell et al. 2007; Martin et al. 2008b).  Cross-linking 
experiments show direct interactions between substrate tags and pore residues 
(Hinnerwisch et al. 2005a; Martin et al. 2008a).  These pore-loop residues are not only 
important for substrate recognition, but are also likely involved in the ATP hydrolysis-
dependent movements shuttling the substrate unidirectionally towards ClpP (Reid et al. 
2001; Hinnerwisch et al. 2005a; Martin et al. 2008b). 
Even though all ATP-dependent substrates must pass through the pore, some 
substrates require or are aided by interactions with other regions of the protease.  The 
simplest way in which other regions of the protease can participate in substrate 
interactions is by “tethering” the substrate on the N-terminal domains of the ATPase 
subunit in proximity to the pore.  For example, the ClpXP protease recognizes the 
protein-DNA transposition complex of phage Mu.  This transpososome is comprised of a 
tetramer of the phage-encoded protein MuA bound to DNA in a hyper-stable structure 
that must be disassembled for transposition of phage DNA into host DNA to continue 
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(Levchenko et al. 1995).   ClpX acts upon the Mu transpososome by removing one MuA 
monomer, thereby destabilizing the structure to allow subsequent steps of transposition 
(Burton and Baker 2003).  Both ClpX and ClpX∆N are able to bind and process isolated 
MuA monomers.  However, only full-length ClpX is able to unfold a MuA monomer in 
the context of the Mu transpososome.  The current model states that there are 
conformational differences in the MuA protein when it is a monomer versus when it is a 
tetramer on DNA.  This conformational difference could yield new contacts in the 
tetramer that interact with the N-domain of ClpX while tethering and positioning the core 
contacts to the pore for processing (Abdelhakim et al. 2008).  Thus, the N-terminal 
domains of AAA+ proteases can also interact with substrates distinctly from pore 
contacts, adding further control and complexity to regulated proteolysis. 
Conversely, other substrates can be processed by ClpXP with or without the N-
terminal domain of ClpX.  One example is ssrA-tagged substrates, which can be 
degraded by ClpX∆NP (Neher et al. 2003; Wojtyra et al. 2003).  As mentioned earlier, 
the ssrA-tag is directly recognized in the pore of ClpX and therefore lacks any 
requirement for the N-terminal domain.  Thus, the N-terminal domains of the ClpX 
hexamer and other AAA+ proteins can participate in additional regulatory roles but are 
not always essential.   
 
Adaptors 
The cell regulates protein degradation at many different points along the 
proteolytic pathway, such as by the revelation or creation of substrate tags, recognition of 
degradation motifs by the protease, and differential processing of substrates based on 
conformation and stability.  The use of adaptor proteins provides yet another manner in 
which recognition is increasingly controlled and intricate.  In general, adaptors function 
by binding to both the substrate and to the enzyme, increasing the local concentration of 
the substrate to the enzyme.  The N-terminal domains of AAA+ proteases serve as 
docking sites for adaptors, exhibiting another use for these domains.  In the cell, not only 
is there competition between substrates for degradation, but adaptors also compete for 
binding space on the N-terminal domains.  Up-regulating an adaptor can prioritize its 
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partner substrate for degradation over other substrates and substrate-adaptor pairs.  
Hence, adaptor proteins can modulate the selection of substrates degraded by a protease. 
 
SspB, a canonical adaptor 
E. coli SspB is a well-characterized adaptor for the protease ClpXP (Fig. 1.4).  
SspB recognizes the ssrA tag and delivers ssrA-tagged substrates to ClpXP, increasing 
the rate of degradation (Levchenko et al. 2000).  The SspB adaptor protein is a dimer, and 
each monomer is composed of a substrate binding domain, a flexible linker, and a short 
ClpX-binding (XB) motif at the C-terminus (Wah et al. 2002; Dougan et al. 2003; 
Levchenko et al. 2003; Wah et al. 2003).  The XB motif binds to the ClpX N-terminal 
domain, and the flexible linker keeps the substrate domain on a short leash in close 
proximity to the pore of ClpX.  Interestingly, ClpX recognizes the extreme C-terminal 
amino acids of the ssrA tag and SspB recognizes the N-terminal residues, such that the 
adaptor hands off the substrate to the protease rather than competing for binding to the 
same residues (Flynn et al. 2001).  Due to its simple yet elegant method of delivery, SspB 
has become the paradigm of a tethering adaptor protein. 
 
 
Figure 1.4.  Mechanism of SspB. 
The SspB dimer binds to the N-terminal section of the ssrA tag (blue) on the tagged 
substrate and delivers the substrate to the protease ClpXP.  The XB motifs on SspB bind 
to the N-terminal domain of ClpX, tethering the ssrA-tagged substrate in close proximity 
to the enzyme pore.  ClpX recognizes the C-terminal section of the ssrA tag and proceeds 
to degrade the substrate, releasing the SspB to recruit another substrate. 
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Other bacterial adaptors 
Some substrates require an adaptor for degradation.  For example, the stress sigma 
factor in E. coli, sigmaS, is only degraded with the assistance of the adaptor protein 
RssB.  RssB function, in turn, can be controlled by phosphorylation and the presence of 
anti-adaptors, showing how regulation of the adaptor protein itself can be a component in 
the regulation of overall proteolysis (Klauck et al. 2001; Zhou et al. 2001; Bougdour et al. 
2006; Bougdour et al. 2008).  Similarly, the adaptor protein MecA is required for 
virtually all functions of the Bacillus subtillis AAA+ protease ClpCP (Schlothauer et al. 
2003).  It was discovered that the adaptor MecA is required for ClpC oligomerization 
(Kirstein et al. 2006).  B. subtillis ClpC is structurally similar to ClpA in E. coli, but ClpA 
does not require an adaptor to form an oligomer.  Hence, adaptors can play essential roles 
in the degradation of particular substrates rather than simply enhancing the basal 
degradation by the protease. 
 
THE PROTEASE CLPAP AND THE ADAPTOR CLPS 
 The protease ClpAP in E. coli is a AAA+ protease that still holds many mysteries.  
ClpAP has several similarities to ClpXP in E. coli in that both proteases have identical 
ClpP proteolytic units, are composed of hexameric AAA+ domains, and degrade some 
shared substrates.  However, the similarities end there, and not all insights into ClpXP 
structure and function can be translated to ClpAP.  There are numerous outstanding 
questions regarding the physiological significance of ClpAP as well as the detailed 
mechanisms behind substrate recognition and processing.  Furthermore, the field is 
learning that the mechanism of the adaptor protein ClpS for ClpA is dissimilar from the 
paradigm of adaptor function that was largely worked out based on the mechanistic 
studies with the ClpX adaptor SspB.   
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Figure 1.5.  The AAA+ enzyme ClpA. 
(a) Domain layout of ClpA in E. coli.  (b) Crystal structure of a ClpA monomer, with 
unresolved portions depicted as a dotted line (Guo et al. 2002b). (c) Cutaway 
representation of the ClpA hexamer bound to the ClpP tetradecamer.  D1 and D2 pore 
loops are depicted in white. 
 
 
The ATP-dependent unfoldase ClpA 
 ClpAP was discovered in E. coli in 1987 as a protein complex that has ATPase 
and proteolytic capabilities.  The discovery that the purified complex could degrade 
casein led to the name Clp (caseinolytic protease, and later, chaperone-linked protease) 
(Hwang et al. 1987; Katayama-Fujimura et al. 1987).  The milk protein, casein, does not 
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exist in bacteria, but casein is still used today as a model substrate for purified ClpAP.  
Alpha-casein is a protein without a well-defined secondary or tertiary structure (Susi et 
al. 1967), and ClpAP has since been characterized to recognize unfolded proteins. 
 The physiological role of ClpAP is still undefined.  In E. coli, the clpA and clpP 
genes are both non-essential.  clpA knockouts by themselves do not exhibit any reported 
growth phenotype (Katayama et al. 1988).  E. coli with the clpP gene deleted do not have 
a strong growth defect but are slightly less able to survive in starvation conditions 
compared to wild-type cells (Damerau and St John 1993; Weichart et al. 2003).  It is 
important to note, however, that ClpP is also a component of the protease ClpXP in E. 
coli, thus deletion of clpP produces pleiotropic effects due to its roles in other proteolytic 
machines.  Furthermore, the clpA gene is not upregulated by heat shock, unlike other 
some other genes for protein unfoldases (Katayama et al. 1988). 
There are very few known physiological substrates for ClpAP.  One known 
substrate is MazE, part of the MazEF toxin-antitoxin system.  MazF is toxic towards cells 
but is neutralized when partnered with MazE.  The mazEF cassette is constantly being 
expressed, but upon encountering stress, mazEF transcription is diminished.  The labile 
MazE is degraded by ClpAP, leaving MazF to initiate programmed cell death (Aizenman 
et al. 1996; Engelberg-Kulka et al. 2005).  Under stress conditions, it is sometimes 
advantageous to kill some cells of the population in order to preserve others, and the 
degradation of MazE by ClpAP appears to play a role in this rapid regulation. 
ClpAP is able to degrade ssrA proteins, and ssrA-tagged proteins have been 
extensively used as a model substrate (Gottesman et al. 1998).  However, studies have 
shown that although ClpAP independently has the ability to degrade ssrA-tagged 
proteins, ClpAP is not a large contributor to the degradation of these tagged proteins in 
vivo.  In E. coli, ClpXP is the primary protease responsible for degrading ssrA-tagged 
proteins, and only if the clpX gene is disrupted does ClpAP show an effect on decreasing 
ssrA levels in the cell (Farrell et al. 2005; Lies and Maurizi 2008).  The adaptor ClpS 
inhibits the degradation of ssrA-tagged proteins by ClpAP in vitro (discussed below), but 
even disruption of the clpS gene does not greatly affect ClpAP’s ability to assist in ssrA-
tagged protein degradation in vivo when ClpX is present (Farrell et al. 2005; Lies and 
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Maurizi 2008).  It is possible that the cell has created a redundancy for quality control 
mechanisms such as by having multiple proteases clear ssrA-tagged proteins. 
 Another likely physiological role of ClpAP is the active degradation of substrates 
bearing an N-degron.  Earlier studies have shown ClpAP to be the principle protease 
involved in degrading this class of substrates.  However, these studies have utilized 
model N-end rule substrates, and so far, there are no known physiological N-end-rule 
substrates in bacteria.  It is not clear whether the N-end-rule in bacteria is for specific 
regulatory pathways or more of a quality control mechanism, ensuring that the cell 
eliminates proteins that might be damaged or mis-processed, alerted by sensing 
unnaturally with large, bulky residues at N-termini. 
 The gene for clpA exists virtually only in bacteria, unlike clpX and clpP which are 
encoded in human mitochondrial DNA.  ClpA is not even prevalent in all bacteria; some 
bacteria such as Bacillus subtilis have similar Clp proteins such as ClpC.  It is unclear 
whether ClpA and ClpC should be considered orthologs, and it is possible that these two 
proteins have evolved to play different roles in different organisms.   
 ClpAP possesses a similar structure to the proteasome and to the other bacterial 
AAA+ proteases.  ClpA is a nucleotide-dependent hexamer, and each ClpA monomer is 
comprised of an N-terminal domain and two ATPase domains, called D1 and D2 (Fig. 
1.5).  The D2 domain is most similar to the single AAA+ domain of ClpX, and it has 
been suggested that in the hexamer, the D2 domain plays the active role in ATP 
hydrolysis (Singh and Maurizi 1994; Seol et al. 1995).  The same studies purport that the 
D1 domain bound to nucleotide is the main domain responsible for oligomerization.  In 
the absence of ClpA, ClpP can only proteolyze peptides (Katayama-Fujimura et al. 1987; 
Woo et al. 1989).  Like other AAA+ proteases, the addition of the ATPase chaperone is 
required to process entire proteins.  The ssrA-tag attached to a substrate protein has been 
shown to interact with pore residues in the D2 domain of ClpA through cross-linking 
(Hinnerwisch et al. 2005a).  The cross-linking freezes an interaction of the substrate-
enzyme complex, but it does not rule out other transient pore interactions that may occur 
closer to the ClpA pore opening by the D1 domain.  In fact, mutation of pore loop 
residues in the D1 domain also disrupt binding and/or processing of substrates by ClpAP 
(Hinnerwisch et al. 2005a). 
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The ClpA N-terminal domains do not play a role in hexamerization, as ClpA 
lacking its N-terminal domain (ClpA∆N) can hexamerize and process substrates (Lo et al. 
2001; Singh et al. 2001; Hinnerwisch et al. 2005b; Cranz-Mileva et al. 2008; Maglica et 
al. 2008).  Nevertheless, one study suggests that ClpA∆N has lower ATPase activity and 
a weakened affinity to the ClpP tetradecamer (Hinnerwisch et al. 2005b).  The ClpA N-
terminal domain also might contain peptide binding sites that assist in substrate 
recognition and/or processing (Xia et al. 2004; Erbse et al. 2008).  Accordingly, the N-
terminal domains most likely play important but incompletely characterized roles in 
ClpAP mechanism in addition to adaptor-binding. 
 
The Adaptor ClpS 
 To date, only one known adaptor has been found to bind to ClpA, the ClpS 
protein.  ClpS is a small, monomeric protein that binds to the N-terminal domains of 
ClpA.  The clpS gene was discovered as a short open reading frame immediately 
upstream of the clpA gene in the same operon (Dougan et al. 2002).  It is unclear how the 
transcription and translation of both of these genes are regulated.  A recent study showed 
that there are around 250-300 molecules of ClpS per E. coli cell.  ClpA levels, on the 
other hand, varied by growth stage.  In exponential phase, there are approximately 40-50 
ClpA hexamers.  ClpA levels rise in stationary phase to about 150 hexamers per cell 
(Farrell et al. 2005).  The regulatory mechanism controlling the levels of both proteins is 
not understood but altering the relative stoichiometries of these proteins could provide an 
additional layer of regulation in protease activity (see Chapter Two). 
 ClpS has been crystallized in conjunction with the isolated N-terminal domain of 
ClpA (Guo et al. 2002a; Zeth et al. 2002).  The majority of the N-terminal 24 residues of 
E. coli ClpS is not visible in crystal structures and is presumed to be quite flexible.  The 
remainder of the ClpS protein is folded into a single domain, and the interface with the 
ClpA N-terminal domain is through the folded domain of the adaptor (Fig. 1.6a).  The 
core folded domain of ClpS is well conserved throughout bacteria; however, the N-
terminal extension is not conserved in sequence or in length.  The residues in the core 
domain of ClpS responsible for binding to the ClpA N-terminal domain are relatively 
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invariant (Zeth et al. 2002), implying that the ClpS-ClpA interaction is also well 
conserved. 
 ClpS is able to inhibit ClpA’s ability to degrade several types of substrates.  ClpA 
in the presence of ClpP has the ability to degrade itself, and ClpS inhibits this 
autodegradation (Dougan et al. 2002).  It was previously suggested that there was a ClpA 
degradation tag in the N-terminus of ClpA itself and that ClpS simply masked this signal 
(Gottesman et al. 1990; Dougan et al. 2002), but recent evidence advocates that the 
degradation tag is at the C-terminus of ClpA and that ClpS binding results in a substrate 
specificity switch (Maglica et al. 2008).  It is unclear whether ClpA autodegradation is a 
phenomenon that is relevant in vivo, but it is possible that ClpS can affect the levels of 
ClpA in the cell.  Furthermore, ClpS also blocks the degradation of ssrA-tagged proteins 
(Dougan et al. 2002).  As mentioned above, ClpAP is not a major contributor of ssrA-
tagged protein degradation in the cell, but ClpS is unlikely to be the only reason for the 
lack of ClpA participation (Farrell et al. 2005; Lies and Maurizi 2008).  Lastly, ClpS 
appears to inhibit ClpAP’s ability to degrade unfolded proteins, such as the model in vitro 
substrate casein (Guo et al. 2002a).  Perhaps unfolded proteins, ssrA-tagged proteins, and 
ClpA itself are recognized for degradation by ClpAP in a similar manner and are 
consequently inhibited by ClpS binding by a unified mechanism.   
 ClpS also plays a positive role in stimulating the delivery of N-end-rule substrates 
to ClpAP for degradation.  Conserved residues on the folded domain of ClpS recognize 
the N-degron, and adaptor binding to ClpAP recruits bound substrates to the protease 
(Erbse et al. 2006; Wang et al. 2008b).  A bioinformatics study established that ClpS is 
homologous to a domain of the E3 ubiquitin ligase N-recognin (Lupas and Koretke 
2003), and together with the knowledge that ClpAP is the protease responsible for N-end-
rule degradation, it was logical that ClpS played an important role in this process.   
ClpAP alone has the ability to recognize and degrade N-degrons slowly, but the 
addition of ClpS greatly increases the rate of this degradation (Wang et al. 2007).  There 
are several features that generate a good N-end-rule substrate.  The first feature is having 
an N-terminal destabilizing residue combined with a free α-amino group at the N-
terminus (Wang et al. 2008a).  A recent crystal structure indicates that the ClpS binding 
pocket for N-degrons makes molecular contacts with the N-terminal α-amino group as 
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well as the side chain of the first residue (Fig. 1.6b) (Wang et al. 2008b).  The second 
feature of a good N-degron is the lack of negatively-charged side chains near the amino 
terminus.  Moving a negatively charged residue closer to the N-terminal position 
decreases the observed rate of substrate degradation (Wang et al. 2008b).  Thirdly, to be 
degraded efficiently, the N-degron must not be too close to the folded region of the 
substrate protein (Erbse et al. 2006; Wang et al. 2008a).  For example, the four-residue 
N-degron YAAA (YA3) appended onto the N-terminus of GFP can be recognized by 
ClpS but cannot be degraded by ClpAP.  Similarly, the stability of the substrate at its N-
terminus and its propensity to being unfolded by ClpAP determines whether or not it is a 
good N-end-rule substrate (Wang et al. 2008a). 
 
 
Figure 1.6.  Structures of ClpS. 
(a) Structure of E. coli ClpS.  The unstructured region depicted is the N-terminal 
extension commencing at residue 16.  Residues prior to position 16 are completely 
disordered in this structure (PDB 1LZW).  (b) Structure of C. crescentus ClpS bound 
with an N-degron-containing peptide.  A truncated form of ClpS from residues 31-119 
was used for crystallization, and only residues 35-119 are visible in the resolved 
structure.  Only the first two residues of the N-end-rule peptide (red) are visible (PDB 
3DNJ).   
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Though both ClpAP and ClpS can directly recognize the N-degron, the 
requirements for binding and processing are not identical.  As mentioned above, YA3-
GFP can be bound to ClpS but cannot be recognized by ClpAP.  ClpAP seems to require 
a slightly longer linker length between the N-degron and the folded substrate (Erbse et al. 
2006; Wang et al. 2008a).  Additionally, ClpAP can recognize the N-terminal motif 
ILFVQEL fused to GFP, which is not a bacterial N-degron per se.  ClpS does not bind a 
peptide containing the ILFVQEL motif (Wang et al. 2008a; Wang et al. 2008b).   
Because both ClpS and ClpAP must recognize ClpS-mediated N-end-rule substrates, the 
differential substrate requirements are intriguing.   
 
THESIS OVERVIEW 
My work aims to further characterize the roles and mechanism of the adaptor 
protein ClpS.  Chapter Two describes an initial characterization of ClpS as an adaptor 
protein, showing that ClpS breaks the mold of how the field previously thought adaptor 
proteins operated.  Chapter Three details further dissection of the ClpS protein, focusing 
on the N-terminal extension of the adaptor and how it affects the ability to delivery N-
end-rule substrates.  This work aims to find the minimal required features for a functional 
adaptor.  Chapter Four describes a proteome-wide approach for gaining insight into the in 
vivo role of ClpS and how it alters ClpAP substrate selectivity.   
Determining how ClpS molecularly shifts ClpAP substrate selection allows a 
deeper understanding of the strategies used by the cell in shaping the proteome.  
Furthermore, understanding how ClpS interacts with ClpA and how it affects the 
mechanics of substrate processing leads to a broadened appreciation of how adaptor 
proteins in general influence their AAA+ enzyme.  Thus, ClpS and ClpAP expand our 
knowledge of how AAA+ proteins are regulated has implications beyond bacteria and 
proteolysis. 
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CHAPTER TWO 
 
Distinct structural elements of the adaptor ClpS are required for 
regulating degradation by ClpAP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter was previously published as Hou J.Y., Sauer R.T., Baker T.A. Distinct 
structural elements of the adaptor ClpS are required for regulating degradation by ClpAP. 
Nature Structural & Molecular Biology 15, 288 - 294 (2008).   
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ABSTRACT 
Adaptor proteins modify substrate recognition by AAA+ ATPases.  We examined 
how the adaptor ClpS regulates substrate choice by the Escherichia coli protease ClpAP.  
Binding of six ClpS molecules to a ClpA hexamer enhanced N-end-rule substrate 
degradation and inhibited ssrA-tagged protein proteolysis.  Substoichiometric ClpS 
binding allowed intermediate degradation of both substrate types, revealing that adaptor 
stoichiometry influences substrate choice.  ClpS controls substrate selection using distinct 
mechanisms.  The N-terminal segment is essential for delivering N-end-rule substrates 
but dispensable for ssrA-protein inhibition.  We tested existing models for ClpS action 
and found that ClpS does not block recognition of ssrA-tagged substrates by steric 
occlusion and that adaptor-mediated tethering of N-end-rule substrates to ClpAP was 
insufficient to explain facilitated delivery.  We propose that ClpS functions, at least in 
part, as an allosteric effector of ClpAP, broadening our understanding of how AAA+ 
adaptors control substrate selection. 
 
INTRODUCTION 
AAA+ enzymes (ATPases associated with cellular activities) have evolved to 
catalyze a broad range of cellular functions, including protein degradation, cytoskeletally 
based motility, and DNA replication, in organisms ranging from bacteria to mammals 
(Neuwald et al. 1999; Vale 2000; Hanson and Whiteheart 2005).  Many AAA+ proteins 
remodel macromolecular substrates.  In these processes, substrate binding and enzyme 
conformational changes driven by cycles of ATP binding, hydrolysis and nucleotide 
release result in application of mechanical force that disrupts native protein structures or 
dismantles complexes.  Substrate recognition by AAA+ enzymes is highly regulated, 
often by the actions of specific adaptor proteins, which have been classically regarded as 
molecular matchmakers (Mogk et al. 2004; Baker and Sauer 2006).  Elucidating adaptor 
mechanism is therefore essential for a full understanding of substrate selection by AAA+ 
proteins. 
AAA+ proteases ensure protein quality control and are key in many regulatory 
circuits (Baker and Sauer 2006).  ClpAP, one of five AAA+ proteases in E. coli, consists 
of the ClpA ATPase and the ClpP peptidase (Katayama et al. 1988).  Hexamers of ClpA 
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recognize substrates, unfold these proteins, and then translocate the denatured 
polypeptide through a central pore and into an interior chamber of the ClpP tetradecamer 
for degradation (Woo et al. 1989; Beuron et al. 1998; Weber-Ban et al. 1999).  As 
observed for many bacterial AAA+ proteases, the ClpA component of ClpAP typically 
recognizes short peptide tags located at the N or C terminus of substrates (Baker and 
Sauer 2006).  For example, when ribosomal protein synthesis stalls, the tmRNA system, 
which has tRNA- and mRNA-like functions, mediates cotranslational addition of an 11-
residue C-terminal tag (ssrA) onto the nascent polypeptide, which marks the tagged 
protein for degradation by several proteases, including ClpAP (Keiler et al. 1996; 
Gottesman et al. 1998). 
 
 
Figure 2.1.  Dual roles of ClpS in changing ClpAP substrate preference. 
Schematic illustrating the effect of ClpS on the degradation of ssrA-tagged substrates and 
N-end-rule substrates by ClpAP. 
 
ClpS is a monomeric adaptor protein that binds to the N-terminal domain of ClpA 
and regulates ClpAP substrate selection (Dougan et al. 2002; Guo et al. 2002a; Zeth et al. 
2002) (Fig. 2.1).  ClpS inhibits ClpAP degradation of ssrA-tagged substrates and 
enhances degradation of N-end-rule proteins (Dougan et al. 2002; Erbse et al. 2006; 
Wang et al. 2007).  The N-end rule correlates susceptibility to proteolysis with a protein’s 
N-terminal residue, leucine, tryptophan, tyrosine and phenylalanine being highly 
 40
destabilizing at this position (Tobias et al. 1991).  ClpS binds directly to N-end-rule 
substrates and to ClpAP (Erbse et al. 2006), suggesting that simple adaptor-mediated 
tethering of these substrates to ClpAP might account for their enhanced degradation.  
Although the structure of ClpS bound to the N-terminal domain of ClpA is known, the 
mechanisms that allow this adaptor to function both as an enhancer and inhibitor of 
ClpAP substrate degradation are poorly understood (Guo et al. 2002a; Zeth et al. 2002).  
The contrasting positive and negative regulatory activities of ClpS intrigued us. Here, we 
examined how ClpS, by binding to ClpA, inhibits degradation of ssrA-tagged proteins 
and enhances proteolysis of N-end-rule substrates.  We found that substoichiometric 
binding of ClpS to ClpAP permitted degradation of both substrates.  The N-terminal 
segment of ClpS, which is disordered in several crystal structures (Guo et al. 2002a; Zeth 
et al. 2002; Xia et al. 2004), was dispensable for inhibition of ssrA-tagged substrate 
degradation and for directly binding N-end-rule substrates.  Unexpectedly, however, N-
end-rule protein delivery and ClpS’s ability to suppress rates of ClpAP ATP hydrolysis 
required the N-terminal polypeptide segment, but not a specific sequence, of ClpS.  We 
propose that binding of ClpS to the protease results in conformational rearrangements 
that allow handoff of N-end-rule substrates to ClpA and prevent binding to ssrA-tagged 
proteins.  Thus, these studies expand the repertoire of molecular mechanisms used by 
AAA+ adaptor proteins to regulate substrate selectivity. 
 
RESULTS 
ClpS binding to ClpA 
One ClpS monomer can bind to each subunit in the ClpA hexamer, allowing a 
maximum stoichiometry of 6:1 (Dougan et al. 2002; Guo et al. 2002a; Zeth et al. 2002).  
To establish working conditions for subsequent experiments, we explored ClpS binding 
to hexameric ClpA by immunoprecipitating ClpS–ClpA6 complexes and quantifying 
bound ClpS (Fig. 2.2a).  Half-maximal binding was observed at a ClpS concentration of 
~0.4 µM, a value similar to the dissociation constant of 0.33 µM reported for a ClpS 
complex with the isolated N-terminal domain of ClpA (Zeth et al. 2002).  The resulting 
binding curve revealed an absence of strong cooperativity in the ClpS–ClpA6 interaction 
(Fig. 2.2b; fit shown uses a Hill coefficient n = 1.5).  For comparison, we generated 
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Figure 2.2.  Stoichiometry of ClpS.  
(a) Western blot of ClpS bound to ClpA6 at increasing concentrations of ClpS.  (b) Fitted 
binding curve of ClpS to ClpA6 from four separate experiments.  The red line shows the 
calculated curve for no cooperativity, and the blue curve is that expected for complete 
positive cooperativity.  Inset, standard curve for the binding assay; all data points fall 
within the linear range.  (c) Residuals showing fit of the data to the various cooperativity 
models.  Black circles, best fit model with cooperativity, n = 1.5; red diamonds, model 
with no cooperativity, n = 1; blue squares, model with full cooperativity, n = 6.  (d) 
Degradation of GFP-ssrA (5 µM) by ClpAP (1 µM) measured with increasing 
concentrations of ClpS.  (e) Curve showing ClpS stoichiometric effect on GFP-ssrA 
degradation rates from a with degradation rate in the absence of ClpS set to 1.  (f) Curve 
showing ClpS stoichiometric effect on YLFVQ-titinI27 (5 µM) degradation rates by 
ClpAP (1 µM).  Degradation rates were calculated from the increase in trichloroacetic 
acid–soluble counts in first 110 s of substrate degradation.  All error bars indicate ± 1 s.d. 
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curves of full positive cooperativity (n = 6) and no cooperativity (n = 1).  Our data are 
clearly distinguishable from the binding results expected by a fully cooperative ClpS-
ClpA6 interaction (Fig. 2.2b,c).  In contrast, the curve for noncooperative binding fit our 
observed data reasonably well. These results therefore support the idea that ClpS binds to 
ClpA with little cooperativity, and, as a consequence, many ClpSn–ClpA6 species will be 
populated at subsaturating levels of ClpS.  These data guided our subsequent experiments 
to study the functional impact of ClpS stoichiometry, which were conducted well above 
the KD for the ClpS-ClpA6 interaction. 
 
Effects of subsaturating ClpS on substrate selectivity 
ClpS:ClpA6 ratios are known to change under different growth conditions in E. 
coli (Farrell et al. 2005).  The stoichiometry of ClpS to ClpA6 could thus provide one 
level of control on substrate selectivity.  To test this model, we monitored ClpAP 
degradation of an ssrA-tagged protein and an N-end-rule protein, substrates whose 
degradation ClpS inhibits and enhances, respectively.  Degradation reactions were 
performed at different ClpS:ClpA6 ratios, using ClpA concentrations high enough to 
ensure that virtually all added ClpS was bound to ClpA.  Substantial degradation of green 
fluorescent protein (GFP) C-terminally tagged with ssrA occurred with one to three 
equivalents of ClpS, whereas degradation was strongly inhibited when an average of four 
to six ClpS molecules was bound to ClpA6 (Fig. 2.2d,e).  These data further support the 
conclusion that the ClpS-ClpA6 interaction is not highly cooperative.  If ClpS-ClpA6 
binding were completely cooperative, addition of 3 µM ClpS would yield precisely 50% 
GFP-ssrA inhibition because half of the ClpA hexamers would be fully liganded and the 
other half unliganded.  In contrast, we observed ~30% inhibition with this amount of 
ClpS.  Moreover, these functional assays were conducted in the presence of ClpP, 
indicating that ClpP association does not make binding of ClpS to ClpA6 strongly 
cooperative.  Thus, partial ClpS occupancy of the six sites in a ClpA hexamer permits 
ClpAP degradation of ssrA-tagged substrates.  When ClpA6 is more highly liganded, 
inhibition becomes stronger and then complete. 
Next, we examined how different amounts of ClpS affected ClpAP degradation of 
a model N-end-rule substrate, the I27 domain of human titin with an appended N-end-
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rule signal (YLFVQ-titinI27).  To allow observation of stimulatory effects of ClpS, we 
used a concentration of the YLFVQ-titinI27 substrate about six-fold below the Michaelis 
constant (KM) determined in the absence of ClpS (Wang et al. 2007).  Addition of ClpS 
enhanced ClpAP degradation of YLFVQ-titinI27, with maximal stimulation occurring 
when four or more ClpS molecules bound ClpA6 (Fig. 2.2f).  However, we also observed 
substantial increases in degradation with fewer than three equivalents of ClpS.  Although 
decreased degradation of ssrA-tagged substrates and enhanced degradation of N-end-rule 
substrates occurred over similar ClpS:ClpA6 ratios, the curves were not strictly 
reciprocal, raising the possibility that different mechanisms could be responsible for the 
inhibitory and activating activities of ClpS. 
 
Small changes in ClpS levels alter proteolytic preference 
Our results suggested that ClpS acts as a variable rheostat rather than a binary 
switch for ClpA, with substoichiometric levels of bound ClpS yielding intermediate 
activities.  Based on the data in Figure 2.2, we sought to determine whether ClpAP 
partially filled with ClpS molecules could degrade a mixture of GFP-ssrA and YLFVQ-
titinI27 at substantial rates or whether one of these substrates would be preferentially 
degraded.  In the absence of ClpS, ClpAP degraded GFP-ssrA faster than YLFVQ-titinI27 
(Fig. 2.3a).  These differences in rate were due to the identity of the tags rather than the 
use of different attached substrate proteins (Flynn et al. 2001; Wang et al. 2007) (see Fig. 
2.3 legend).  When two ClpS equivalents were added, this substrate preference was 
reversed, although both substrates were still efficiently degraded.  Moreover, adding two 
ClpS equivalents had a stronger effect on the ClpAP degradation rate of YLFVQ-titinI27 
than of GFP-ssrA (Fig. 2.3b).  These results demonstrate that addition of a few 
equivalents of ClpS is sufficient to switch the proteolytic preference of ClpAP to favor N-
end-rule substrates without excluding recognition of ssrA-tagged substrates.  Substrate 
preferences can therefore be fine-tuned by modest changes in adaptor-enzyme 
stoichiometry. 
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Figure 2.3.  Co-degradation of GFP-ssrA and YLFVQ-titinI27.   
Comparison of GFP-ssrA and YLFVQ-titinI27 degradation rates with substrates combined 
in the same reaction.  (a) Degradation of GFP-ssrA (5 µM) and YLFVQ-titinI27 (5 µM), 
each in the presence of the other substrate, with 1 µM ClpAP and 0 µM or 2 µM ClpS.  
(b) The addition of two equivalents of ClpS alters the degradation rate of each substrate 
as well as modifies ClpAP’s substrate preference.  Degradation rates are from a. Reported 
Vmax and KM values for YLFVQ-titinI27 in the absence of ClpS are 11 molecules degraded 
per minute per ClpA6 and 29 µM, respectively (Wang et al. 2007).  Reported Vmax and KM 
values for GFP-ssrA in the absence of ClpS are 4.9 molecules per minute per ClpA6 and 
1.5 µM, respectively (Flynn et al. 2001). 
 
The N terminus of ClpS is not a steric inhibitor 
Because it seemed unlikely that a common set of interactions was responsible for 
both the inhibitory and stimulatory effects of ClpS, we sought to identify the distinct 
structural elements of ClpS that might be important for its dual regulatory roles.  ClpS 
contains a folded core domain, which binds the N-terminal domain of ClpA and is highly 
conserved phylogenetically.  This domain is preceded by an N-terminal extension, which 
is highly variable in both length and sequence among ClpS orthologs (Dougan et al. 
2002; Guo et al. 2002a; Zeth et al. 2002; Xia et al. 2004) (Fig. 2.4a, Fig. 2.5a).  Despite 
the lack of conservation, E. coli ClpS with the 17 N-terminal residues removed by 
proteolysis does not inhibit degradation of GFP-ssrA, suggesting that at least some of the 
missing residues are functionally important (Guo et al. 2002a; Xia et al. 2004).  
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Previous experiments indicate that ClpA binding to full-length ClpS and to the 
ssrA tag is competitive (Dougan et al. 2002).  These results, together with the observed 
effect of removing the first 17 residues, led us to propose a model in which the N-
terminal peptide of ClpS and the ssrA-tag compete directly for a common binding site in 
ClpA (Guo et al. 2002a; Xia et al. 2004) (Fig. 2.4b).  To test the importance of the N-
terminal sequence of ClpS, we constructed variants in which sequential blocks of four 
residues were mutated to alanine, as well as a protein with residues 2-17 mutated en 
masse to an arbitrary assortment of small and positively charged residues (Fig. 2.4c).  
The methionine at position 1 is removed in vivo in wild-type ClpS and the full-length 
variants (data not shown).  All of the full-length ClpS proteins inhibited ClpAP 
degradation of GFP-ssrA degradation with activities indistinguishable from wild-type 
ClpS (Fig. 2.4d).  We conclude that the identity of the N-terminal amino acid sequence of 
E. coli ClpS is not important for its function in inhibiting ClpAP’s ability to degrade 
GFP-ssrA.  
To further address whether the N-terminal region of ClpS was important for 
inhibition, we constructed and purified a truncated ClpS variant starting at residue 18 
(ClpSM18-106).  Mass spectrometry showed that most of this truncated protein retained the 
initiator methionine, making it one residue longer than ClpS with the first seventeen 
residues removed proteolytically.  Unexpectedly, ClpSM18-106 inhibited ClpAP 
degradation of GFP-ssrA to an extent similar to that of wild-type ClpS (Fig. 2.4e).  By 
contrast, when we prepared N-terminally truncated ClpS by protease cleavage in vitro, it 
had the reported behavior and did not inhibit ClpAP degradation of GFP-ssrA (Guo et al. 
2002a) (data not shown).  We conclude that contacts between ClpA and determinants in 
or near residue 17 of ClpS are required to inhibit degradation of GFP-ssrA, whereas the 
N-terminal 16 residues of ClpS are not needed for this activity.  
Overexpression of ClpSM18-106 protein probably overwhelmed the cellular 
processing machinery, resulting in poor cleavage of the N-terminal Met-Val peptide bond 
by methionine aminopeptidase.  To avoid this problem, we constructed ClpS18-106 V18A, 
because Met-Ala is processed more efficiently than Met-Val (Hirel et al. 1989).  Mass 
spectrometry and Edman degradation showed that the N-terminal methionine of this 
protein was removed (data not shown).  ClpS18-106 V18A, like the proteolytically 
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generated ClpS18-106, did not inhibit ClpAP degradation of GFP-ssrA substantially (Fig. 
2.4e), but it did bind ClpA, as observed by size-exclusion chromatography (data not 
shown).  Further truncations beginning C-terminal to the seventeenth residue of ClpS did 
not inhibit degradation of GFP-ssrA, but a variant one residue larger than ClpSM18-106 
(ClpSM17-106) showed roughly 80% of the inhibitory activity of wild type (Fig. 2.5b).  
These results reinforce the importance of a residue at position 17 of ClpS for efficient 
inhibition of ClpAP degradation of an ssrA-tagged protein.  However, based on 
observations with ClpSM18-106, we can rule out the model (Fig. 2.4b) in which the first 
sixteen residues sterically block the binding site for the ssrA-tag in ClpA, suggesting that 
another mechanism must be responsible for inhibition. 
 
Figure 2.4.  ClpS N-terminal extension is not a steric inhibitor of GFP-ssrA.   
(a) Structure of ClpS (blue) and ClpA N-domain (gold), PDB accession code 1LZW 
(Zeth et al. 2002). Residues on ClpS proposed to bind N-end-rule motifs (Erbse et al. 
2006) are depicted as red sticks (on left), and the lysine at the seventeenth position is 
shown with green sticks (on right).  The first fifteen residues are not modeled into this 
structure.  (b) Model for ClpS (S, blue) inhibition of ssrA-tagged protein degradation by 
ClpAP in which the ClpS N-terminal extensions directly occlude ssrA binding sites on 
ClpA.  (c) ClpS variants constructed in this study.  ClpS 2-5A, ClpS 6–9A F10W, ClpS 
10–13A and ClpS 14–17A are full-length variants of ClpS in which the ranges of residues 
indicated are mutated to alanines.  (d) Comparison of the inhibition of GFP-ssrA (1 mM) 
degradation by 1 mM full-length ClpS variants (filled circle, no ClpS; open circle, ClpS; 
filled triangle, ClpS 2–5A; open triangle, ClpS 6–9 F10W; +, ClpS 10–13A; ×, ClpS 14–
17A; dotted circle, GSGK-ClpS) and by (e) ClpS N-terminal extension truncations (filled 
diamond, ClpSM18–106; open diamond, ClpS18–106 V18A) with ClpAP (0.1 µM ClpA6, 0.27 
µM ClpP14). 
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Figure 2.5.  Activity of ClpS deletion mutants. 
(a) Alignment of ClpS from various bacterial species. Residues similar in nature are 
colored.  (b) Degradation of GFP-ssrA (1 µM) by ClpA6 (0.1 µM) and ClpP14 (0.27 µM) 
with variable length ClpS deletion proteins (1 µM). (c) Concentration-dependent 
degradation of YLFVQ-titinI27 (5 µM) by ClpA6 (1 µM) and ClpP14 (1 µM) with ClpS 
deletion proteins.  The wild-type ClpS curve from Figure 2f is shown in gray for 
comparison. 
 
 
The ClpS extension is necessary for N-end-rule delivery 
We next tested whether ClpS variants with mutations in or truncations of the N-
terminal extension could enhance ClpAP degradation of an N-end-rule substrate.  Figure 
2.6a depicts a model in which enhanced N-end-rule degradation results solely from ClpS-
mediated tethering of the substrate to ClpA.  The purported N-degron binding site of 
ClpS lies within the core domain, and the simple tethering model predicts that ClpS 
variants that bind both to N-end-rule substrates and to ClpA should enhance degradation 
(Erbse et al. 2006).  However, the ClpSM18-106 and ClpS18-106 V18A mutants inhibited 
ClpAP degradation of YLFVQ-titinI27 instead of stimulating turnover (Fig. 2.6b).  Both 
mutants bound YLFVQ-GFP (which is degraded by ClpAP; K. Wang, Massachusetts 
 48
Institute of Technology, personal communication) in gel filtration experiments (Fig. 2.6c) 
but did not bind a GFP variant lacking the N-degron (data not shown).  Moreover, both 
ClpSM18-106 and ClpS18-106 V18A bound ClpA (data not shown).  Hence, the ClpS18-106 
variants maintained the ability to bind an N-end-rule degradation tag and the ClpA 
enzyme but could not deliver tagged substrates to ClpAP for degradation.  Other ClpS 
truncations (ClpSM17-106 (∆16), ClpSM19-106 (∆18), and ClpSM20-106 (∆19)) also failed to 
deliver YLFVQ-titinI27.  Thus, residues N-terminal to the sixteenth position of ClpS are 
important for N-end-rule substrate delivery (Fig. 2.5c). 
The full-length mutant GSGK-ClpS and even ClpS 14-17A bearing an alanine at 
the seventeenth residue had activity similar to wild-type ClpS for N-end-rule substrate 
delivery (Fig. 2.6b and data not shown).  Taken together, these results show that the 
sequence of the ClpS N-terminal extension is not important for N-end-rule protein 
degradation, but the presence of this polypeptide segment is essential.  We conclude that 
simple tethering of N-end-rule substrates to ClpA by ClpS is insufficient to explain ClpS-
stimulated degradation.  Rather, the N terminus of ClpS must play an active role in 
triggering the delivery and degradation of N-end-rule substrates. 
To gain further insight into the role of the N-terminal extension of ClpS in 
substrate delivery, we asked whether wild-type ClpS could stimulate degradation N-end-
rule proteins when some sites on ClpAP were occupied by an inhibitory version of ClpS 
lacking the N-terminal extension (ClpSM18-106).  Notably, the presence of an N-terminal 
extension was able to overcome the suppressive effects of ClpSM18–106 alone (Fig. 2.7).  
These data demonstrate that the N-terminal extension of ClpS is a distinct and critical 
module of the adaptor as well as reinforce the conclusion that substoichiometric levels of 
the wild-type adaptor are able to influence the substrate preference of the entire ClpA 
hexamer. 
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Figure 2.6.  ClpS N-terminal extension is required for active delivery of YLFVQ-titinI27 
and for effect on ClpAP ATPase rate.   
(a) Model in which simple tethering of N-end-rule proteins by the folded domain of ClpS 
to ClpA is sufficient to enhance degradation.  The white triangles on ClpS (S, blue) 
represent the key adaptor residues suggested to bind and tether N-end-rule substrates.  (b) 
Concentration-dependent degradation of YLFVQ-titinI27 (5 µM) by ClpAP (1 µM) in the 
presence of ClpSM18-106, ClpS18-106 V18A and GSGK-ClpS.  Shown for comparison in 
gray squares connected by the dotted line is the data for wild-type ClpS from Figure 2.2b.  
(c) Size-exclusion chromatography results showing binding of truncated ClpS variants to 
YLFVQ-GFP.  (d) Comparison of concentration-dependent effects of ClpS and variants 
on ClpA (1 µM) ATPase rate in the presence of ClpP (1 µM). 
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Figure 2.7.  The N-terminal extension of ClpS is a separable and critical module for N-
end-rule delivery. 
Degradation of YLFVQ-titinI27 (5 µM) with wild-type or truncated ClpS alone or in 
mixtures. 
 
The N terminus of ClpS alters ATP hydrolysis by ClpA 
ClpP binding increases the rate of ATP hydrolysis by ClpA two-fold 
(Hinnerwisch et al. 2005b), an effect that is likely to reflect an alteration of ClpA’s 
conformation accompanying ClpP interaction.  We asked whether ClpS binding and/or 
the presence of the N-terminal extension might also change the ATPase activity of ClpAP 
in a fashion consistent with the promotion or stabilization of a conformational change in 
the protease.  Indeed, ClpS binding depressed the ATPase rate of ClpAP ~40% (Fig. 
2.6d), as did the full-length variants depicted in Figure 2.4c (data not shown).  In contrast, 
adding ClpSM18–106 caused little change in ATPase rate, whereas adding ClpS18-106 V18A 
increased the rate of ATP hydrolysis (Fig. 2.6d).  Both truncated ClpS preparations were 
free of contaminating ATPase activity (data not shown).  We considered the possibility 
that wild-type ClpS could be lowering ClpAP ATPase rates by weakening the ClpA-ClpP 
interaction in a manner similar to the weakening of the interaction between ClpP and 
ClpA observed when ClpA lacks its N-terminal domain (Hinnerwisch et al. 2005b).  
However, control binding experiments indicated that the ClpA-ClpP interaction was not 
appreciably altered by ClpS association (data not shown), and it seems unlikely that ClpP 
would dissociate from the ClpS–ClpA6 complex during degradation, especially for 
degradation of N-end-rule substrates.  We conclude that binding of the core ClpS domain 
to ClpAP enhances ATPase activity slightly, whereas interactions mediated by the N-
terminal 16 residues of ClpS result in a substantial depression of ATPase activity.  
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Because the rate of ATP hydrolysis by ClpAP must ultimately depend on enzyme 
conformation and the kinetic barriers between conformations, our results indicate that the 
N-terminal residues of ClpS cause a structural shift in the ClpA hexamer.  This altered 
conformation of ClpA could, in turn, be an important mechanistic component of ClpS-
mediated substrate selection. 
 
DISCUSSION 
The ClpS adaptor controls ClpAP using multiple strategies.  Previous studies 
established that saturating ClpS levels prevent ClpAP degradation of ssrA-tagged 
proteins and stimulate degradation of N-end-rule substrates (Dougan et al. 2002; Guo et 
al. 2002a; Erbse et al. 2006; Wang et al. 2007).  We found that subsaturating ClpS 
concentrations allowed ClpAP to degrade both types of substrates.  With 2 µM ClpS and 
1 µM ClpA6 (2:1 ratio), for example, ClpAP degraded ssrA-tagged and N-end-rule 
substrates at 40–60% of maximal rates in vitro. In contrast, with 5 µM ClpS and 1 µM 
ClpA6 (5:1 ratio), degradation of ssrA-tagged substrates was minimal, and N-end-rule 
degradation reached maximal efficiency.  In E. coli, the ClpS:ClpA6 ratio is ~6:1 during 
exponential growth but changes to ~2:1 as cells enter stationary phase. During this 
transition, ClpAP degradation of GFP-ssrA increases substantially (Farrell et al. 2005).  
Thus, changes in the ClpS:ClpA6 ratio fine-tune the substrate preferences of ClpAP, 
presumably promoting degradation of N-end-rule and perhaps other classes of substrates 
during logarithmic growth but expanding the effective substrate repertoire during 
stationary phase. 
The mechanisms that allow ClpS to enhance N-end-rule substrate degradation but 
inhibit ssrA-tagged protein degradation are clearly different.  We found that much of the 
unstructured N-terminal extension of ClpS was required for stimulation of N-end-rule 
degradation but was dispensable for inhibition of ClpAP degradation of ssrA-tagged 
substrates.  Specifically, a ClpS variant missing the N-terminal 16 residues and having a 
Lys17 to Met substitution (ClpSM18-106) inhibited ClpAP degradation of GFP-ssrA but did 
not stimulate degradation of the model N-end-rule substrate YLFVQ-titinI27.  Notably, 
both ClpSM18-106 and ClpS18-106 V18A still bound N-end-rule substrates.  Two main 
conclusions emerge from these observations. First, a model in which the 16 N-terminal 
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residues of ClpS physically occlude binding of the ssrA tag to ClpA (Fig. 2.4b) is ruled 
out, as ClpSM18-106 inhibited GFP-ssrA degradation efficiently.  The ssrA tag binds in the 
central channel of the ClpA hexamer (Hinnerwisch et al. 2005a; Piszczek et al. 2005), 
and steric blockage by the remaining unstructured residues of ClpSM18-106 seems unlikely.  
Second, simple tethering of N-end-rule substrates to ClpAP by the ClpS adaptor (Fig. 
2.6a) cannot explain the enhanced degradation of this class of substrates.  ClpA and ClpS 
both bind N-end-rule substrates independently and therefore must both contain N-degron 
binding sites (Erbse et al. 2006; Wang et al. 2007).  Because both ClpS18-106 variants 
inhibit rather than enhance degradation of YLFVQ-titinI27, a mechanism that involves 
more than simple tethering must be required.  Thus, preexisting models of adaptor 
function do not explain how ClpS functions either as a positive or negative regulator of 
protein degradation. 
With the simplest mechanistic models ruled out, we turned our attention toward 
the observation that ClpS binding altered ClpAP ATPase rates.  ClpS variants that lacked 
most of the N-terminal extension were both unable to deliver N-end-rule proteins for 
degradation and unable to suppress ClpAP ATPase rates, suggesting that the two effects 
are related.  Similarly, the difference between the abilities of ClpSM18-106 and ClpS18-106 
V18A to stimulate ClpAP ATPase rates may reflect their differing abilities to inhibit 
GFP-ssrA degradation. These data suggest that an allosteric mechanism contributes to 
ClpS’s ability to control substrate choice (Fig. 2.8).  Although ClpS binding to ClpA6 is 
almost completely independent, there is likely to be communication between ClpA 
subunits, resulting in substrate binding and processing that is nonlinear in response to 
ClpS stoichiometry.  Binding of a single ClpS molecule to a ClpA hexamer, for example, 
could relay a conformational signal within the bound ClpA monomer, which in turn 
would affect neighboring subunits.  We therefore rule out the two simple models for ClpS 
activity and present an initial version of a unified model consistent with our results. 
In this model, the N-terminal extension of ClpS interacts with two regions on 
ClpA that induce conformational changes in the enzyme.  The contact near residue 17 of 
ClpS is critical for altering the ssrA recognition, whereas the contact made by the more 
N-terminal residues is important for altering N-end-rule protein recognition (Fig. 2.8a,b). 
Present evidence indicates that the ssrA tag is recognized by the pore of ClpA 
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(Hinnerwisch et al. 2005a; Piszczek et al. 2005); similar analysis has not yet been done 
with N-degron tags, but we have schematically represented these binding sites in the 
ClpA pore in Figure 2.8b.  We speculate that the allosteric change induced upon ClpS 
binding make the ssrA binding sites less favorable and the N-degron sites more favorable, 
altering observed degradation rates.  Changes in substrate preference would be reflected 
by the relative changes in the sizes of the substrate binding sites in the central channel of 
the protease (Fig. 2.8b).  Because there is no absolute sequence requirement for the N-
terminal extension of ClpS, it seems likely that peptide backbone atoms mediate the 
interaction with ClpA.  In addition to inducing conformational changes in ClpA, the N-
terminal ClpS extension may also play an active role in orchestrating handoff of N-end-
rule substrates from the adaptor to ClpA.  For example, this flexible N-terminal region 
may be engaged by ClpA to help ‘pull in’ the adaptor-bound substrate closer to the 
central pore.  More experiments will be needed to clarify the detailed mechanisms 
underlying ClpS-mediated modulation of ClpAP substrate selection. 
Many AAA+ adaptors function by binding to both a substrate and a AAA+ 
protease, thereby increasing the local concentration of the substrate relative to the 
enzyme and allowing it to be degraded more efficiently.  SspB, an adaptor for the ClpXP 
protease, represents a paradigm for this class of positive regulation of substrate choice by 
tethering (Levchenko et al. 2000; Dougan et al. 2003; Wah et al. 2003).  Dimers of SspB 
bind to sites in the N-terminal domains of ClpX and to peptide sequences in specific 
substrates but allow the degradation tags of these substrates to be engaged in the central 
pore of the ClpX hexamer (Bolon et al. 2004).  When loaded with substrate, only one 
SspB dimer binds stably to ClpXP (Wah et al. 2002).  Thus, SspB delivers substrates in 
an all-or-none fashion.  ClpS represents a new class of AAA+ adaptor. Simple tethering 
is not sufficient for its function in stimulating ClpAP degradation of N-end-rule 
substrates.  ClpS acts both as a positive and negative regulator of substrate choice, and 
changes in ClpSn-ClpA6 binding stoichiometry allow variable rather than switch-like 
regulation.  It will be important to determine whether adaptors like MecA, an 
indispensable activator that binds the Bacillus subtilis ClpCP protease with an apparent 
stoichiometry of 6:1, function using mechanisms analogous to those of ClpS (Kirstein et 
al. 2006). 
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Figure 2.8.  Model for ClpS-mediated change in ClpA binding preferences.   
Top, regions of ClpS conferring distinct activities.  Bottom, cutaway views of ClpA 
hexamers (gold) with representation of N-degron binding sites (purple) and ssrA binding 
sites (white) in the central pore.  ClpS, blue; putative N-degron binding site on the 
adaptor, white triangles; first sixteen residues of the N-terminal extension, dashed blue 
line (visible in the top panel); black triangles and circles, points of contact on ClpA for 
the distinct regions of the N-terminal extension responsible for relaying the ClpS signal 
and modifying ClpA substrate preference.  The initial binding sites for the ssrA and N-
end-rule tags are unknown, but because proteins slated for degradation must travel 
through the axial pore, we model substrate binding sites in the central pore of ClpA.  The 
size differences of substrate binding sites represent the degree of ClpA’s affinity toward 
the respective substrates.  Upon adaptor binding, the ClpS N-terminal extensions contact 
the symbolic black triangles and circles on ClpA, triggering a conformational change in 
the enzyme.  The allostery induced by ClpS binding modifies the affinities of substrates 
of ClpA, represented by changes in binding-pocket sizes in the pore and overall enzyme 
shape. 
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MATERIALS AND METHODS 
Strains, plasmids, proteins and peptides 
Full-length ClpS alanine variants were generated using the QuikChange Site-
Directed Mutagenesis Kit protocol (Stratagene).  We chose N-terminal residues of 
GSGK-ClpS that were mostly small and positively charged to retain solubility and 
flexibility.  We cloned all ClpS constructs (untagged) into pET-23b(+) (EMD 
Biosciences).  ClpSM18-106 and ClpS18-106 V18A were expressed in strain BL21 (DE3) 
clpS::kan pLysS.  Other ClpS variants were expressed in BL21 (DE3) pLysS.  For 
expression, cells were grown at 30 °C until OD600 0.4-0.6 and then induced with 0.4 mM 
IPTG for two hours.  All variants were purified as described (Dougan et al. 2002) with 
the following modifications: we did not use ion exchange purification for ClpSM18-106, 
ClpS18-106 V18A and ClpS 10-13A; we purified the GSGK-ClpS construct using a MonoS 
cation exchange column instead of a MonoQ anion exchange column; and ClpS 6-9A 
F10W protein failed to bind to the MonoQ column and we further purified it by gel 
filtration as described (Dougan et al. 2002). 
ClpA was expressed from plasmid clpA M169T/pET9a (see Acknowledgments) 
in strain BL21 (DE3) pLysS.  After French-press lysis, we brought the cleared lysate to 
40% (w/v) saturated ammonium sulfate and centrifuged it, then resuspended the pellet in 
S-Sepharose buffer (25 mM HEPES, pH 7.5, 2 mM DTT, 0.1 mM EDTA, 10% (v/v) 
glycerol) and centrifuged again.  We loaded the supernatant onto an S-Sepharose column 
and eluted the protein in a gradient from 200 mM to 1 M KCl in S-Sepharose buffer.  
Peak fractions were combined, brought up to 15% (w/v) saturated ammonium sulfate and 
chromatographed on a Source 15PHE column.  The protein eluted in a linear gradient 
from 0.6 M ammonium sulfate to 0.6% (w/v) CHAPS detergent in 50 mM sodium 
phosphate, pH 7.5, 2 mM DTT, and 10% (v/v) glycerol.  Peak fractions were dialyzed 
into 50 mM HEPES, pH 7.5, 20 mM MgCl2, 0.3 M NaCl, 10% (v/v) glycerol and 0.5 mM 
DTT.  Columns and separation media were from GE Healthcare. 
YLFVQ-titinI27, [35S] YLFVQ-titinI27 and YLFVQ-GFP protein were provided by 
K. Wang and purified as described (Wang et al. 2007).  GFP-ssrA and ClpP were purified 
as described (Kim et al. 2000; Flynn et al. 2001). 
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Biochemical assays 
To test binding of ClpS to ClpA6, we preincubated different concentrations of 
ClpS for a minimum of 5 min with 10 nM ClpA6 in 50 mM HEPES (pH 7.5), 20 mM 
MgCl2, 0.3 M NaCl, 10% (v/v) glycerol, 0.1% (v/v) Tween, 0.5 mM DTT and 1 mM 
ATP-γS at 30 °C.  Protein A Dynabeads (Invitrogen) conjugated with purified antibody 
to ClpA were added to the protein mixture for 5 min at 30 °C.  We isolated the beads 
were isolated and removed the supernatant (‘unbound’ samples), then added SDS loading 
buffer to the beads and incubated briefly at 37 °C (‘bound’ samples).  Bound samples and 
ClpS standards were separated by SDS-PAGE followed by an anti-ClpS western blot.  
We quantified bands with ImageQuant TL software (GE Healthcare). Nonspecific 
association of ClpS to the beads in the absence of ClpA6 was quantified and subtracted 
from binding data. 
We assayed degradation with stoichiometric ClpS at 30 °C with 1 µM ClpA6, 1 
µM ClpP14, 4 mM ATP, an ATP-regeneration system (2.5 mM creatine phosphate and 50 
µg ml–1 creatine kinase) and 5 µM substrate in 50 mM HEPES (pH 7.5), 20 mM MgCl2, 
0.3 M NaCl, 10% (v/v) glycerol and 0.5 mM DTT.  GFP-ssrA degradation was monitored 
by decreases in fluorescence (excitation, 467 nm; emission, 511 nm) using a Photon 
Technology International instrument. [35S] YLFVQ-titinI27 degradation was monitored by 
the release of trichloroacetic acid–soluble counts as described (Wang et al. 2007).  Other 
degradation assays were conducted using the same conditions but with 0.1 µM ClpA6, 
0.27 µM ClpP14, 1 µM ClpS and 1 µM GFP-ssrA substrate. 
To assay binding of N-end-rule substrates to ClpS or variants, we 
chromatographed approximately 20 µM initial concentrations of wild-type ClpS, 
ClpSM18-106 and ClpS18-106 V18A alone or in complex with YLFVQ-GFP on a Superdex75 
PC 3.2/30 gel filtration column in 20 mM HEPES, pH 7.5, and 150 mM KCl. Elution 
profiles were monitored by absorbance at 280 nm and 488 nm. 
We measured rates of ClpAP ATP hydrolysis using a coupled assay as described 
(Kim et al. 2001).  ClpA6 (1 µM), ClpP14 (1 µM) and different concentrations of ClpS 
were incubated for 1 min at 30 °C before adding ATP mix III. 
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Alignment of ClpS sequences 
ClustalW alignments from ClpS protein sequences of various bacterial species 
were analyzed using the Jalview alignment editor (Clamp et al. 2004). 
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CHAPTER THREE 
The ClpS N-terminal extension requires a minimal length and is affected by 
chemical composition 
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ABSTRACT 
 Adaptor proteins play key regulatory roles in substrate selection by intracellular 
energy-dependent proteases.  Here, we expand upon previous studies in which we 
discovered that the N-terminal extension of the E. coli adaptor ClpS is essential for its 
role in delivering N-end-rule proteins for degradation by the AAA+ protease ClpAP.  We 
suggest that the N-terminus of ClpS is an essential allosteric effector of substrate 
recognition, despite a lack of length and sequence conservation among ClpS orthologs.  
We uncover a striking length-dependent function for the N-terminal extension; a 
difference in length of one residue distinguishes functional and non-functional variants of 
ClpS.  Furthermore, drastic sequence mutations of the N-terminal extension reveal a 
previously unobserved effect on substrate delivery ability.  Finally, we localize an 
interaction site of the ClpS N-terminal extension to the region of the ClpA pore.  These 
studies, therefore, increase our knowledge for how this unique adaptor modulates 
protease substrate selection. 
 
INTRODUCTION 
 ATP-dependent enzymes are involved in a multitude of cellular processes.  Many 
of these proteins contain a similar ATP-binding protein domain, called the AAA+ 
domain.  The AAA+ (ATPases associated with various cellular activities) protein fold has 
been well-conserved throughout evolution, and these domains, whether in isolated form 
or as part of a larger protein subunit, typically form hexameric ring structures with the 
ATP-binding site between monomers.  The conformational change in the AAA+ hexamer 
resulting from ATP binding and hydrolysis supplies a mechanical force that can be 
imparted onto other proteins.  Thus, AAA+ proteins are involved in many cellular 
processes requiring the use of mechanical force such as protein unfolding, protein 
disaggregation, and complex disassembly (Hanson and Whiteheart 2005).   
 The processing of substrate proteins by AAA+ enzymes typically involves the 
recognition and threading of the substrate protein through the central pore of the AAA+ 
hexamer, resulting in substrate unfolding and potentially substrate complex dissociation.  
AAA+ proteins have particular substrate recognition properties, but other domains and 
regulatory proteins can also have a profound effect on the substrate selection of AAA+ 
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enzymes.  For the E. coli protease ClpAP, composed of the hexameric AAA+ unfoldase 
ClpA and the barrel-shaped serine peptidase ClpP, the N-terminal domains of ClpA and 
the adaptor protein ClpS play additional regulatory roles in choosing which proteins in 
the cell are degraded. 
Adaptor proteins have been particularly well-studied with respect to their role in 
affecting their partner AAA+ enzyme.  The adaptor SspB for ClpXP is one of the best 
studied systems.  An SspB dimer functions by binding to both to the ClpX N-terminal 
domains and to the substrate degradation tag.  By binding both the substrate and the 
enzyme, SspB serves as a tether, increasing the local concentration of the substrate as 
well as the observed rate of processing (Levchenko et al. 2000; Wah et al. 2002; Dougan 
et al. 2003; Levchenko et al. 2003; Wah et al. 2003).  This system for enhancing 
degradation of specific proteins by adaptors is an elegant way for the cell to prioritize 
substrates.   
The adaptor ClpS for ClpAP, however, does not function like a simple tethering 
adaptor.  ClpS can enhance the degradation of N-end-rule substrates by ClpAP.  The N-
end rule relates the half-life of a protein to its N-terminal residue, in which proteins 
starting with large, bulky residues are degraded the fastest (Varshavsky 1995).  This 
degradation tag, which is comprised of a destabilizing N-terminal residue, is denoted the 
N-degron.  Proteins possessing an N-degron are recognized by ClpAP for degradation, 
and ClpS enhances the rate of proteolysis (Erbse et al. 2006; Wang et al. 2007).  ClpS 
itself also has a recognition site for N-degrons (Wang et al. 2008b).  Thus, the initial 
assumption was that ClpS could tether N-end-rule proteins to ClpAP for degradation like 
SspB.  Previous work indicated that a variant of ClpS that lacks its first 17 residues, but 
can still bind to both ClpA and to an N-degron, fails to deliver an N-end-rule protein to 
ClpAP (Hou et al. 2008).  Therefore, the delivery of N-end-rule proteins by ClpS to ClpA 
cannot be explained by tethering alone.  Although ClpS is indeed likely increasing the 
local concentration of N-end-rule substrate to ClpAP, this recruitment is not sufficient for 
increasing the rate of substrate degradation.  ClpS must use another mechanism to 
transfer the substrate to ClpAP for processing (Hou et al. 2008). 
Because the first seventeen residues of ClpS appeared to greatly alter the behavior 
of the adaptor protein, we decided to investigate its properties more thoroughly.  In E. 
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coli, the first 24 residues of ClpS are disordered in ClpS-ClpA N-domain co-crystal 
structures (Guo et al. 2002a; Zeth et al. 2002).  Because of the lack of structure, it is 
believed that the N-terminal residues of ClpS are flexible.  The remainder of the ClpS 
protein forms a folded domain, and this folded core possesses the primary ClpA binding 
interface as well as the N-degron binding pocket.  Therefore, the core of ClpS bears all 
the components to allow ClpS to function as a tethering adaptor.  Interestingly, the N-
terminal extension of ClpS is not conserved in sequence or in length among ClpS 
orthologs in bacteria.  It is therefore surprising that the N-terminal extension plays such a 
critical role in ClpS function.   
ClpS binds to the N-terminal domains of ClpA, and binding of wild-type ClpS to 
ClpA causes a suppression in ClpAP ATPase rates (Hinnerwisch et al. 2005b; Hou et al. 
2008).  Because the N-terminal domains and the ATP-binding sites are separated in the 
ClpA molecule, we proposed that ClpS binding causes an allosteric change in ClpA.  We 
believe that the conformational change resultant from ClpS binding alters the substrate 
preference in ClpAP.  Our previous work showed that N-terminally truncated ClpS 
molecules did not suppress ClpAP ATPase rates like wild-type ClpS.  Therefore, the data 
suggested that the truncated ClpS variants do not allosterically affect ClpAP and thus do 
not cause a modulation in ClpAP substrate specificity.  Furthermore, full-length variants 
of ClpS with different N-terminal sequences behaved like wild-type ClpS in multiple 
assays, showing that the function is not dependent on a strict sequence.   
In this study, the nature of the N-terminal residues of ClpS is further explored.  A 
series of truncations showed a dramatic length dependence of the E. coli ClpS N-terminal 
extension in which adaptors that are too short inhibit the delivery of N-end-rule substrates 
to ClpAP.  Although previous experiments showed that the sequence of the N-terminal 
extension lacks strict requirements, we have created and tested new ClpS variants in 
which alteration of the N-terminal residues appears to affect the ability to deliver N-end-
rule substrates.  Lastly, we determined that the region of ClpA interaction by the ClpS N-
terminus is near the central pore of ClpA.  These studies expand upon our knowledge of 
how the ClpS adaptor protein operates, furthering our understanding of the diverse nature 
of adaptor function. 
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RESULTS 
A minimal length of the ClpS N-terminal extension is required for N-end-rule 
delivery 
 Our previous work demonstrated that unlike wild-type ClpS, ClpS lacking its first 
16, 17, 18, or 19 residues was no longer able to deliver N-end-rule substrates for 
degradation by ClpAP (Hou et al. 2008).  To gain a better sense of how ClpS interacts 
with ClpAP, I wished to determine if there was a gradual decline in adaptor activity with 
shorter ClpS variants or whether there was a specific length of the N-terminal extension 
that was required for ClpS’s delivery function.  A series of deletion constructs was 
created in which one residue was removed at a time from wild-type ClpS.  Figure 3.1a 
shows the first 17 residues of ClpS; in wild-type ClpS, the initiator methionine is 
removed upon expression.  For each ClpS deletion construct, the initiator methionine was 
designed to be retained to prevent artifacts of exposing N-degrons on ClpS itself.  After 
purification, the integrity of every ClpS protein was verified by mass spectrometry.  Each 
ClpS deletion retained its initiator methionine with two exceptions.  A portion of the 
methionines were cleaved from ClpSM4-106 due to the threonine at the following position.  
This processing was not unexpected because initial methionines are cleaved when the 
second residue is small (Hirel et al. 1989).  Shockingly, a large portion of the methionines 
were cleaved from ClpSM7-106, which contains a tryptophan following the methionine.  
According to the established rules of methionine aminopeptidase, a methionine should 
not be cleaved when the second residue is as large and hydrophobic as tryptophan (Hirel 
et al. 1989).  A repeat purification of this protein yielded the same partial processing.  It 
has not been determined why this ClpS construct is partially processed, and more 
investigations to address this issue are being considered. 
We tested the series of ClpS truncations in several assays to determine the effect 
of the deletions on function.  It was first necessary to ensure that all of the ClpS variants 
were correctly folded.  We expected that all of the ClpS truncated variants should be able 
to inhibit degradation of GFP-ssrA by ClpAP because these adaptors all had a longer N-
terminal extension than the minimal length established previously as needed for 
inhibition of degradation of ssrA substrates (Hou et al. 2008).  Figure 3.1b shows that 
these variants all inhibited GFP-ssrA degradation as expected, and these data also 
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indicate that the variants were correctly folded and interacted with ClpA in order to 
exhibit this activity.  The series of ClpS deletion constructs was then tested for the ability 
to stimulate degradation of an N-end-rule protein.  With the exception of ClpSM7-106, there 
appears to be a definitive drop in activity between ClpSM13-106 and ClpSM14-108 (Fig. 3.1c).  
Considering the presence of the initiator methionines, the length breakpoint in ClpS 
activity lies between residues 12 and 13.  Thus, the minimum functional ClpS variant 
begins at the position of residue 12 in wild-type ClpS.  ClpSM7-106 behaved aberrantly 
with respect to N-end-rule stimulation, and this lack of stimulation is likely to due the N-
terminal exposure of tryptophan in the majority of those ClpS proteins (Fig. 3.1c,d).  
Although there was no evidence for degradation of ClpSM7-106 (Fig. 3.1e), this ClpS 
construct may be competing in trans with substrate for N-degron binding sites. 
The series of ClpS truncation variants was also tested for ability to suppress 
ClpAP ATPase rates.  All of the variants longer than ClpSM14-106 behaved similarly to 
wild-type ClpS in suppressing the rate of ATP hydrolysis (Fig. 3.1f).  In contrast, shorter 
ClpS variants failed to suppress ATPase rates.  Short ClpS variants such as ClpSM18-106 
have already been reported not to lower ClpAP ATPase activity and to even slightly raise 
the ATPase rate (Hou et al. 2008).  Therefore, the sharp cut-off in activity between 
residues 12 and 13 on ClpS applies to ATPase suppression as well as N-end-rule 
substrate delivery.   
Because a sharp change in activity was observed between variants instead of a 
gradual decline, the ClpS constructs on either side of this line of activity, ClpSM13-106 and 
ClpSM14-106, were further studied.  Degradation rates at different N-end-rule substrate 
concentrations were determined with a fixed concentration of ClpAP and ClpS mutant.  
The values for KM (2.7 µM) and relative (to wild-type) Vmax (0.86) for ClpSM13-106 are 
similar to those of wild-type ClpS (1.3 µM KM, 1.00 relative Vmax), reinforcing the trend 
that variants longer than ClpSM13-106 confer similar functional results (Fig. 3.1g).  In 
contrast, ClpSM14-106 had a slightly greater KM (7.4 µM) as well as a much lower relative 
Vmax (0.10) compared to ClpSM13-106 and wild-type ClpS.  In fact, the relative Vmax of 
ClpSM14-106 is lower than that of ClpAP alone (0.83), suggesting that at high substrate 
concentrations, ClpAP is more impaired in degrading an N-end-rule substrate with 
ClpSM14-106 than with no ClpS at all (Fig. 3.1g,h).  Because the KM values of ClpSM13-106 
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and ClpSM14-108 are similar, one can infer that both ClpS variants bind N-end-rule 
substrates similarly.  It was previously shown that ClpS with truncations in the N-
terminal extension can still bind N-degrons (Hou et al. 2008).   The main difference 
between the ClpS variants on either side of the activity divide is the maximal rate.  The 
much lower relative Vmax of ClpSM14-108 suggests a defective hand-off of the substrate 
from the adaptor to ClpA.  These two ClpS proteins differ by only one residue in the N-
terminal extension, emphasizing the importance of this region’s role in adaptor function. 
 
 
 
 
 
 
 
Figure 3.1.  A minimal length of the ClpS N-terminus is required for N-end-rule substrate 
delivery. 
(a) The wild-type sequence of the ClpS N-terminal extension is shown with residue 
positions numbered.  (b) Degradation of GFP-ssrA by ClpAP with series of ClpS N-
terminal truncations.  Degradation rates less than zero were due to slight upward drift of 
the fluorescence signal over time, and these negative values were normalized to “0.”  (c) 
Degradation of YLFAQ-GFP by ClpAP with series of ClpS N-terminal truncations.  
Negative degradation rates were normalized as described above.  (d) Degradation of 
YLFAQ-GFP by ClpAP showing inability of ClpSM7-106 to greatly stimulate degradation.  
Samples of the degradation reaction were taken at 10-minute time intervals and run on 
SDS-PAGE.  The substrate band was then quantified.  (e) Wild-type ClpS or ClpSM7-106 
adaptor was not degraded during the degradation assay of YLFAQ-GFP in (d).  (f) ClpAP 
ATPase rates were observed with the series of ClpS N-terminal truncations.  (g) (Top) 
Graph showing degradation of YLFVQ-I27 at different concentrations with ClpSM13-106.  
Data from three independent experiments are shown with the best-fit Michaelis-Menton 
curve.  The degradation rates were normalized to the Vmax of wild-type ClpS to account 
for variation between substrate protein preparations.  The KM for ClpSM13-106 is 2.7 µM, 
and the relative Vmax is 0.9. (Bottom left) Graph showing degradation of YLFVQ-I27 at 
different concentrations with wild-type ClpS.  The KM of wild-type ClpS is 1.3 µM, and 
the relative Vmax is 1.0.  (Bottom right) Substrate concentration-dependent experiment 
showing degradation of YLFVQ-I27 at different concentrations without ClpS.  The KM 
without ClpS is 57 µM, and the relative Vmax is 0.8.  (h) Graph showing degradation of 
YLFVQ-I27 at different concentrations with ClpSM14-106.  Data from two independent 
experiments are shown.  The KM for ClpSM13-106 is 7.4 µM, and the relative Vmax is 0.1. 
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Altering the sequence of a shortened ClpS N-terminus affects function 
 Prior mutagenesis of the full-length ClpS N-terminus suggested that there was no 
strict sequence requirement for the first 17 amino acids of E. coli ClpS.  The previous 
mutagenesis experiments were conducted in full-length ClpS in which either blocks of 
four contiguous residues were changed to alanine, or the entire first 17-residue segment 
was mutated to an assortment of small and positively charged residues (Hou et al. 2008).   
All of these full-length ClpS variants behaved like wild-type ClpS, and this lack of 
sequence specificity corroborated the lack of sequence and length conservation of the N-
terminal extension.  Although we still believe that there is no absolute sequence 
requirement, we reasoned that the non-mutated regions of the N-terminal extensions, 
chiefly in the alanine block-replacement experiments, could have compensated for the 
mutated residues given the extension’s expected flexibility.  The previous sequence 
variant in which we generated a wholesale change in the first 17 residues might have 
been sufficiently complex in sequence to mimic wild-type ClpS.  Our current data reveal 
a length-dependence in the N-terminal extension of ClpS.  We therefore decided to revisit 
mutagenesis of this region, but in the context of a short ClpS variant such that other N-
terminal segments could not compensate. 
ClpS variants starting at position 10 were created in which a string of residues is 
mutated to alanine, to glycine, or to proline (Fig. 3.2a).  By examining the substrate-
concentration dependence on the rate of degradation of an N-end-rule substrate by 
ClpAP, we observe that 8Ala-ClpS18-106 (Alanine-ClpS) possesses a similar but slightly 
higher KM (5.1 µM) to wild-type ClpS but a lower relative maximal rate (0.29) (Fig. 
3.2b).  Conversely, 8Gly-ClpS18-106 (Glycine-ClpS) demonstrated a relative Vmax (1.06) 
similar to wild-type ClpS but had a substantially higher KM (155 µM) (Fig. 3.2c).  Ala-
7Pro-ClpS18-106 (Proline-ClpS) is the most impaired variant compared to wild-type ClpS, 
yielding a low relative Vmax (0.25) and a high KM (109 µM) (Fig. 3.2d).   
 These three ClpS variants were tested in other functional assays.  All three ClpS 
variants inhibited GFP-ssrA degradation by ClpAP as expected by their length, although 
Glycine-ClpS may be slightly less functional than the other variants (Fig. 3.2e).  
Furthermore, Glycine and Proline variants of ClpS were not as functional as wild-type 
and Alanine-ClpS in an assay to test for inhibition of ClpAP ATP hydrolysis rates, 
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displaying values mimicking the level observed with no ClpS or versions of ClpS starting 
C-terminal to the fourteenth residue (Fig. 3.2f).   
Two control experiments were conducted to ensure that altering the N-terminal 
backbone did not adversely affect the core domain of ClpS, especially given the inability 
of Glycine-ClpS and Proline-ClpS to inhibit ClpAP ATPase rates.  Fluorescence 
anisotropy indicated that all three ClpS variants were able to bind to a peptide bearing an 
N-degron like wild-type ClpS (Fig. 3.2g).  Additionally, all three ClpS variants inhibited 
ClpA autodegradation like wild-type ClpS (Fig. 3.2h).  Taken together with the GFP-ssrA 
inhibition data, these control experiments demonstrate that the core of ClpS in these 
amino acid variants is still functional and can bind both ClpA and to N-degrons.   
 Although these three ClpS variants should theoretically be long enough to 
function like wild-type ClpS and ClpSM13-106, the Glycine and Proline variants are clearly 
defective in the delivery of N-end-rule proteins and in the suppression of enzyme ATPase 
rates.  It is also unclear why the Alanine variant has a slightly lower Vmax than wild-type 
ClpS.  The functional debilitation of these amino acid variants has uncovered a sequence 
dependence not previously observed.  It is possible that the use of short ClpS variants 
eliminated the possibility of functional redundancy of other N-terminal extension 
segments.  However, these relatively severe variants might elucidate a requirement for 
variation in amino acid composition in the N-terminal extension rather than a sequence 
strongly biased for one residue.   
Due to the nature of our mutations in which we alter a string of residues to 
alanine, glycine, or proline, we are assuredly altering the backbone flexibility in addition 
to the side chains.  We expected that the alanines would have little overall effect on the 
backbone but that the glycines and prolines would greatly increase and decrease 
flexibility, respectively.  Even though it is unclear whether the impairment of these ClpS 
variants is due to changing the side-chains or the backbone, we clearly observe that 
mutating the amino acids of a minimal-length ClpS variant decreases the ability to deliver 
an N-end-rule substrate for degradation by ClpAP.   
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Figure 3.2.  ClpS requires a normal chemical composition for function. 
(a) Depiction of ClpS constructs used in these experiments.  (b) Graph showing 
degradation of YLFVQ-I27 at different concentrations with 8Ala-ClpS18-106.  Data from 
independent experiments were variable, but a representative plot is shown. The KM for 
8Ala-ClpS18-106 in this experiment is 5.1 µM, and the relative Vmax is 0.3.  (c) Graph 
showing degradation of YLFVQ-I27 at different concentrations with 8Gly-ClpS18-106.  
Data from two independent experiments are shown.  The KM for 8Gly-ClpS18-106 is 155 
µM, and the relative Vmax is 1.1.  (d) Graph showing degradation of YLFVQ-I27 at 
different concentrations with Ala-7Pro-ClpS18-106.  Data from two independent 
experiments are shown.  The KM for Ala-7Pro-ClpS18-106 is 109 µM, and the relative Vmax 
is 0.3.  (e) Degradation of GFP-ssrA by ClpAP with sequence variants of ClpS.  All 
constructs can inhibit GFP-ssrA degradation.  Negative degradation rates were 
normalized as described in Figure 3.1b.  (f) ATP hydrolysis rates of ClpAP with ClpS 
sequence variants.  Glycine-ClpS and Proline-ClpS were unable to suppress rates like 
wild-type ClpS and the Alanine-ClpS.  (g) Binding of a peptide with an N-degron to ClpS 
sequence variants.  All variants bound the N-degron like wild-type ClpS with a KD of 6-7 
µM.  (h) Measurement of the ability of ClpS variants to inhibit ClpA autodegradation.  
Two time points from N-end-rule substrate reactions with the appropriate ClpS molecule 
were taken and run on SDS-PAGE.  The Coomassie-stained ClpA band was quantified. 
 
 
 
The N-terminal extension of ClpS interacts with the pore of ClpA 
 Using ATPase suppression as a read-out, it is clear that the N-terminal extension 
of ClpS has a direct effect on ClpAP in the absence of substrate (Fig. 3.1f).  Therefore, 
the N-terminal extension of the adaptor is most likely making a contact with the enzyme.  
The main ClpS-ClpA binding interface has already been established by x-ray 
crystallography to be between the core folded domain of ClpS and the N-terminal domain 
of ClpA (Guo et al. 2002a; Zeth et al. 2002; Xia et al. 2004).  The ClpS N-terminal 
extension is not visible in existing crystal structures, and it is currently unknown whether 
ClpS makes contacts with the other ClpA domains.  We speculate that the extension can 
bind to full-length, hexameric ClpA, perhaps transiently, as part of ClpS’s function in 
altering ClpAP’s substrate preference. 
 To understand the role of the N-terminal extension of ClpS, we searched for the 
location on ClpA where it might interact.  We employed a protein cleavage reagent, 
FeBABE, attached to the N-terminal extension of ClpS.  Because the region around 
residues 12 and 13 are critical for the role of ClpS in delivering N-end-rule substrates, we 
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engineered individual cysteines on each of these residues on which to fuse FeBABE (Fig. 
3.3a,b).  The FeBABE reagent contains a chelated Fe3+ atom that when activated by 
ascorbic acid and hydrogen peroxide, will generate radicals that can cleave protein side 
chains.  The FeBABE reagent also includes a sulfhydryl-reactive group that can 
covalently bind to cysteine side chains on ClpS.  The activated FeBABE attached to the 
N-terminal extension of ClpS will cleave the region of ClpA in closest proximity, and the 
cleavage site can be mapped.  The FeBABE reagent did not greatly inhibit ClpS function 
and therefore binding to ClpA (data not shown). 
 The FeBABE cleavage reaction yielded four primary bands, two bands of 
approximately 50 kilodaltons and two bands of approximately 29 kilodaltons.  Both ClpS 
Q12C and ClpS L13C gave the same pattern, and ATPγS was required for efficient 
cleavage (Fig. 3.3c).  The sum of the molecular weights of one small band and one large 
band approximately equals the molecular weight of the 84 kilodalton ClpA monomer, 
strongly suggesting that each pair of large and small bands resulted from a single 
cleavage.  This cleavage is specific to the ClpS-bound FeBABE reaction because 
competition with an unlabeled ClpS molecule or the use of ClpA lacking an N-terminal 
domain for ClpS binding eliminated FeBABE-cleavage of ClpA (Fig. 3.3d).  To 
determine the location of the cuts, it was necessary to determine which band 
corresponded to which end of ClpA.  To address this question, we replicated the cleavage 
reaction with a C-terminally FLAG-tagged ClpA.  The C-terminal FLAG tag does not 
inhibit ClpA function (data not shown).  A western blot against the FLAG tag indicated 
that the larger cleavage products corresponded to the C-terminal protein fragment, and 
the smaller bands corresponded to the N-terminal fragments (Fig. 3.3e). 
 To estimate the location of the cleavage sites, we compared the migration of the 
resultant bands by SDS-PAGE compared to the molecular size standards (Fig. 3.3f).  Our 
initial estimation of the cleavage site was around residue 260 of ClpA.  Based on the 
crystal structure of the ClpA monomer, the pore of the D1 ATPase domain lies in this 
region (Guo et al. 2002b).  To refine our estimation on the cleavage site and the hence the 
site of interaction by the ClpS N-terminal extension, we employed variants of ClpA with 
cysteines engineered in and around the D1 pore.  The reagent NTCB was used to 
chemically cleave ClpA immediately before cysteines.  We analyzed the products of 
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NTCB cleavage on a gel and used the fragments generated from the cleavage before 
known cysteines in the pore as more precise size standards for the FeBABE reactions.  
The new estimation indicated that one cleavage site is approximately between ClpA 
residues 243 and 259.   The other cleavage site is C-terminal to residue 272.  The use of 
two other ClpS variants on which to position the FeBABE reagent, ClpS K17C and Cys-
ClpS18-106, did not yield different band sizes but yielded less efficient cleavage.  The 
inefficiency of reaction with Cys-ClpS18-106 supports the need for a minimal length of the 
N-terminal extension to make a proper contact with ClpA. 
 
 
 
 
 
 
Figure 3.3.  The ClpS N-terminus interacts with ClpA. 
(a) Depiction of the FeBABE reagent used for artificial cleavage of ClpA when attached 
to ClpS.  The sulfur group on the cysteine of the bait protein covalently binds to the 
molecule.  The EDTA-chelated iron atom reacts with nearby residues when triggered by 
ascorbic acid and hydrogen peroxide treatment.   (b) Depiction of ClpS variants used in 
the FeBABE studies.  The ClpS cysteine variants were constructed in a C73V C101S 
background to avoid binding of FeBABE at these cysteines.  (c) Cleavage reaction of 
ClpA by FeBABE with ClpS Q12C (Q), ClpS L13C (L), or with ClpA only.  The 
reaction was most efficient with ATPγS as nucleotide to hexamerize ClpA.  (d) Control 
experiments showing that the FeBABE cleavage is ClpS-specific.  Lane 1 – ClpA only, 
no reaction; Lane 2 – ClpA only, with reaction; Lane 3 – ClpA with ClpS Q12C-
FeBABE and reaction; Lane 4 – ClpA with ClpS Q12C (no bound FeBABE), and 
reaction; Lane 5 – ClpA with ClpS Q12C-FeBABE, excess ClpS Q12C (no bound 
FeBABE), and reaction; Lane 6 – ClpA∆N, no reaction; Lane 7 – ClpA∆N, with 
reaction; Lane 8 – ClpA∆N with ClpS Q12C-FeBABE, with reaction.  Although some 
smaller molecular weight bands are seen in lanes with ClpA∆N, because they exist in the 
lanes without the FeBABE reagent, they were deemed contaminants.  “No reaction” 
refers to lack of ascorbic acid and hydrogen peroxide addition.  The full-length ClpA 
molecules were C-terminally FLAG-tagged in this experiment.  (e) (Left) Coomassie blot 
of FeBABE reaction taken from Lane 3 in (d).  (Right) Anti-FLAG western blot showing 
that the upper cleavage bands correspond to the C-terminal ClpA fragments.  (f) 
Comparison of FeBABE cleavage reactions when bound to ClpS Q12C, ClpS K17C, or 
Cys-ClpS18-106.  The larger cleavage bands are shown next to ClpA fragments generated 
from NTCB digestions of ClpA cysteines in the pore.   
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The exact region of N-terminal ClpS-ClpA contact is still unidentified 
 We wished to test the pore region of ClpA to determine if the N-terminal 
extension of ClpS indeed makes a contact.  We made several additional ClpA pore 
mutations and sought a mutant that would allow the degradation of an N-end-rule 
substrate by ClpAP alone but be defective with the addition of ClpS.  Our assumption 
was that a defect in ClpS-mediated delivery would indicate that the mutated residue on 
ClpA was necessary for the interaction of the ClpS N-terminal extension.  Two sets of 
ClpA mutants were utilized.  One set included singly mutated residues in ClpA, Y259C, 
K265C, K268C, and K272C, most of which were used earlier as NTCB-generated size 
standards.  These mutations are in solvent accessible regions on the N-terminal surface of 
the D1 domain near the pore except for ClpA Y259C, which is directly in the D1 pore.  
With the exception of ClpA Y259C, all of these ClpA mutants were stimulated by ClpS 
with respect to N-degron protein degradation (Fig.3.4a).  The rate of substrate delivery 
with the Y259C mutant plus ClpS is not as low as wild-type ClpA alone, suggesting that 
this difference in degradation is not substantial.  Furthermore, Y259C is the only of these 
ClpA mutants that failed to degrade of GFP-ssrA (Fig. 3.4b).  Although it is possible that 
this residue plays unique roles in the degradation of an ssrA-tagged substrate versus an 
N-end-rule substrate, we believe that a mutation at Y259 generates a generally inactive 
ClpA protein independent of ClpS. 
 The second set of ClpA mutations were made in conserved residues flanking the 
ClpA D1 pore.  We anticipated that the reason for conservation might be because of the 
necessity of these amino acids for ClpS interaction, although these residues are likely also 
important for general pore function.  Unfortunately, all of these ClpA mutants were also 
stimulated by ClpS with respect to N-end-rule protein delivery with the exception of 
L254D, which appeared to be generally inactive (Fig. 3.4c).  Interestingly, most of these 
mutations yielded ClpA proteins defective for GFP-ssrA degradation (Fig. 3.4d).  This 
result was not surprising because we targeted conserved residues likely to be important 
for the integrity of the D1 pore.  Defects in GFP-ssrA degradation by some of these ClpA 
mutants have been previously reported (Hinnerwisch et al. 2005).  It is uncertain why 
mutations in these ClpA pore residues would allow active degradation of an N-end-rule 
 74
substrate but not an ssrA-tagged substrate.  Perhaps we have uncovered residues 
important uniquely for ssrA-like substrates, but this hypothesis requires further testing. 
We also tested these ClpA variants for ATPase activity in the presence of ClpP.  It 
is unclear why there is variability in the absolute rate of hydrolysis between variants, but 
with the exception of ClpA L254D, all of these ClpA proteins showed rates of ATP 
hydrolysis that could be suppressed by ClpS (Fig. 3.4e).  Taken together, all of our ClpA 
mutants that were not globally defective in substrate processing were still able to be 
stimulated by ClpS for degradation of N-end-rule substrates.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4.  Testing of the ClpA pore as the likely site of interaction with the ClpS N-
terminal extension. 
(a) Degradation of YLFAQ-GFP by ClpA cysteine mutants with and without ClpS.  (b) 
Degradation of GFP-ssrA by ClpA cysteine mutants with and without ClpS.  Negative 
degradation rates were normalized as described in Figure 3.1b.  (c) Degradation of 
YLFVQ-I27 by conserved residue ClpA mutants with and without ClpS.  For this 
experiment, 5 µM of substrate was used, differing from 1 µM used elsewhere in this 
figure, to elucidate differences between degradation rates with and without ClpS. 
(d) Degradation of GFP-ssrA by conserved residue ClpA mutants with and without ClpS.  
Negative degradation rates were normalized as described in Figure 3.1b.  (e) ATP 
hydrolysis rates of ClpA mutants with ClpP with and without ClpS. 
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DISCUSSION 
 The elucidation of the complete role and function of the ClpS adaptor protein 
remains quite complex.  This study uncovers more information about the role of the N-
terminal extension, specifically with respect to its importance in the delivery of N-end-
rule substrates to ClpAP.  A striking length dependence in the N-terminal extension has 
been determined in which ClpS mutants that are too short are unable to deliver N-end-
rule substrates.  Our previous and current data suggest that the N-terminal extension is 
required to impose a conformational change upon the ClpA enzyme.  This 
conformational change results in the substrate specificity switch that redirects ClpAP 
away from ssrA-tagged substrates and towards N-end-rule substrates (Dougan et al. 2002; 
Zeth et al. 2002).  By this model, the N-terminal extension needs to be of a certain length 
to interact with the putative binding pocket on ClpA.   
How do we explain the observation that a short version of ClpS, such as 
ClpSM14-106, results in a lower degradation rate of an N-end-rule protein than with ClpAP 
alone?  Similarly, why do increasing amounts of short ClpS inhibit the rate of N-end-rule 
degradation (Hou et al. 2008)?  One hypothesis is that the ClpS core domain and/or the 
remaining portion of the N-terminal extension sterically hinders ClpA’s ability to directly 
bind N-end-rule proteins.  So, the short ClpS not only does not enhance degradation of an 
N-end-rule substrate due to the lack of a sufficient N-terminal extension for allosteric 
activation, but the remainder of the protein blocks ClpA’s original ability to recognize N-
degrons in the absence of adaptor.  Furthermore, in this model, the ClpS folded domains 
might compete with ClpA for N-degrons, although this potential competition should not 
factor in saturating substrate conditions.   
Another hypothesis for the observed suppression of degradation rates by 
ClpSM14-106 is that two conformational changes in fact occur instead of one: the first 
change occurs when the ClpS core binds to the N-terminal domains, and the second 
change occurs when the N-terminal extensions of ClpS bind their respective pocket in 
ClpA.  This distinction in conformational changes might explain why short ClpS 
constructs reproducibly elevate levels of ClpAP ATP hydrolysis rather than depress rates 
or keep rates completely unchanged (Fig. 3.1f) (Hou et al. 2008).  By this model, the first 
conformational change exerted by ClpS binding to the ClpA N-terminal domain renders 
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ClpA unable to recognize ssrA-tags and N-degrons.  The second conformational change, 
which is exerted only by binding of the ClpS N-terminal peptide, re-exposes a higher-
affinity N-degron binding site.  Thus, the overall effect of wild-type ClpS is the shift of 
specificity away from ssrA-tagged substrates towards N-degrons.  It is currently unknown 
whether the change in ATPase rate has functional importance, such as shifting the ClpA 
motor into different “gears” to degrade different classes of substrates, or if changes in 
hydrolysis rates are simply a tolerable consequence of an enzymatic conformational 
change.  It is important to note, however, that ClpS binding does not suppress ATPase 
rates to zero; ClpAP in the presence of ClpS must still be able to degrade N-end-rule 
substrates. 
The data from Alanine-ClpS, Glycine-ClpS, and Proline-ClpS provide further 
insight into the nature of molecular contacts between the ClpS N-terminal extension and 
ClpA.  Although the lack of sequence conservation among ClpS orthologs and results 
from previous mutagenesis both pointed against sequence-specific contacts, we now see 
an effect due to drastic alteration of the N-terminal sequence of ClpS.  It is possible that 
sequence complexity, rather than a strict sequence, is necessary for binding of the N-
terminal extension into its putative ClpA pocket.  However, backbone dynamics may 
indeed play a role in the ability of these ClpS variants to activate ClpAP.  The string of 
glycines in Glycine-ClpS might be too flexible to stably bind a discrete binding site, and 
the string of prolines in Proline-ClpS might form a configuration that is not recognized by 
ClpA.   
Repeated proline residues can form helices in two configurations.  Form I is a 
right-handed helix of cis residues with a rise of 1.9 Å per residue, and Form II is a left-
handed helix of trans residues with a rise of 3.1 Å per residue (Cowan and McGavin 
1955; Traub and Shmueli 1963).  Therefore, assuming that the commencing alanine is 
unstructured and has a translational length of  3.6 Å, then if the alanine plus the 7 
prolines – equivalent to residues 10 through 17 – formed a helix, the overall length could 
be approximately 16.9 Å (3.6 + 1.9 × 7) or 25.3 Å (3.6 + 3.1 × 7) (Huggins 1943).  If 
fully extended, the distance from residue 12 – the start of the minimal ClpS adaptor – 
through residue 17 in wild-type ClpS would be 21.6 Å.  It is unknown which type of 
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helix this proline chain could form, if any, but form I would yield a length insufficiently 
long for N-end-rule substrate delivery based on our deletion studies. 
A survey of some ClpS orthologs from other species show that most N-terminal 
extensions are indeed of minimal length as determined by our studies with E. coli ClpS.  
However, it is intriguing why the N-terminus of the ClpS ortholog from Helicobacter 
pylori, for example, is shorter than the determined minimal length.  Perhaps differences 
in H. pylori ClpA can compensate for the shorter ClpS N-terminus.   Interestingly, the 
protein Aat, a leucyl/phenylalanyl-tRNA-protein transferase that is an important and 
conserved component of the N-end-rule pathway in bacteria (Shrader et al. 1993), is not 
annotated as being present in H. pylori.  It will be useful to establish if the N-end rule as 
we understand it indeed operates in H. pylori to determine if ClpS functions as expected. 
The FeBABE reagent has permitted the refinement of the interaction zone for the 
ClpS N-terminal extension.  Even though the exact residue or group of residues on ClpA 
that interacts with the ClpS N-terminus remains elusive, we have narrowed down the 
region of interaction to near the D1 ring pore of ClpA.  Finding the region of interaction 
is challenging because we expect the ClpS N-terminal extension to be flexible.  The 
length of each residue in an extended polypeptide is 3.6 Å, thus the first 17 residues of 
ClpS if fully extended could sweep a sphere with a radius of 57.6 Å (Huggins 1943).  
Furthermore, because the ClpA N-terminal domain on which ClpS sits is thought to be 
mobile (Ishikawa et al. 2004), the overall spatial possibilities of the ClpS N-terminus 
with respect to the main ClpA barrel are tremendous.  However, because we mapped a 
region of contact with the FeBABE reagent, which has a length of 12 Å, we can assume 
that the actual site of ClpS-ClpA contact might be only 3 residue-lengths away in 
distance.  Given the expected flexibility of the ClpS N-terminal extension, our regional 
refinement greatly facilitates future continued exploration of the ClpS interaction site.  
It is logical that the region of interaction between the ClpS N-terminal extension 
and ClpA has been localized to the pore of the ClpA D1 domain, given that all ATP-
dependent substrates of ClpAP are thought to pass through the central pore.  We 
speculate that the N-terminal extension of ClpS binds to a site on ClpA, which results in a 
conformational change that modifies the substrate preference of ClpAP.  However, the 
role of the D1 AAA+ domain in tandem-AAA+-domain proteins such as ClpA is unclear.  
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Prior experiments suggest that the D1 ring plays a role in ClpA hexamerization whereas 
the D2 ring functions more in ATP hydrolysis (Singh and Maurizi 1994; Seol et al. 
1995).  The ATP-binding rings of single-ring AAA+ proteins such as ClpX correspond 
most closely to the D2 ring of ClpA, and it is uncertain if the D1 domain participates in 
ATP hydrolysis and active translocation or whether it serves other regulatory functions.  
In this case, the D1 domain may act as a link between the N-terminal domain and the D2 
domain, relaying a conformational change resulting from ClpS binding the ClpA N-
terminal domain to the D2 domain where the chief pulling motion may take place.    
How does hand-off of the N-end-rule substrate to ClpAP occur?  It was 
previously suggested that as the ClpS N-terminal extension reveals an enhanced binding 
pocket for N-degrons in ClpA, other residues in ClpS might also transiently interact with 
ClpA, destabilizing ClpS’s N-degron binding pocket such that the substrate is released 
from the adaptor toward the ClpA pore (Wang et al. 2008b). 
 Another attractive and previously untested model for the function of ClpS in N-
end-rule protein delivery is that ClpA engages the tantalizingly long N-terminal 
extensions of the adaptor as if it were a substrate, pulling the ClpS molecule in complex 
with an N-end-rule substrate in closer proximity to the processing pore after which the N-
end-rule substrate is transferred to ClpA.  There has been no evidence that ClpS itself 
gets degraded or even engaged by ClpAP; however, we speculated that ClpS’s structural 
stability might prevent degradation by ClpA.  Although we have not observed strong 
evidence that substrate presence influences enzyme ATPase rates, it is possible that the 
putative core stability of ClpS may explain the suppression in ATPase rates as ClpAP 
struggles to unfold the adaptor.  ClpXP hydrolyzes ATP at a slower rate when degrading 
tightly folded proteins compared to unfolded ones (Kenniston et al. 2003).  ClpAP may 
be operating in a similar mechanism with ClpS.   
Support for the ClpS “pseudo-substrate” theory lies in evidence that ClpAP can 
degrade generally unfolded substrates, that ClpS is not degraded by ClpAP despite its 
long N-terminal extension, that even ClpS bearing an N-degron is not degraded in trans 
as a substrate (Fig. 3.1e), and that precedent exists for the proteasomal adaptor Rad23 
being resistant to degradation due to its UBA2 stabilizing domain (Heessen et al. 2005).  
Incorporating data from this study, it is logical that a minimal length of the N-terminal 
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extension would be required for ClpA binding if the core of ClpS is anchored onto 
ClpA’s N-terminal domains.  Similarly, the ClpA pore might not favor interacting with a 
string of glycines, prolines, or even all alanines as present in the ClpS variants above.  
Studies suggest that proteasomal substrates generally have two requirements for 
degradation: proximity to the processing pore and possession of an unstructured protein 
region of complex sequence for initiation of degradation (Tian et al. 2005; Inobe and 
Matouschek 2008).  These studies show that a variation in sequence, but not necessarily 
the identity of the residues themselves, influences whether or not an unstructured region 
can be captured by the proteasome.  A report with ClpXP showed that a variant of GFP-
ssrA in which the majority of the ssrA tag was mutated to glycine except for the critical 
C-terminal LAA was not degraded at concentrations below 50 µM in the conditions 
tested (Flynn et al. 2001).  It was hypothesized that the glycine linker may be too flexible 
to allow proper recognition and processing of the LAA C-terminal motif by ClpXP.  A 
similar phenomenon might apply to ClpAP in which even the string of eight alanines on 
the ClpS variant mentioned above is too low in complexity for ClpA to grip, thus 
resulting in a slightly lower Vmax compared to wild-type ClpS.  If the D2 ring of ClpA 
were in fact the principal center for substrate binding and pulling, a substrate’s 
degradation tag would have to reach 40 Å into the ClpA’s D1 pore to reach D2 (Ishikawa 
et al. 2004; Hinnerwisch et al. 2005a).  As mentioned earlier, the first seventeen residues 
of ClpS are predicted to reach approximately 58 Å if fully extended, which would 
support this model.            
 All of these models require direct testing, but our data reveal more of the 
intricacies behind ClpS function.  Understanding the mechanism for ClpS will enrich our 
knowledge for how proteolytic substrates are prioritized.  Furthermore, ClpS is an 
example of the diverse adaptors that AAA+ proteins use to modulate their substrate 
preference.   
 
MATERIALS AND METHODS 
Proteins 
 ClpS truncations with the exception of ClpSM13-106 and ClpSM14-106 were created 
by amplifying the appropriate gene segment from genomic DNA and cloning into a 
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pET23b vector (Novagen).  These plasmids were transformed into ER2556 (DE3) pLysS 
cells, and the cells were grown in LB with 0.4 mM IPTG added at OD600 0.4-0.6 to 
induce protein expression.  Cells were harvested and lysed, after which the cleared lysate 
was precipitated with 35% saturated ammonium sulfate.  Precipitated proteins were 
resuspended, cleared of un-resuspended matter, and applied to a MonoQ anion exchange 
column followed by a Superdex 75 size exclusion column (GE Healthcare) equilibrated 
in 20 mM HEPES pH 7.5, 150 mM KCl, 10% glycerol, and 1 mM DTT. 
 The 8Ala-ClpS18-106 (Alanine-ClpS), 8Gly-ClpS18-106 (Glycine-ClpS), Ala-7Pro-
ClpS18-106 (Proline-ClpS), and Cys-ClpS18-106 variants were cloned into a SUMO fusion 
vector bearing a His6 tag preceding the N-terminal SUMO domain.  Cells were grown 
similarly to above, but the protein was purified over Ni-NTA resin (Qiagen).  The SUMO 
domain of the fusion was cleaved overnight with Ulp1 SUMO protease.  The resultant 
cleavage mix was reapplied over Ni-NTA resin to eliminate full-length fusion protein as 
well as the isolated SUMO domains, yielding the appropriate ClpS protein.  The ClpS 
proteins were then buffer exchanged into its final buffer (above).   
 ClpSM13-106 and ClpSM14-106 were also generated from SUMO cleavage and 
purification due to lack of expression when cloned with the other deletion panel. 
 Plasmids expressing ClpS Q12C C73V C101S, ClpS L13C C73V C101S, and 
ClpS K17C C73V C101S were generated by QuikChange mutagenesis (Stratagene).  
Proteins were purified similarly to the non-His-tagged ClpS proteins above. 
 ClpA variants were generated by QuikChange mutagenesis (Stratagene).  Proteins 
were purified similarly to wild-type ClpA.  Cleared cellular lysate was precipitated with 
40% saturated ammonium sulfate.  The resuspended protein was cleared and purified 
over an SP Sepharose Fast Flow cation exchange column.  Peak fractions were pooled, 
and ammonium sulfate was added to 0.6 M concentration.  The salted sample was then 
purified over a Phe-Source column.  The peak fractions were dialyzed into ClpA reaction 
buffer (50 mM HEPES 7.5, 20 mM MgCl2, 0.3 M NaCl, 10% glycerol, and 0.5 mM 
DTT).   
 ClpA∆N (ClpA143-758) was cloned into and expressed from pET3a (Novagen) in 
ER2556 (DE3) pLysS.  Proteins were purified similarly to the ClpA variants above 
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except the protein was purified over a MonoS followed by a MonoQ column.  Peak 
fractions were dialyzed into ClpA dialysis buffer. 
 Unlabelled and 35S-labelled YLFVQ-I27 protein were purified from the SUMO 
vector and purified as the ClpS variants indicated above.  I27 is a stably-folded domain of 
the human titin protein.  The complete peptide sequence preceding the I27 domain is: 
YLFVQMSHLA.  A FLAG tag is C-terminal to the I27 domain.   
 
Protein degradation 
 All degradation assays were conducted at 30 ºC in ClpA activity buffer with 0.1 
µM ClpA6, 0.27 µM ClpP14, 4 mM ATP, 2.5 mM creatine phosphate, and 50 µg/mL 
creatine kinase.  Where applicable, 1 µM ClpS was added.  Except where indicated, most 
assays utilizing a GFP substrate were at a fixed substrate concentration of 1 µM.  Most 
assays measuring GFP degradation were conducted in a PTI fluorimeter.  Degradation of 
YLFVQ-I27 at different concentrations was monitored by removing reaction time points 
and measuring TCA soluble counts in a liquid scintillation counter.  ClpA 
autodegradation was monitored by quantifying changes in band density on SDS-PAGE 
among samples taken over a time course. 
 
ATP hydrolysis 
 ClpAP ATPase rates were monitored with similar conditions as the degradation 
assays above but with a coupled ATP hydrolysis assay (Kim et al. 2001). 
 
Peptide binding 
 Binding of the peptide YLFVQY-H6-C with a C-terminal fluorescein was 
measured by fluorescence anisotropy in a PTI fluorimeter at 30 ºC.  200 nM peptide was 
added to a range of concentrations of ClpS protein.  No light scattering was evident with 
the Glycine ClpS variant, therefore all of the anisotropy values for all of the variants were 
calculated without correcting for light scattering.   
 
FeBABE cutting assay 
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 The assay with FeBABE (Fe(III) (s)-1-(p-Bromoacetamidobenzyl) 
ethylenediaminetetraacetic acid) (Pierce) was conducted according to the manufacturer’s 
protocol with some changes.  ClpS cysteine variants were buffer exchanged into a metal 
removal buffer (30 mM MOPS, 4 mM EDTA, pH 8.1) overnight at 4 ºC.  The next day, 
the protein was buffer exchanged into conjugation buffer (30 mM MOPS, 100 mM NaCl, 
1 mM EDTA, 5 % glycerol, pH 8.1) after which FeBABE Cutting Reagent resuspended 
in conjugation buffer was added for 1 hour at 37 ºC.  The ClpS bound to FeBABE as well 
as ClpA was buffer exchanged into modified cutting buffer (50 mM MOPS, 300 mM 
NaCl, 10 mM MgCl2, 10% glycerol, pH 8.1).  ClpS-FeBABE and ClpA were mixed with 
1 mM nucleotide and cutting buffer and incubated at room temperature for 30 minutes.  
The cutting reaction was initiated by the addition of 40 mM ascorbic acid and 10 mM 
EDTA immediately followed by 40 mM hydrogen peroxide and 10 mM EDTA.  The 
reaction was quenched by adding electrophoresis sample buffer with 40% glycerol.  The 
reactions were then run on SDS-PAGE.   
 Bands on Coomassie-stained protein gels were analyzed with ImageQuant TL 
software (GE Healthcare).   
 
NTCB cleavage 
 ClpA size standards were created by cleavage with NTCB (2-Nitro-5-
thiocyanobenzoate).  The ClpA variants were incubated with 50 mM DTT at 37 ºC for 
approximately 10 minutes to completely reduce cysteines.  The proteins were then buffer 
exchanged into 200 mM Tris-acetate pH 8, 1 mM EDTA, 5 M urea, and 0.1% SDS after 
which the proteins were incubated at 37 ºC for 20 minutes to react the cysteines with 
NTCB.  Proteins were then immediately buffer exchanged into 200 mM Tris-acetate pH 9 
and incubated at 45 ºC for 2 hours to cleave the protein.   
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CHAPTER FOUR 
A proteomic screen yields candidates for ClpS-dependent ClpAP substrates 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work was done in collaboration with Elizabeth Oakes, Kevin Wang, and Judit Villén 
(laboratory of Steven Gygi, Harvard Medical School).  E.O. assisted with initial mass 
spectrometric analysis, K.W. contributed some initial ClpAP trapping data, and J.V. 
conducted the mass spectrometry and peptide analysis for trapping using SILAC. 
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ABSTRACT 
ClpAP is one of five ATP-dependent proteases in Escherichia coli, and the unique 
cellular role of each of these proteases is still being uncovered.  Here, we used a 
proteomics screen to search for the substrates of ClpAP in an effort to elucidate its 
physiological function.  Using a “trap” form of the ClpP peptidase, we isolated putative 
ClpAP substrates in the presence or absence of its adaptor protein ClpS.  Quantitative 
mass spectrometry using SILAC (stable isotope labeling by amino acids in cell culture) 
has provided a ClpS-dependent comparative identification of putative ClpAP substrates.  
Although two proteins with ssrA-like C-termini, RecN and the N-terminal fragment of 
RseA, have shown to be degraded by ClpAP in a ClpS-dependent manner, thorough 
validation of the trapped substrates has been largely unsuccessful.  We believe that 
substrate-processing steps may be occurring in the cell prior to ClpAP recognition and 
that in vivo validation will enhance substrate verification.   
 
INTRODUCTION 
 Although the AAA+ protease ClpAP has been studied for over 20 years, the field 
does not have a strong understanding of its role in the cell.  Only a few physiological 
substrates are known, and many of these reported substrates are not fully characterized.  
ClpAP has been most studied in E. coli, but several of the putative ClpAP substrates are 
reported from other bacterial species.  It is therefore not determined if all of these 
proteins are degraded by ClpAP in E. coli.  For example, although the protease ClpXP is 
not essential in E. coli for viability, this protease is essential in the bacterium Caulobacter 
crescentus and plays a key role in cell cycle control (Jenal and Fuchs 1998).  Thus, 
ClpXP has known dissimilarities in physiological roles, given the non-identical nature of 
proteomes between organisms.   
 MazE is one of few proteins reported to be degraded by ClpAP in E. coli 
(Aizenman et al. 1996).  It is currently unknown how ClpAP recognizes the 9 kilodalton 
MazE as a substrate.  Because ClpAP has been observed to degrade unfolded proteins 
lacking specifically-characterized degradation tags, it is possible that ClpAP recognizes 
an unfolded region of MazE for degradation.  A more specific degradation tag has not 
been identified on this substrate.  As described earlier in this thesis, ClpAP can degrade 
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ssrA-tagged substrates and N-end-rule substrates.  However, no physiological N-end-rule 
substrates have been well-characterized to date, and ClpAP is not a major contributor to 
ssrA-tagged protein degradation in the cell under the conditions tested (Farrell et al. 
2005; Lies and Maurizi 2008).   
 Overlapping specificities between different proteases also makes understanding 
the physiological role of ClpAP difficult.  Both ClpXP and ClpAP degrade ssrA-tagged 
proteins, for example (Gottesman et al. 1998).  It is very likely that other redundant 
substrates exist in E. coli, and this redundancy may be the cell’s mechanism to ensure 
that priority substrates are degraded, even when the principal protease is incapacitated.   
 Previously, proteome-wide approaches were used to uncover substrates of the 
ClpXP protease (Flynn et al. 2003; Neher et al. 2006).  In these studies, E. coli strains 
were deleted in the genes for clpP, clpA, and smpB.  The wild-type copy of the clpP gene 
was deleted and a peptidase active site mutant (clpP S97A, also known as ClpPTrap) was 
introduced on a plasmid.  As a result, ClpX was only able to feed substrates into ClpPTrap 
instead of wild-type ClpP.  Instead of being degraded, the substrates were sequestered 
intact inside of the ClpP barrel.  These ClpP variants were then purified, and the 
encapsulated substrate proteins were identified by tandem mass spectrometry (Fig. 4.1).  
In these studies, the clpA gene was deleted such that the substrates fed into the mutant 
ClpP were the result of ClpX only, and smpB, a protein involved in ssrA-tagging, was 
deleted such that the isolated substrates did not include stalled translation products slated 
for destruction.  This in vivo protein trapping method generated a list of putative ClpXP 
substrates, many of which have been validated in vivo and in vitro.   
 The first of these ClpXP trapping studies also looked for ClpAP substrates in E. 
coli.  Only a few proteins were identified, and none were tested further for validation: 
AceA (aconitase), GapA (glyceraldehyde 3-phosphate dehydrogenase), OmpA (outer 
membrane protein A), and TnaA (tryptophanase) (Flynn et al. 2003).  It seemed unusual 
that the clpA gene would be conserved solely to degrade a few substrates when ClpXP 
had been attributed dozens of substrates.  Therefore, we embarked on a new study to 
more thoroughly search for ClpAP substrates.   
 The second ClpXP proteomics study uses the method of SILAC (stable isotope 
labeling by amino acids in cell culture) (Neher et al. 2006).  This labeling method, 
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originally used in mammalian cell culture, takes advantage of the ability to grow cells in 
a medium supplemented with heavy-isotope amino acids (Ong et al. 2002).  The study 
conducted by Neher and colleagues aimed to identify ClpXP substrates induced by DNA 
damage.  Leucine auxotrophic strains were employed in which untreated cells were 
grown with 13C-leucine and cells exposed to DNA-damaging agents were grown with 
12C-leucine.  After growth and in vivo protein trapping with ClpPTrap, the two cellular 
extracts were combined, and the trapped substrates were purified and identified by mass 
spectrometry (Fig. 4.2).  Peptides used for mass spectrophotometric analysis from 
substrate proteins trapped in the 13C-leucine medium differ from 12C-leucine substrate 
peptides by six mass units per leucine.  Leucine was selected because it is one of the most 
abundant amino acids in E. coli (Neidhardt and Curtiss 1996), increasing the probability 
that at least one leucine will exist per peptide analyzed.  Due to the differences in mass, 
SILAC can quantify the ratio of peptides from substrates trapped in one strain versus the 
other.  Thus, this method can reveal whether or not particular substrates are preferentially 
trapped in one cell type versus another.   
 In extension of these studies, we have utilized the ClpPTrap to identify in vivo 
substrates of ClpAP.  Furthermore, we are specifically interested in how the adaptor ClpS 
affects ClpAP substrate selectivity.  Here, we describe the utilization of the conventional 
trapping method as well as SILAC to reveal potential ClpAP substrates.   
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Figure 4.1.  In vivo ClpP trapping. 
The AAA+ chaperone (red) recognizes substrates in the cell by their degradation tag 
(orange) and feeds them into the ClpPTrap (green).  Cells are lysed, and the ClpPTrap 
proteins harboring the undegraded substrates are purified using its epitope tag (shown as 
a green tail).  After purification, the ClpPTrap is removed, and the isolated substrate 
proteins are trypsinized and prepared for tandem mass spectrometry.  Peptides are then 
identified and matched to their corresponding protein in the E. coli proteome.   
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Figure 4.2.  SILAC procedure. 
Overall schematic of the clpS+ versus clpS- trapping experiment using heavy-isotope 
labeling.  Proteins are trapped in exclusively light or heavy leucine, and samples are 
mixed prior to purification of ClpPTrap. 
 
 
 
RESULTS 
Initial protein trapping in ClpAP 
 Protease systems have modular components that influence their substrate profiles.  
For example, the presence or absence of adaptor proteins can play a major role in 
deciding which substrates are degraded.  The N-terminal domains of the AAA+ subunit 
of the protease typically serve as docking sites for adaptors, but N-terminal domains are 
also modular entities that have been characterized to bind some substrates.  We used 
ClpP trapping to identify substrates of ClpAP, but more specifically, we sought to 
examine differences in substrate landscapes between cells with differing substrate 
modulators.  The goal therefore was to identify substrates uniquely trapped by ClpAP in 
cells with or without clpS and with or without the N-terminal domain of ClpA.  By 
probing the role of ClpS, we hoped to determine how the adaptor influences ClpAP 
substrate selection.  The trapping experiments targeted towards the N-terminal domain of 
ClpA aimed to identify substrates that either require initial binding to ClpA’s N-terminal 
domain or are delivered by unidentified ClpA adaptors. 
 Multiple repetitions of the trapping experiments followed by mass spectrometry 
showed little overlap in the substrate profile.  It is reported that mass spectrometric 
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analysis of large samples often only reveals a small percentage of the available proteomic 
space, often biased toward abundant proteins (Bantscheff et al. 2007).  This lack of 
reproducibility might explain why multiple repetitions of the same trapping experiments 
would yield results with little overlap.  Moreover, most substrates were identified by 
mass spectrometry by only one or two unique peptides.  These identifications are more 
prone to sampling error and are therefore less confident than if peptides covering the 
entire length of the putative substrates had been detected, and no particular substrate 
emerged as a very strong “hit.”   
With regards to searching for N-end-rule substrates, it is difficult to determine if 
the putative substrate is an intact protein or one that has been cleaved prior to degradation 
by ClpAP.  It is possible that a subset of substrates requires proteolytic processing before 
being recognized by ClpAP.  Trapped proteins were prepared for mass spectrometry by 
running the sample on SDS-PAGE, excising gel bands, and performing trypsinization on 
each gel slice (Fig. 4.1).  After mass spectrometry and identification of the trypsinized 
peptides, the mass of the identified protein was checked to see if it corresponded with the 
average mass of the proteins in its gel slice.  Our results were unclear if any putative 
substrate was processed prior to targeting to yield a significantly different size. 
Because the data lacked sufficiently high resolution to differentiate between ± 
clpS and ± ClpA N-domain substrates, the initial protein trapping studies focused on 
simply assembling a general list of potential ClpAP substrates irrespective of modulating 
factors.  Control trapping experiments were conducted in which both the clpA and clpX 
genes are deleted from the genome.  Any proteins isolated in ClpPTrap from the clpA- and 
clpX- strain were designated as non-specific proteins.  There are several possibilities to 
explain the presence of proteins in the control trapping experiment.  These identified 
proteins might interact with the exterior of ClpPTrap, be fed into ClpPTrap by an 
unidentified AAA+ partner unfoldase, or co-purify with ClpPTrap after cell lysis as 
contaminants.  A list of proteins from the control experiments was generated, and trace 
amounts of several proteins such as RpoB, the beta subunit of RNA polymerase, likely 
persisted through the purification process as contaminants due to their high abundance in 
the cell (Ishihama et al. 2008).   
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 Several candidate substrates that appeared in multiple runs of trapping 
experiments were selected for validation of ClpAP degradation.  Two of the putative 
substrates that were tested by in vivo degradations were HchA (chaperone Hsp31) and Prs 
(phosphoribosylpyrophosphate synthetase).  Genes encoding these proteins were cloned 
into plasmids bearing either an N-terminal tag or a C-terminal tag and expressed in cells 
with and without the clpA gene.  The epitope tags enabled the use of antibody detection 
on western blots to monitor substrate degradation, and because most known degradation 
tags exist on the N- or C-terminus of proteins in bacteria, both N- and C-terminally-
tagged constructs were created for each protein tested in the case that one particular tag 
blocked recognition by ClpAP.   
If a protein was indeed a ClpAP substrate, degradation should be stabilized or 
proceed more slowly in the clpA mutant cell.  Neither HchA nor Prs appeared to be 
reproducibly degraded, let alone stabilized in a clpA- strain (Fig. 4.3a).  We took into 
consideration that under these growth conditions, ClpAP might be degrading too many 
other substrates to demonstrate degradation of our target substrates.  Our trapping strains 
were deleted at the smpB locus to eliminate the possible competition of and confounding 
by ssrA-tagged proteins.  We thus used strains with the same deletion to test for 
degradation.  However, the elimination of the smpB gene did not result in any significant 
and reproducible changes in the putative substrate degradations (Fig. 4.3b).   
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Figure 4.3.  Testing of initial trapped proteins. 
(a) Western blots showing degradation experiments of N- and C-terminally-tagged HchA 
and Prs in vivo with or without ClpA in a wild-type or clpX- background.  (b) Western 
blots showing degradation experiments of HchA and Prs in W3110 ∆smpB cells to test 
for competition with ssrA-tagged proteins. 
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Degradation of substrates with ssrA-like C-terminal tags 
ClpAP is able to degrade ssrA-tagged proteins in vitro (Gottesman et al. 1998), 
and we noticed the presence of trapped proteins with ssrA-like motifs at their C-termini.  
HchA has a C-terminal motif with several di-alanine sequences like the ssrA tag, even 
though this protein did not appear to be degraded under our tested conditions.  RecN, a 
DNA repair protein, ends in a di-alanine sequence and had been characterized to be a 
substrate of ClpXP (Nagashima et al. 2006; Neher et al. 2006).  RecN was identified in 
several trapping experiments, suggesting that it might be a ClpAP substrate.  A plasmid 
bearing an N-terminally-tagged construct of RecN was transformed into wild-type and 
clpA- strains and tested for degradation.  RecN was degraded in wild-type cells and 
slightly stabilized in clpA- cells (Fig. 4.4a).  We hypothesized that the degradation of 
RecN in the absence of ClpAP is likely due to ClpXP.  Figure 4.4b shows the degradation 
of N-terminally-tagged RecN in a clpX- background, and although it is clear that ClpAP 
is making a contribution to the degradation, other proteases appear to participate in RecN 
proteolysis.  Moreover, a version of RecN with two aspartates in place of the final two 
alanines was not degraded by ClpAP (Fig. 4.4c), showing that, similarly to ClpXP, the C-
terminal alanines are important for ClpAP recognition (Neher et al. 2006).  These results 
suggest that ClpAP is one of several proteases able to degrade RecN in the cell, and like 
ssrA-tagged proteins, further demonstrates the overlapping proteolytic capabilities of 
AAA+ proteases.   
Because RecN was degraded in a manner dependent on its C-terminal di-alanines, 
we sought other proteins that might behave similarly.  Although it did not appear in our 
trapping experiments, the N-terminal portion of RseA (RseA1-108), an inhibitor of sigmaE, 
is a ClpXP substrate that bears similarities to the ssrA-tag and can be delivered for 
degradation by the adaptor SspB (Flynn et al. 2004; Levchenko et al. 2005).   Multiple 
proteases have been shown to degrade purified RseA1-108, including ClpAP (Chaba et al. 
2007).  In ClpAP, the degradation of RseA1-108 is inhibited by ClpS and by SspB (Fig. 
4.4d,e).  The inhibition by ClpS is likely due to the ability of ClpS to alter ClpAP’s 
substrate preference away from ssrA-like substrates, and SspB likely inhibits degradation 
by binding to RseA1-108 and sequestering it from ClpA.  Because RseA1-108 has another 
set of di-alanines near the C-terminus, we tested whether or not these alanines could 
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serve as a degradation tag as well.  Interestingly, ClpAP is also able to degrade this even 
shorter truncation of RseA ending with these upstream di-alanines (RseA1-99), albeit less 
well than RseA1-108, and this degradation is also inhibited by ClpS (Fig. 4.4f).  It is thus 
unclear whether ClpAP prefers more sets of di-alanine motifs such that RseA1-108 is 
degraded faster than RseA1-99, or if RseA1-108 simply has a longer unstructured C-
terminus for ClpAP to grasp for degradation.  Although RseA1-108 is clearly degraded by 
ClpAP in vitro, we arise at several possibilities for why RseA was not identified in the 
ClpAP trap: limited sampling of mass spectrometry, ClpAP not degrading RseA1-108 in 
vivo, and lack of extracytoplasmic stress to liberate RseA1-108 (see Chapter One). 
Although it is reasonable to assume that ClpAP would degrade a substrate more 
robustly in vitro in the absence of competitors than in vivo, no substrate tested from our 
initial list with the exception of RecN was degraded as definitively as model proteins, 
such as ssrA-tagged proteins that are degraded in vitro.  Unlike ClpXPTrap, which yielded 
several dozen “hits,” some with many detected peptides, ClpAPTrap yielded longer lists of 
putative substrates with fewer peptides each.  From our initial observations, one might 
conclude that ClpAP does not focus on degrading a small set of specific substrates, but 
instead degrades a wider range of substrates, each at a lower level.  This hypothesis is 
consistent with in vitro experiments showing that ClpAP can degrade many, perhaps 
most, unfolded proteins.  Additionally, with a large list of candidate proteins, the 
likelihood that the tested substrates would be degraded robustly is lower.  Because mass 
spectrometry is not inherently a quantitative technique, we sought to find a method that 
could more accurately quantify the level of proteins in one trapping experiment versus 
another as well as distinguish actual substrates from contaminants.  We expect that a 
quantitative technique should elucidate subtle differences between two traps rather than 
impose black-and-white standards on substrate qualifications. 
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Figure 4.4.  Degradation of ssrA-like proteins. 
(a) Top: The C-terminal sequence of RecN is shown with di-alanines highlighted in bold.  
Bottom: Western blot showing in vivo degradation of N-terminally-tagged RecN.  (b) 
Blot showing in vivo degradation of RecN in a clpX- background to highlight role of 
ClpAP.  (c) In vivo degradation experiment of RecN-DD, in which the last two di-
alanines are substituted by aspartates.  (d) Top: C-terminal sequence of RseA1-108.  
RseA1-99 ends in –WAA.  Di-alanines are highlighted in bold.  Bottom: In vitro 
degradation of RseA1-108 by ClpAP with and without ClpS.  (e) In vitro degradation of 
RseA1-108 by ClpAP with and without SspB as a competitor.  (f) In vitro degradation of 
RseA1-99 with and without ClpS.   
 
 
Comparative protein trapping with SILAC 
 The SILAC approach permits a quantitative comparison of two different samples.  
Based on the ambiguous data observed from our initial trapping studies, we decided to 
employ SILAC as an approach to illuminate subtle differences between trapped protein 
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samples from different strain backgrounds.  We primarily aimed to use SILAC to 
examine the role of ClpS in influencing ClpAP substrate preference in addition to 
understanding the general role of ClpAP in vivo.  Furthermore, we made our purification 
of ClpPTrap slightly more stringent by using a different tagged construct and adding an 
extra purification step.  Additionally, we ran the samples on a more sensitive mass 
spectrometer to detect low abundance peptides.  Two different comparative SILAC 
experiments were carried out in a clpX- smpB- background: clpA+ versus clpA- (both 
clpS+) and clpS+ versus clpS- (both clpA+).  The goal of the first experiment is to weed 
out the substrate proteins that bind to ClpP non-specifically or are contaminants in the 
purification procedure.  The second experiment aimed to study the role of ClpS directly.  
All strains used in the SILAC protein trapping were deleted in the gene for leuB such that 
leucine was required in the growth media.  The clpA+ and clpS+ strains were grown in 
13C-leucine, and the clpA- and clpS- strains were grown in 12C-leucine. 
 The SILAC ratio is the ratio of heavy to light (H/L) peptides for a given protein.  
In our trap, a low H/L ratio indicates that more peptides of a particular protein were from 
the clpS- strain, and a high ratio indicates that more peptides were from the clpS+ strain.  
A SILAC ratio of 1 indicates that equal amounts of heavy and light peptides were 
detected for a protein.  Thus, a low SILAC ratio implies that ClpS directly or indirectly 
inhibits the degradation of a substrate, and a high SILAC ratio implies that ClpS 
enhances the degradation of a substrate.  Table 4.1 shows a list of substrates detected in 
the clpS+ versus clpS- trapping experiment.  Substrates with a SILAC ratio of <1 in the 
clpA+ versus clpA- experiment have been eliminated from the clpS+ versus clpS- list as 
likely contaminants.  Figure 4.5 depicts the range of SILAC ratios amongst the proteins 
trapped in the clpS+ and clpS- experiment.   
 
 
Table 4.1.  Putative substrates from clpS+ and clpS- SILAC trapping.¥
Gene NCBI GI Peptides*
SILAC 
Ratio 
(H/L)+ Description 
cysH 16130669 2 0.181799 phosphoadenosine phosphosulfate reductase 
lpxC 16128089 2 0.20466 UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine 
deacetylase 
fruK 16130106 2 0.235401 1-phosphofructokinase 
asnB 16128650 2 0.249121 asparagine synthetase B 
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agaR 16131023 2 0.269694 DNA-binding transcriptional dual regulator 
yedO 90111355 3 0.30969 D-cysteine desulfhydrase 
tgt 16128391 2 0.318358 queuine tRNA-ribosyltransferase 
rplJ 16131815 5 0.332085 50S ribosomal protein L10 
mog 16128003 2 0.335395 molybdenum cofactor biosynthesis protein 
yjtD 16132220 2 0.336357 predicted rRNA methyltransferase 
nirB 16131244 13 0.347698 nitrite reductase, large subunit, NAD(P)H-binding 
asd 16131307 2 0.372036 aspartate-semialdehyde dehydrogenase 
oppD 49176090 6 0.376818 oligopeptide transporter ATP-binding component 
accA 16128178 4 0.381838 acetyl-CoA carboxylase subunit alpha 
nfo 16130097 2 0.386495 endonuclease IV 
galF 16129982 7 0.402537 predicted subunit with GalU 
yqiB 16130929 2 0.411119 predicted dehydrogenase 
accC 16131144 2 0.413407 acetyl-CoA carboxylase 
aceE 16128107 11 0.415422 pyruvate dehydrogenase subunit E1 
rfbD 16129980 2 0.418822 dTDP-4-dehydrorhamnose reductase subunit, NAD(P)-
binding, of dTDP-L-rhamnose synthase 
orn 90111697 2 0.420788 oligoribonuclease 
thrS 16129675 3 0.424612 threonyl-tRNA synthetase 
pfkA 16131754 6 0.431837 6-phosphofructokinase 
wrbA 16128970 2 0.434417 TrpR binding protein WrbA 
rpsA 16128878 10 0.435948 30S ribosomal protein S1 
pheS 16129670 4 0.438021 phenylalanyl-tRNA synthetase alpha subunit 
yhfA 16131235 2 0.440664 hypothetical protein 
poxB 16128839 2 0.440869 pyruvate dehydrogenase 
iscS 49176235 7 0.444081 cysteine desulfurase 
yciW 90111242 2 0.444918 predicted oxidoreductase 
yegS 16130026 2 0.464336 hypothetical protein 
eda 16129803 2 0.476927 keto-hydroxyglutarate-aldolase/keto-deoxy-
phosphogluconate aldolase 
rfbC 16129978 5 0.493958 dTDP-4-deoxyrhamnose-3,5-epimerase 
ydaO 16129305 3 0.496246 predicted C32 tRNA thiolase 
pykF 16129632 8 0.502952 pyruvate kinase 
rpoS 16130648 12 0.5056 RNA polymerase sigma factor 
gatZ 16130033 5 0.520004 D-tagatose 1,6-bisphosphate aldolase 2, subunit 
gmd 16129993 4 0.524833 GDP-D-mannose dehydratase, NAD(P)-binding 
fabZ 16128173 3 0.527273 (3R)-hydroxymyristoyl ACP dehydratase 
adhE 16129202 10 0.535466 fused acetaldehyde-CoA dehydrogenase/iron-dependent 
alcohol dehydrogenase/pyruvate-formate lyase 
deactivase 
serS 16128860 2 0.550442 seryl-tRNA synthetase 
ymdB 16129008 2 0.552689 hypothetical protein 
ycaJ 16128859 3 0.553843 recombination protein 
sfcA 90111281 2 0.559554 malate dehydrogenase, (decarboxylating, NAD-
requiring) (malic enzyme) 
ptsI 16130342 9 0.560333 PEP-protein phosphotransferase of PTS system (enzyme 
I) 
rcsB 16130154 2 0.561389 DNA-binding response regulator in two-component 
regulatory system with RcsC and YojN 
tyrB 16131880 3 0.566613 tyrosine aminotransferase, tyrosine-repressible, PLP-
dependent 
nadE 16129694 5 0.568537 NAD synthetase 
glpK 16131764 2 0.574621 glycerol kinase 
ndh 16129072 2 0.57531 respiratory NADH dehydrogenase 2/cupric reductase 
cdd 16130081 4 0.580937 cytidine deaminase 
lrp 16128856 2 0.582644 DNA-binding transcriptional dual regulator, leucine-
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binding 
icd 16129099 2 0.592902 isocitrate dehydrogenase 
udp 16131680 4 0.594177 uridine phosphorylase 
insC-1 16128345 2 0.610037 IS2 insertion element repressor InsA 
aceA 16131841 3 0.621476 isocitrate lyase 
lepA 16130494 5 0.624024 GTP-binding protein LepA 
nuoB 16130222 9 0.62902 NADH dehydrogenase subunit B 
nuoC 16130221 2 0.634109 NADH:ubiquinone oxidoreductase, chain C,D 
acnB 16128111 10 0.641847 aconitate hydratase 
ahpC 16128588 4 0.64442 alkyl hydroperoxide reductase, C22 subunit 
rfbA 16129979 7 0.647576 glucose-1-phosphate thymidylyltransferase 
gatA 16130032 6 0.655826 galactitol-specific enzyme IIA component of PTS 
nudC 49176450 2 0.662687 NADH pyrophosphatase 
oppF 16129208 6 0.663085 oligopeptide transporter subunit 
evgA 16130301 2 0.689258 DNA-binding response regulator in two-component 
regulatory system with EvgS 
glf 16129976 3 0.690615 UDP-galactopyranose mutase, FAD/NAD(P)-binding 
talA 16130389 8 0.6995 transaldolase A 
cytR 16131772 2 0.712274 DNA-binding transcriptional dual regulator 
rpsI 16131120 3 0.716812 30S ribosomal protein S9 
clpA 16128850 3 0.717764 ATPase and specificity subunit of ClpA-ClpP ATP-
dependent serine protease, chaperone activity 
yjjI 16132197 2 0.719278 hypothetical protein 
yeaK 16129741 2 0.722515 hypothetical protein 
miaB 16128644 12 0.728181 isopentenyl-adenosine A37 tRNA methylthiolase 
pepQ 16131693 2 0.74442 proline dipeptidase 
ycfP 90111213 4 0.748727 hypothetical protein 
manX 16129771 3 0.750749 fused mannose-specific PTS enzymes: IIA 
component/IIB component 
rpoA 16131174 6 0.759549 DNA-directed RNA polymerase subunit alpha 
clpX 16128423 5 0.761142 ATP-dependent protease ATP-binding subunit 
amyA 16129874 2 0.765774 cytoplasmic alpha-amylase 
bioB 16128743 2 0.771695 biotin synthase 
dapA 16130403 2 0.774613 dihydrodipicolinate synthase 
iadA 16132149 3 0.777779 isoaspartyl dipeptidase 
murE 16128078 2 0.787788 UDP-N-acetylmuramoylalanyl-D-glutamate--2,6-
diaminopimelate ligase 
yejK 16130124 6 0.790699 nucleoid-associated protein NdpA 
tufA 16131218 7 0.793572 protein chain elongation factor EF-Tu (duplicate of tufB) 
ftn 16129855 2 0.795097 ferritin iron storage protein (cytoplasmic) 
nadB 16130499 2 0.797112 L-aspartate oxidase 
ydjA 16129719 5 0.813597 predicted oxidoreductase 
fruR 16128073 3 0.824745 DNA-binding transcriptional dual regulator 
rpsH 16131185 5 0.844545 30S ribosomal protein S8 
gyrA 16130166 2 0.858286 DNA gyrase subunit A 
bfr 16131215 4 0.86431 bacterioferritin, iron storage and detoxification protein 
guaA 16130432 5 0.870947 bifunctional GMP synthase/glutamine amidotransferase 
protein 
cysK 16130340 7 0.872268 cysteine synthase A, O-acetylserine sulfhydrolase A 
subunit 
hdhA 16129577 3 0.873648 7-alpha-hydroxysteroid dehydrogenase 
fabA 16128921 3 0.87647 3-hydroxydecanoyl-ACP dehydratase 
phoP 16129093 4 0.878044 DNA-binding response regulator in two-component 
regulatory system with PhoQ 
tig 16128421 10 0.881173 trigger factor 
prsA 16129170 3 0.885314 ribose-phosphate pyrophosphokinase 
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yhdH 16131141 2 0.890545 predicted oxidoreductase, Zn-dependent and NAD(P)-
binding 
dhaH 90111232 3 0.894986 fused predicted dihydroxyacetone-specific PTS 
enzymes: HPr component/EI component 
rne 16129047 10 0.907033 fused ribonucleaseE: endoribonuclease/RNA-binding 
protein/RNA degradosome binding protein 
ygcF 16130684 2 0.909408 hypothetical protein 
groL 16131968 8 0.914014 chaperonin GroEL 
pflB 16128870 21 0.917315 pyruvate formate lyase I 
nuoG 49176206 4 0.923445 NADH dehydrogenase subunit G 
yegQ 16130021 2 0.943288 predicted peptidase 
atpH 16131603 2 0.944706 F0F1 ATP synthase subunit delta 
gyrB 49176395 9 0.961725 DNA gyrase subunit B 
rpoB 16131817 21 0.96186 DNA-directed RNA polymerase subunit beta 
pheT 16129669 3 0.972833 phenylalanyl-tRNA synthetase beta subunit 
gpmA 16128723 2 0.973159 phosphoglyceromutase 
ydgA 16129572 7 0.980119 hypothetical protein 
yigI 90111652 5 0.984798 hypothetical protein 
gldA 90111668 5 0.989556 glycerol dehydrogenase 
frdB 16131978 2 1.000946 fumarate reductase (anaerobic), Fe-S subunit 
rpoC 16131818 29 1.00198 DNA-directed RNA polymerase subunit beta' 
rho 16131639 10 1.01238 transcription termination factor Rho 
hepA 16128053 2 1.016214 ATP-dependent helicase HepA 
ahpF 90111152 10 1.025201 alkyl hydroperoxide reductase, F52a subunit, 
FAD/NAD(P)-binding 
rplB 16131196 10 1.028697 50S ribosomal protein L2 
rplT 16129672 2 1.031948 50S ribosomal protein L20 
mpl 16132055 6 1.034562 UDP-N-acetylmuramate:L-alanyl-gamma-D-glutamyl-
meso-diaminopimelate ligase 
hslO 90111586 2 1.035115 Hsp33-like chaperonin 
oxyR 16131799 2 1.037555 DNA-binding transcriptional dual regulator 
mcrB 90111737 2 1.049078 5-methylcytosine-specific restriction enzyme McrBC, 
subunit McrB 
rpsB 16128162 2 1.055113 30S ribosomal protein S2 
sspA 16131119 2 1.059902 stringent starvation protein A 
mreB 90111564 5 1.066764 cell wall structural complex MreBCD, actin-like 
component MreB 
ydcF 16129375 2 1.0774 hypothetical protein 
mrp 90111388 4 1.077511 antiporter inner membrane protein 
rbsK 16131620 2 1.07937 ribokinase 
talB 16128002 7 1.083969 transaldolase B 
ribB 16130937 2 1.086943 3,4-dihydroxy-2-butanone 4-phosphate synthase 
ybhA 16128734 4 1.093995 predicted hydrolase 
pyrG 16130687 5 1.094551 CTP synthetase 
ftsA 16128087 4 1.099742 cell division protein 
ribC 16129620 2 1.100347 riboflavin synthase subunit alpha 
folC 16130250 4 1.105252 bifunctional folylpolyglutamate synthase/ dihydrofolate 
synthase 
cysN 16130658 2 1.109652 sulfate adenylyltransferase subunit 1 
glpR 16131297 2 1.110796 DNA-binding transcriptional repressor 
dnaJ 16128009 5 1.111569 chaperone Hsp40, co-chaperone with DnaK 
yhbG 16131091 2 1.124241 predicted transporter subunit: ATP-binding component 
of ABC superfamily 
hisB 90111373 3 1.12522 imidazole glycerol-phosphate dehydratase/histidinol 
phosphatase 
narP 16130130 5 1.127565 DNA-binding response regulator in two-component 
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regulatory system with NarQ or NarX 
yajL 90111131 2 1.13211 hypothetical protein 
ydhD 16129612 3 1.13322 hypothetical protein 
rfaD 16131490 3 1.135183 ADP-L-glycero-D-mannoheptose-6-epimerase, 
NAD(P)-binding 
iscR 16130456 2 1.136605 DNA-binding transcriptional repressor 
yhdN 16131172 3 1.142832 hypothetical protein 
pdxB 16130255 6 1.17485 erythronate-4-phosphate dehydrogenase 
ygfB 90111511 2 1.179514 hypothetical protein 
cysA 16130348 2 1.179913 sulfate/thiosulfate transporter subunit 
spoT 16131521 2 1.185143 bifunctional (p)ppGpp synthetase II/ guanosine-3',5'-bis 
pyrophosphate 3'-pyrophosphohydrolase 
cysC 16130657 2 1.194343 adenylylsulfate kinase 
yeiE 16130095 5 1.215159 predicted DNA-binding transcriptional regulator 
ansA 16129721 4 1.224707 cytoplasmic asparaginase I 
prmB 90111419 2 1.225542 N5-glutamine methyltransferase 
lipA 16128611 6 1.22884 lipoyl synthase 
acrA 16128447 10 1.251609 multidrug efflux system 
kbl 16131488 4 1.255954 2-amino-3-ketobutyrate coenzyme A ligase 
glmS 16131597 28 1.256188 D-fructose-6-phosphate amidotransferase 
mprA 16130596 2 1.261835 DNA-binding transcriptional repressor of microcin B17 
synthesis and multidrug efflux 
ytfP 16132044 2 1.265386 hypothetical protein 
yeeN 16129927 2 1.267921 hypothetical protein 
yneJ 16129485 3 1.272252 predicted DNA-binding transcriptional regulator 
htpG 16128457 7 1.291656 heat shock protein 90 
fusA 16131219 10 1.311558 elongation factor EF-2 
rsuA 16130121 6 1.318663 16S rRNA pseudouridylate 516 synthase 
ompA 16128924 8 1.319347 outer membrane protein A (3a;II*;G;d) 
pspF 90111246 2 1.322085 DNA-binding transcriptional activator 
dnaK 16128008 52 1.331164 molecular chaperone DnaK 
hslU 16131769 8 1.346604 ATP-dependent protease ATP-binding subunit 
crp 16131236 15 1.349575 DNA-binding transcriptional dual regulator 
clpB 16130513 2 1.356743 protein disaggregation chaperone 
yqjI 16130966 3 1.357565 predicted transcriptional regulator 
dnaX 16128454 2 1.38914 DNA polymerase III subunits gamma and tau 
grpE 16130533 8 1.389407 heat shock protein 
katE 49176140 8 1.396297 hydroperoxidase HPII(III) (catalase) 
rfaE 16130948 7 1.400256 fused heptose 7-phosphate kinase/heptose 1-phosphate 
adenyltransferase 
clpP 16128422 37 1.402548 ATP-dependent Clp protease proteolytic subunit 
wbbI 16129974 2 1.41023 hypothetical protein 
trkA 16131169 18 1.410882 potassium transporter peripheral membrane component 
hypB 16130634 11 1.41572 GTP hydrolase involved in nickel liganding into 
hydrogenases 
glnD 16128160 3 1.430993 PII uridylyl-transferase 
lon 16128424 10 1.465546 DNA-binding ATP-dependent protease La 
fnr 16129295 2 1.468049 DNA-binding transcriptional dual regulator, global 
regulator of anaerobic growth 
tpx 16129285 2 1.470169 thiol peroxidase 
dps 16128780 7 1.478395 DNA protection during starvation conditions 
ybeZ 16128643 3 1.497608 predicted protein with nucleoside triphosphate hydrolase 
domain 
greA 90111554 4 1.528812 transcription elongation factor GreA 
speG 16129542 3 1.539196 spermidine N1-acetyltransferase 
rplN 16131189 7 1.555762 50S ribosomal protein L14 
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radA 16132206 5 1.620587 predicted repair protein 
yahK 16128310 3 1.650819 predicted oxidoreductase, Zn-dependent and NAD(P)-
binding 
hscA 16130451 5 1.686969 chaperone protein HscA 
rbfA 16131059 2 1.690763 ribosome-binding factor A 
nagC 16128652 2 1.69563 DNA-binding transcriptional dual regulator, repressor of 
N-acetylglucosamine 
moaB 16128750 2 1.734879 molybdopterin biosynthesis protein B 
sthA 90111670 3 1.743317 soluble pyridine nucleotide transhydrogenase 
recN 49176247 11 1.749762 recombination and repair protein 
hns 16129198 2 1.800124 global DNA-binding transcriptional dual regulator H-NS 
ykgG 90111113 5 1.820142 predicted transporter 
ybaB 16128455 2 1.838957 hypothetical protein 
tdk 16129199 3 1.845321 thymidine kinase 
gadB 16129452 7 1.889412 glutamate decarboxylase B, PLP-dependent 
glgA 16131303 8 1.924133 glycogen synthase 
sucB 16128702 6 2.005071 dihydrolipoamide acetyltransferase 
efp 16131972 2 2.065575 elongation factor P 
atpA 16131602 9 2.098482 F0F1 ATP synthase subunit alpha 
znuA 90111346 5 2.153056 high-affinity zinc transporter periplasmic component 
hha 16128444 2 2.374178 modulator of gene expression, with H-NS 
slyB 49176129 3 2.424912 outer membrane lipoprotein 
yifE 16131624 2 2.530014 hypothetical protein 
yceB 16129026 2 2.71146 predicted lipoprotein 
znuC 16129811 4 2.808923 high-affinity zinc transporter ATPase 
degQ 16131124 2 3.027239 serine endoprotease, periplasmic 
murA 16131079 3 3.158488 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
degP 16128154 4 3.187974 serine endoprotease (protease Do), membrane-associated 
ibpB 90111637 2 3.28724 heat shock chaperone 
pgi 16131851 2 3.407882 glucose-6-phosphate isomerase 
hemA 16129173 2 3.488775 glutamyl-tRNA reductase 
nhaR 16128014 2 3.600085 DNA-binding transcriptional activator 
pyrB 16132067 2 3.612842 aspartate carbamoyltransferase catalytic subunit 
mqo 16130147 2 3.715075 malate:quinone oxidoreductase 
yhjK 90111607 3 3.773987 predicted diguanylate cyclase 
fis 16131149 4 4.043683 DNA-binding protein Fis 
atpF 16131604 3 4.267656 F0F1 ATP synthase subunit B 
cbl 16129929 2 4.459872 DNA-binding transcriptional activator of cysteine 
biosynthesis 
ftsH 16131068 5 5.517936 protease, ATP-dependent zinc-metallo 
cysJ 16130671 4 6.224329 sulfite reductase, alpha subunit, flavoprotein 
ibpA 16131555 2 6.272969 heat shock chaperone 
yhjJ 16131399 2 6.778832 predicted zinc-dependent peptidase 
carA 16128026 2 8.4552 carbamoyl-phosphate synthase small subunit 
yrbC 16131082 2 9.575311 predicted ABC-type organic solvent transporter 
carB 16128027 2 10.44367 carbamoyl-phosphate synthase large subunit 
rseB 16130496 2 15.51535 periplasmic negative regulator of sigmaE 
yiiD 16131728 3 17.75486 predicted acetyltransferase 
¥ Proteins identified in the clpA+ versus clpA- trapping experiment with a SILAC ratio <1 (enriched in the 
clpA- trap) are removed from this list.  Proteins 3-fold enriched in the clpS- or the clpS+ trap are 
highlighted in bold.   
* This column refers to the number of unique peptides identified that were quantified (both heavy and light 
peptides detected), with outliers removed.   
+The SILAC ratio shown reflects the average SILAC ratio of the peptides included in the previous column. 
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Figure 4.5.  SILAC protein trapping. 
Depiction of the protein trapped in the clpS+ versus clpS- experiment, with proteins 
trapped in clpA- cells removed.  On the x-axis, proteins are numbered according to their 
SILAC ratio.   
 
 
 Some proteins in this list of over 200 genes are recognizable from lists generated 
from our initial trapping studies.  Even though the list is weeded for proteins enriched in 
the clpA- trap, it is possible that non-specific substrates are still present in the clpS+ 
versus clpS- list due to experiment-to-experiment sampling limitations for mass 
spectrometry.  For example, RpoB (ratio 0.96186) was detected in the clpA- control traps 
from our initial studies, but escaped screening in the SILAC experiment.  HchA is not 
found in this experiment, but Prs (PrsA) is listed with a SILAC ratio of 0.885314.  
However, proteins like RecN (ratio 1.749762) and HemA (ratio 3.488775), a gene for 
glutamate synthesis characterized to be a ClpAP substrate in Salmonella typhimurium, 
appear in the SILAC list, providing one level of substrate verification.   
 We selected several SILAC substrates for further validation.  We chose proteins 
with relatively extreme SILAC ratios because these substrates are more likely to exhibit 
the expected behavior with respect to ClpS.  Furthermore, we decided to focus our 
attention on transcriptional regulators because transcription factors are generally in low 
abundance in the cells, and their presence in ClpPTrap is more likely to be specific 
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(Ishihama et al. 2008).  Lastly, the proteins that we selected for further testing were 
annotated as being cytoplasmic, as proteins reported to be in the membrane or periplasm 
are more likely to be artifactual.  The four transcription factors we chose for in vivo and 
in vitro verification are Cbl, NhaR, Fis, and AgaR.  Cbl (ratio 4.459872), NhaR (ratio 
3.600085), and Fis (ratio 4.043682) have high SILAC ratios, and AgaR (ratio 0.269694) 
has a low ratio.   
 
Validation of trapping candidates identified by SILAC 
 First, N- or C-terminal epitope tagged versions of these proteins were expressed 
in cells for in vivo validation.  Tagged Cbl, NhaR, and Fis did not show reproducible and 
robust evidence of proteolysis under these growth and induction conditions (Fig 4.6a).  
AgaR was visibly degraded in vivo, but neither N- or C-terminally tagged AgaR appeared 
to be stabilized in the clpA- strain (Fig. 4.6a).  Because ClpAP and ClpXP share some 
substrates, the degradation of AgaR was tested in clpX- cells (Fig. 4.6b).  However, there 
was no strong observable change in the degradation pattern, although C-terminally-
tagged AgaR may be slightly stabilized in clpX- clpA- cells.  As with validation of the 
first round of trapping studies using non-quantitative mass spectrometry, we considered 
testing the degradations in strains with smpB and other protease genes deleted to 
highlight a potentially subtle ClpA-dependent role.  However, to directly monitor if ClpA 
recognizes these proteins, we decided to test for degradation in vitro.   
 Purified His-tag putative substrates were tested in vitro with and without ClpS, 
with the exception of N-terminally-tagged Fis which did not overexpress for purification.  
No degradation was observed under the tested conditions with or without ClpS (Fig. 
4.7a).  Degradation of these purified proteins was also tested with ClpXP because there is 
some overlap in substrate selectivity between ClpAP and ClpXP.  However, neither Cbl, 
NhaR, Fis, nor AgaR was proteolyzed by ClpXP under these conditions, although there 
might be some clipping of C-tagged AgaR, as indicated by the increase of a slightly 
smaller truncation band (Fig. 4.7b).   
 None of the proteins from this small validation pool appeared to be ClpAP 
substrates under conditions tested.  Furthermore, IbpA and IbpB, two small heat-shock 
proteins enriched in the clpS+ trap also did not appear to be degraded by ClpAP in vivo or 
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in vitro, with or without ClpS, under a number of surveyed conditions (S. Bissonnette, 
personal communication).  The lack of ClpAP/ClpAPS-dependent degradation of all the 
tested trapping substrates might occur for several reasons.  First, it is possible that the 
proteins identified in ClpAPTrap are substrates because they are recognized as unfolded 
proteins in the cell.  For example, a small percentage of a putative substrate may be 
unfolded and recognized, and the purified protein and plasmid-overexpressed substrates 
may be primarily folded and therefore not visibly degraded.  However, in vitro 
experiments have shown that ClpS inhibits ClpAP’s ability to recognize unfolded 
substrates, so this explanation is not consistent with putative substrates enriched in the 
clpS+ trap.  Second, ClpAP may exist in the cell primarily for N-end-rule substrates, 
despite being a back-up protease to ClpXP for ssrA-like substrates.  Perhaps most 
proteins found in the ClpAPTrap are proteolytically processed to reveal an N-degron.  
Because N-end-rule substrates can also be degraded by ClpAP in the absence of ClpS, 
most of the proteins found in both clpS+ and clpS- traps may be N-end-rule substrates 
(Wang et al. 2007).  Depending on the nature of the N-degron, ClpS may still exert a 
substrate preference to ClpAP, as indicated by the putative substrates that are detected 
with very high or very low SILAC ratios.   
For the validation experiments, the plasmid-overexpressed proteins and proteins 
that are greatly overexpressed prior to being purified might overwhelm the processing 
machinery that reveals the N-degrons and therefore evade recognition by ClpAP(S).  For 
the in vivo degradations, lowering the arabinose concentrations used for protein induction 
may alleviate a potential saturation.  Unfortunately, insufficient peptides for each putative 
substrate were identified to ascertain whether or not a portion of the protein was trapped 
as opposed to the entire gene product.  Moreover, proteins that are processed prior to 
trapping may yield an N-terminal peptide upon tryptic digestion (prior to mass 
spectrometry) that does not correspond to an expected mass and fragmentation pattern 
calculated by in silico protein trypsinization.  Consequently, the truncated N-terminal 
peptide of these trapped proteins will likely be overlooked by the algorithms used to 
identify peptides. 
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Figure 4.6.  In vivo validation of transcription factors. 
(a) Western blot showing in vivo degradation experiments of N- and C-terminally-tagged 
Cbl, NhaR, AgaR, and Fis.  (b) Degradation of AgaR in a clpX- background. 
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Figure 4.7.   In vitro validation of transcription factors. 
(a) In vitro degradation of purified N- and C-terminally-tagged proteins by ClpAP, with 
and without ClpS.   (b) In vitro degradation of purified N- and C-terminally-tagged 
proteins by ClpXP.  The accumulation of a truncation product is noticeable in the 
degradation of C-AgaR.   
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Re-trapping of SILAC-generated trapping candidates 
To determine whether the entire or a part of the protein was trapped, we sought to 
“re-trap” the four candidate ClpAP substrates into ClpPTrap.  First, we conducted a control 
experiment to determine if plasmid-expressed GFP-ssrA could be trapped by ClpAP in 
the cell.  GFP-ssrA was indeed enriched in the ClpAPTrap; a slight band for GFP-ssrA 
appears in the western blot for both clpS+ and clpS- trapping experiments (Fig. 4.8a).  
Because ClpS inhibits the ability of ClpAP to degrade ssrA-tagged proteins, we expected 
GFP-ssrA to be more enriched in the clpS- strain trap.  However, because the ClpS and 
ClpA ratios change during the transition from exponential to stationary phase, and 
substoichiometric levels of ClpS permit some degradation of ssrA-tagged proteins, it was 
not completely unexpected that some GFP-ssrA would also be trapped in a clpS+ strain 
(Farrell et al. 2005; Hou et al. 2008).   
 N- and C-terminal epitope-tagged constructs of the putative substrate genes were 
co-expressed with ClpPTrap.  Only N-terminally-tagged Cbl did not visibly appear by 
western blotting to be re-trapped (Fig. 4.8b).  All of the other constructs appeared to be 
trapped in both clpS+ and clpS- cells.  Unexpectedly, both N- and C-terminally tagged 
AgaR appeared as two bands, with one band at a much higher molecular weight than 
expected.  The nature of this larger band is unknown, but the differential enrichment of 
the upper band is not identical to the differential enrichment of the smaller band.  None of 
the detected bands appeared smaller by gel than predicted, implying that these trapped 
species either did not require a proteolysis step prior to ClpAP recognition or were 
processed very close to a terminus.  Several constructs such as C-Cbl and C-NhaR 
yielded trapping patterns consistent with their SILAC ratio in which protein is enriched in 
clpS+ traps as opposed to clpS- traps.  However, the C-Fis appeared to be slightly 
enriched in the clpS- trap, which contradicts its SILAC ratio.  Although it is difficult to 
quantify the level of substrates trapped in each strain, this experiment shows that some of 
the proteins are able to be re-trapped into ClpP.  However, these results cannot 
definitively address whether or not these proteins are being recognized by ClpAP as N-
end-rule substrates after a processing step.    
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Figure 4.8.  Re-trapping of putative ClpAP substrates. 
(a) Western blots showing the trapped GFP-ssrA in clpS+ and clpS- cells.  ClpPTrap was 
purified over streptactin beads and washed thoroughly before elution with biotin.  (b) 
Western blots showing the relative re-trapping levels of tagged proteins using an antibody 
against the N- or C-terminal epitope tag.  A higher molecular weight band reactive 
appeared in western blots for both N- and C-AgaR.  The nature of this higher molecular 
weight band is unknown.   
 
Fis, an endogenous candidate 
Because there could be many explanations behind the lack of degradation with 
purified or overexpressed proteins, we decided to direct our attention to studying the 
endogenous levels of the candidate substrates.  Fis was chosen for further study because 
previous reports indicate that Fis levels change according to the growth conditions of the 
cell (Ball et al. 1992).  Data from E. coli and Salmonella demonstrate that Fis (factor for 
inversion stimulation) protein is involved in many roles such as site-specific DNA 
recombination, replication initiation, and transcriptional control (Osuna et al. 1995).  Fis 
levels change dramatically according to the cellular growth conditions.  When stationary 
phase bacteria are inoculated into fresh, rich media, Fis levels rise dramatically.  After the 
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cells begin to divide in exponential phase, Fis levels fall to nearly undetectable levels by 
stationary phase (Ball et al. 1992; Osuna et al. 1995).  Although the majority of these 
changes in Fis level can be attributed to changes in mRNA levels, one report suggests 
that the levels of Fis decline slightly more rapidly than would be estimated by cell 
division and dilution alone (Ball et al. 1992).  Therefore, it may be possible that an active 
proteolytic mechanism is functioning at low levels in exponential phase.   
We conducted experiments in which we back-diluted wild-type, clpA-, and clpS- 
cells grown overnight into fresh media.  The growth curves showed that the clpS- cells 
grew consistently more slowly in exponential phase than wild-type or clpA- cells (Fig. 
4.9a).  However, we were unable to clearly detect Fis levels using our antibody.  One 
piece of data suggests a similar growth pattern as reported in which Fis levels rise 
immediately upon back-dilution into fresh media and then drop as the cell proceeds into 
stationary phase (Fig. 4.9b).  Furthermore, Figure 4.9b suggests that Fis levels may be 
slightly more stabilized in clpA- cells, but these results were generally too unclear and 
non-reproducible for certainty.  New antibodies to Fis have recently been generated to 
address these experiments.   
Based on the studies of Ball and colleagues in 1992, if Fis is being degraded in 
exponential phase, this degradation must be at low levels because simple dilution 
explains most of the decline in levels.  Thus, if ClpAP is indeed degrading Fis, then the 
rate of degradation might also be slow.  We returned to in vitro degradations of un-tagged 
Fis (a gift from R. Johnson) but with the use of higher enzyme concentrations.  After 20 
minutes, about 34% of Fis is degraded by ClpAP under these conditions.  ClpS and Fis 
co-migrate on the gel, but quantification of the combined band shows that Fis is not 
detectably degraded (Fig.4.9c).  These results contradict the trapping results.  However, 
we return to our hypothesis that Fis, and other putative substrates, may indeed require 
processing to be efficiently degraded by ClpA, and that the observed degradation in vitro 
may simply be a fraction of protein that is transiently unfolded and engaged by the 
enzyme.  Thus, although our results from Fis are currently inconclusive, we believe that 
studying putative substrates at their normally-expressed levels in vivo is the clearest way 
to determine if proteins are substrates of ClpAP.   
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Figure 4.9.  Validation of Fis degradation. 
(a)  Growth of cells after back-dilution into fresh, warmed LB used for monitoring 
endogenous Fis degradation.  Cells lacking clpS consistently grew more slowly than 
wild-type or clpA- cells.   (b) Western blot using anti-Fis antibodies to monitor Fis levels 
during the course of cell growth shown in A.  Slight stabilization might exist in clpA- and 
clpS- cells, but blots were highly variable, and Fis detection was weak.  (c) In vitro 
degradation of purified, un-tagged Fis protein by ClpAP with and without ClpS.  Fis and 
ClpS co-migrate on SDS-PAGE (top), and the ClpS-Fis band was quantified together, 
assuming ClpS levels are stable (bottom).  Slight degradation of Fis occurred without 
ClpS, and ClpS stabilized this degradation.   
 
 
DISCUSSION 
 Despite extensive mechanistic study, the physiological role of ClpAP has been 
largely a mystery.  Advances in mass spectrometry have assisted in proteomics 
experiments and have provided a powerful and sensitive tool to learning about the 
substrates of AAA+ proteins.  Here, we have explored the substrate landscape of ClpAP 
in E. coli.  Although our picture on the physiological role of ClpAP is still unclear, our 
mass spectrometry data suggests that ClpAP is not dedicated to degrading a few key 
substrates in the cell.  Rather, ClpAP likely degrades a wide variety of proteins in vivo.  
The degradation of most of these proteins may be largely for quality control as opposed 
to being a key step in a regulatory pathway.  The degradation of unfolded proteins and 
proteins possessing an N-degron may fall into the category of quality control.  In theory, 
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any protein in the cell can potentially be unfolded or aberrantly cleaved to reveal an N-
terminally destabilizing residue.  This potential generality in substrate selection may 
explain why the trapping experiments for ClpAP yield a long list of substrates but few 
peptides per substrate.  No singular protein stands out from the mass spectrometry data as 
a specific degradation target.   
 The majority of the proteins detected in the SILAC experiment were identified by 
five or fewer unique peptides (Table 1).  Many of the proteins with high levels of unique 
peptides are involved in transcription or translation and are generally abundant in the cell 
and were thought to be non-specific contaminants (Ishihama et al. 2008).  For instance, 
proteins such as RpoS, Crp, and GlmS have been identified in early clpA- control traps.  
We chose the transcription factors Cbl, NhaR, Fis, and AgaR for further testing because 
they had relatively extreme SILAC ratios, and the levels of transcription factors are 
generally low in the cell, suggesting that their presence in the trap may be more specific.  
Furthermore, transcription factors often gave positive results in validation experiments 
for ClpXP trapping studies (Flynn et al. 2003; Neher et al. 2003; Neher et al. 2006; 
Pruteanu et al. 2007).  However, Cbl, NhaR, Fis, and AgaR were each only identified by 
2-4 unique peptides.  It is interesting to note that RecN, a validated substrate from our 
initial traps, was detected by 11 peptides.  Though, RecN was enriched in the clpS+ trap 
yet seems to be inhibited by ClpS when tested directly in vitro.  The correlation between 
peptide number and likelihood of being a substrate is not precise because smaller proteins 
will yield fewer peptides.  Nevertheless, changing the strategy of validation toward 
testing proteins with the highest number of unique peptides, even if it is thought that the 
reason for the high numbers are due to contamination by abundant cellular proteins, 
might yield more success than guessing which proteins are the most specific by their 
function and generally low cellular abundance.   
 Because of the conservation of N-end-rule machinery, it is an attractive 
hypothesis that we have trapped some N-end-rule substrates.  Substrate validation using a 
plasmid-overexpressed or purified full-length protein may not reveal degradation in this 
case.  How do we determine which and how proteins are processed?  One approach to 
determining if proteins are processed prior to degradation is by examining putative 
substrates individually.  A set of specific antibodies would greatly assist in conducting in 
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vivo experiments, either by monitoring the size and degradation pattern of a putative 
substrate in vivo with and without ClpA and ClpS as well as detecting the size of a 
substrate from purified trap samples.  Alternatively, a pull-down approach using ClpS as 
bait might isolate physiological N-end substrates (see Appendix).   
 Complementary SILAC studies might also elucidate the ClpAP substrate 
landscape.  For example, the clpS+ versus clpS- experiment could be repeated but with 
ClpS overexpressed in the clpS+ strain to emphasize a difference caused by the presence 
of the adaptor.  Protein trapping can be done under a variety of stress conditions such as 
heat-shock to determine if there are specific substrates under stressful environmental 
states.  Much remains to be learned about the role of ClpAP and ClpS in the cell.  
Understanding the role of this protease system will not only expand our knowledge of 
this particular machine, but we will also understand more fully how the cell handles and 
prioritizes protein degradation.   
 
MATERIALS AND METHODS 
Strains and plasmids 
 All strains and plasmids used in this study are described in Table 4.2.  JH43, 
JH41, and JH42 are strains used for the initial trapping experiments.  Strains JH105, 
JH106, and SN26 were used for SILAC trapping experiments, in which pJF105 was 
transformed into SN26.  For in vivo degradations, the appropriate pBAD plasmids were 
transformed into W3110-based test strains.   Re-trapping experiments were conducted 
with putative substrate genes encoded into a fusion of pBAD-pACYC184 plasmids 
(similar to pJF122) and transformed into W3110-based test strains.   
 
Table 4.2.  Strains and plasmids used in this study. 
Strains/plasmid Relevant genotype Source/reference 
Strains   
W3110 F- λ- IN(rrnD-rrnE)1 rph-1 (Bachmann 1972) 
JH8 W3110 clpA::kan This work 
JH15 W3110 ∆clpS This work 
TB380 W3110 clpX::kan J. Flynn 
JH11 W3110 clpA::kan clpP::cat clpX::kan This work 
TB371 W3110 ∆smpB J. Flynn 
JH32 W3110 ∆smpB clpA::kan This work 
JH43 W3110 ∆smpB clpP::cat clpX::kan, pSBN39  This work 
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JH41  W3110 ∆smpB ∆clpS clpP::cat clpX::kan pSBN39 This work 
JH42 W3110 ∆smpB clpA::kan clpP::cat clpX::kan, pJH101, 
pSBN39 
This work 
JH45 W3110 ∆smpB clpA::kan clpP::cat clpX::kan, pSBN39 This work 
JH105 W3110 ∆leuB ∆smpB clpP::cat clpX::kan, pJF105 This work 
JH106 W3110 ∆leuB ∆smpB ∆clpS clpP::cat clpX::kan pJF105 This work 
SN26 W3110 ∆leuB ∆smpB clpA::kan clpP::cat clpX::kan (Neher et al. 2006) 
JH243 W3110 ∆smpB clpP::cat clpX::kan, pSBN39, pMS30 This work 
JH244 W3110 ∆smpB ∆clpS clpP::cat clpX::kan pSBN39, pMS30 This work 
JH237 W3110 ∆smpB clpP::cat clpX::kan, pSBN39, pJH190 This work 
JH238 W3110 ∆smpB ∆clpS clpP::cat clpX::kan pSBN39, pJH190 This work 
JH239 W3110 ∆smpB clpP::cat clpX::kan, pSBN39, pJH195 This work 
JH240 W3110 ∆smpB ∆clpS clpP::cat clpX::kan pSBN39, pJH195 This work 
JH245 W3110 ∆smpB clpP::cat clpX::kan, pSBN39, pJH191 This work 
JH246 W3110 ∆smpB ∆clpS clpP::cat clpX::kan pSBN39, pJH191 This work 
JH247 W3110 ∆smpB clpP::cat clpX::kan, pSBN39, pJH196 This work 
JH248 W3110 ∆smpB ∆clpS clpP::cat clpX::kan pSBN39, pJH196 This work 
JH249 W3110 ∆smpB clpP::cat clpX::kan, pSBN39, pJH192 This work 
JH250 W3110 ∆smpB ∆clpS clpP::cat clpX::kan pSBN39, pJH192 This work 
JH251 W3110 ∆smpB clpP::cat clpX::kan, pSBN39, pJH197 This work 
JH252 W3110 ∆smpB ∆clpS clpP::cat clpX::kan pSBN39, pJH197 This work 
JH253 W3110 ∆smpB clpP::cat clpX::kan, pSBN39, pJH193 This work 
JH254 W3110 ∆smpB ∆clpS clpP::cat clpX::kan pSBN39, pJH193 This work 
JH255 W3110 ∆smpB clpP::cat clpX::kan, pSBN39, pJH194 This work 
JH256 W3110 ∆smpB ∆clpS clpP::cat clpX::kan pSBN39, pJH194 This work 
   
Plasmids   
pQE70  Vector, ColE1 ori Qiagen 
pACYC184 Vector, p15 ori (Chang and Cohen 1978) 
pJF122 Vector, pACYC ori tetR / pBAD MCS J. Flynn 
pJH101 clpA169-758 / pJF122 This work 
pSBN39 clpP14-207 S97A-His6-TEV-Strep·Tag / pQE70  (Neher et al. 2006) 
pJF105 clpP14-207 S97A-His6-TEV-Myc3 / pQE70  (Flynn et al. 2003) 
pBADHisA Vector, ColE1 ori Invitrogen 
pBADMycHisA Vector, ColE1 ori, NcoI mutated to AvrII   Invitrogen/S. Neher 
pJH112 prs / pBADHisA This work 
pJH116 prs / pBADMycHisA This work 
pJH113 hchA / pBADHisA This work 
pJH114 hchA / pBADMycHisA This work 
pSBN74 recN / pBADHisA (Neher et al. 2006) 
pSBN80 recN-DD / pBADHisA (Neher et al. 2006) 
pJH151 cbl / pBADHisA This work 
pJH152 cbl / pBADMycHisA This work 
pJH153 nhaR / pBADHisA This work 
pJH154 nhaR / pBADMycHisA This work 
pJH155 agaR / pBADHisA This work 
pJH156 agaR / pBADMycHisA This work 
pJH157 fis / pBADHisA This work 
pJH158 fis / pBADMycHisA This work 
pET28b Vector, f1 ori EMD Biosciences 
pET23b Vector, f1 ori EMD Biosciences 
pJH167 cbl / pET28b This work 
pJH168 cbl / pET23b This work 
pJH160 nhaR / pET28b This work 
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pJH161 nhaR / pET23b This work 
pJH169 agaR / pET28b This work 
pJH170 agaR / pET23b This work 
pJH171 fis / pET23b This work 
pMS30 GFP-ssrA / pACYC184 (Flynn et al. 2003) 
pJH190 cbl / pBADHisA-pACYC184 This work 
pJH195 cbl / pBADMycHisA-pACYC184 This work 
pJH191 nhaR / pBADHisA-pACYC184 This work 
pJH196 nhaR / pBADMycHisA-pACYC184 This work 
pJH192 agaR / pBADHisA-pACYC184 This work 
pJH197 agaR / pBADMycHisA-pACYC184 This work 
pJH193 fis / pBADHisA-pACYC184 This work 
pJH194 fis / pBADMycHisA-pACYC184 This work 
 
Proteins 
 The genes for Cbl, NhaR, AgaR, and Fis were cloned into overexpression 
plasmids.  pET28b was used to create N-terminal His-tag fusions, and pET23b was used 
to create C-terminal His-tag fusions.  The overexpressed proteins were purified with 8 M 
urea and 50 mM sodium phosphate over Ni-NTA resin (Qiagen).  The bound proteins 
were washed and eluted with the same buffer and 500 mM imidazole.  Eluted proteins 
were then step dialyzed into 50 mM sodium phosphate (pH 8), 300 mM NaCl, 10% 
glycerol, and 1 mM DTT.   
 Purified Fis was a gift from R. Johnson (UCLA). 
 
Non-quantitative protein trapping 
 Overnight cultures of the trapping strains were inoculated into fresh medium and 
grown at 30 ºC.  At OD600 0.4, the cells were induced with 0.2 mM IPTG for 3 hours.  
Cells were harvested and lysed, and 200 µL of 2 mg/mL avidin was added per initial liter 
of starting culture to bind free biotin.  Cells were spun and the lysate added to Ni-NTA 
beads.  The bound protein was washed and eluted with high imidazole buffer, and the 
eluate was combined with IBA streptactin-sepharose beads.  After additional washing, 
the protein was eluted with 10 mM biotin.  The eluted protein was then dialyzed into 
buffered 8 M urea, and the ClpPTrap was removed by binding to Ni-NTA beads.  The 
flow-through containing the trapped proteins was concentrated and prepared for mass 
spectrometry.  The samples were either subjected to in-solution trypsinization or in-gel 
trypsinization after running the samples on a denaturing polyacrylamide gel, staining with 
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Coomassie, and excising gel slices.  The resultant peptides were subjected to reverse-
phase HPLC followed by tandem mass spectrometry. 
 
SILAC protein trapping 
 The preparation of SILAC media and growth of trapping strains are as described, 
and pairs of strains were trapped for equal amounts of time (Neher et al. 2006).  The final 
cell densities were measured by absorbance at 600 nm light, and equal amounts of cells 
were harvested from each trapping strain, mixed, and the ClpPTrap was purified as 
described (Flynn et al. 2003).  The purified trapped proteins were dialyzed into buffered 8 
M urea, and the ClpPTrap was removed by binding to Ni-NTA resin.  The protein trapping 
samples from the clpA+ versus clpA- experiment were run on a 12.5% tris-glycine 
polyacrylamide gel.  The clpS+ versus clpS- samples were run on a 12% tris-glycine gel 
(Bio-Rad).  Both gels were stained with Coomassie after which gel slices were excised 
and the proteins were trypsinized and prepared for mass spectrometry (Neher et al. 2006).   
 
In vivo degradations 
 pBADHisA or pBADHisMycA plasmids containing the candidate substrate gene 
of interest were transformed into wild-type W3110 and W3110 with the appropriate 
deletion(s).    A single transformed colony was grown at 37 ºC in a 3-4 mL culture until 
reaching mid-exponential phase.  Cells were then back-diluted into 20 or 25 mL fresh 
media, starting at an OD600 0.2 or 0.3.  0.2% fresh L-arabinose was added to the culture, 
and the cells were grown to OD600 0.3-0.4.  100 µg/mL chloramphenicol was added to 
stop protein synthesis, and 1 mL samples of cells were TCA-precipitated at various time 
points.  150 µg/mL spectinomycin was used when cells contained a chloramphenicol-
resistant clpP::cat disruption.  The TCA-precipitated cells were spun, wash with acetone, 
and resuspended with sample buffer before SDS-PAGE.  The proteins were transferred to 
a PVDF membrane (Millipore) and probed with 1:5000 dilution of either rabbit anti-His 
(Santa Cruz Biotechnology) or mouse anti-Xpress antibody (Invitrogen) followed by a 
1:5000 dilution of goat anti-rabbit or goat anti-mouse (Bio-Rad).  The western blots were 
developed with ECF substrate (GE Healthcare) according to the manufacturer’s 
instructions and scanned on a Typhoon 9400 (GE Healthcare).   
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 In vitro degradations 
RseA.  4 µM RseA1-108 or RseA1-99 was degraded with 0.1 µM ClpA6, 0.27 µM 
ClpP14 and either 0.6 µM ClpS or 6 µM SspB1-119 monomer in 1X HO Buffer (50 mM 
HEPES pH 7.5, 20 mM MgCl2, 0.3 M NaCl, 10% glycerol, 0.5 mM DTT) at 30 ºC with 4 
mM ATP and an ATP regeneration system (2.5 µM creatine phosphate, 50 µg/mL 
creatine kinase).  RseA1-108 migrates closely with ClpS on SDS-PAGE, so a western blot 
was conducted to visualize RseA1-108 degradation, probed with 1:10,000 rabbit anti-
cytoplasmic RseA followed by 1:10,000 goat anti-rabbit.  The protein blots were 
developed as described above. 
N- and C-terminally-tagged Cbl, NhaR, AgaR, and Fis.  5 µM substrate was 
degraded with 0.1 µM ClpA6, 0.27 µM ClpP14, and 1 µM ClpS in 1X HO buffer or 0.3 
µM ClpX6, 0.8 µM ClpP14 in 1X PD buffer (25 mM HEPES pH 7.6, 5 mM MgCl2, 5 mM 
KCl, 15 mM NaCl, 0.032% [v/v] Nonidet P-40, and 10% glycerol) at 30 ºC with 4 mM 
ATP and the ATP regeneration system described above.   
Fis.    5 µM un-tagged Fis was degraded with 1 µM ClpA6, 1 µM ClpP14, 10 µM 
ClpS, 5 mM ATP, 0.5 mg/mL creatine kinase, and 20 mM creatine phosphate at 30 ºC in 
1X HO Buffer.  
 
Protein re-trapping 
 Fusion pBAD-pACYC184 plasmids bearing N- or C-terminally-tagged genes for 
Cbl, NhaR, AgaR, and Fis were transformed into W3110 ∆smpB clpP::cat clpX::kan 
pSBN39 or W3110 ∆clpS ∆smpB clpP::cat clpX::kan pSBN39.  GFP-ssrA was 
constitutively expressed, but Cbl, NhaR, AgaR, and Fis were induced with 0.2% 
arabinose.  The ClpPTrap (His-TEV-Strep·tag) was induced with 0.2 mM IPTG during cell 
growth.  Cells were harvested and lysed, after which the lysate was bound to streptactin 
beads, washed, and eluted with 10 mM d-biotin.  The eluates were then run on a 12.5% 
tris-glycine gel and probed against the Xpress tag (for N-terminally tagged constructs), 
the Myc-tag (for C-terminally-tagged constructs) or GFP (for GFP-ssrA).  Band densities 
were analyzed by ImageQuant TL software (GE Healthcare). 
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Fis growth curves 
 500 µL of W3110, W3110 clpA::kan, and W3110 ∆clpS cells grown overnight 
were inoculated into a total of 25 mL fresh, warmed Luria-Bertani (LB) broth.  Cell 
densities were measured and cell samples were analyzed by anti-Fis western blotting 
using 1:20,000 rabbit anti-Fis primary antibody (a gift from R. Johnson [UCLA]) and 
1:10,000 goat anti-rabbit secondary antibody.  
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CHAPTER FIVE 
The future outlook of ClpS and ClpAP 
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Intense research has been conducted on the AAA+ protease ClpAP and its adaptor 
protein ClpS in recent years.  Most of the work involving these proteins has been done in 
vitro in order to biochemically probe structure-function relationships.  However, there are 
more mechanisms behind this system yet to be uncovered.  Less work has been done 
examining the role of ClpAP and ClpS in vivo, and there are many lessons to be learned 
in understanding the role of this proteolytic system and why it has been conserved in so 
many bacterial species.  Here, I address some future directions of ClpAP and ClpS 
research, some stemming immediately from the work presented in this thesis and others 
arising from gaps in knowledge in the field.   
 
ClpS mechanism 
 Evidence supports a model in which ClpS serves to allosterically alter ClpAP 
substrate preference.  The various parts of ClpS, comprised of the folded core with the N-
degron binding pocket and the proximal and distal regions of the N-terminal extension, 
have distinct functions.  What is unclear is how these distinct parts of ClpS work together 
to form a functional adaptor with respect to ClpAP and its substrates.  Future work on the 
mechanism of ClpS will aim to understand the step-wise roles of the adaptor.  
 One of the most exciting areas to research is uncovering how ClpS hands-off N-
end-rule substrates to ClpAP.  ClpS docks onto the N-terminal domains of ClpA, which 
are thought to be highly mobile around the AAA+ rings of ClpA (Ishikawa et al. 2004).  
It is unknown whether ClpS binding affects the conformation and/or the mobility of the 
N-terminal domains.  How can the ClpS N-terminus bind the ClpA pore regions if the 
ClpA N-terminal domains are still mobile?  Perhaps the interaction of the ClpS N-
terminus to ClpA is very transient, allowing only enough time for the N-end-rule 
substrate to be passed along to ClpA.  This dynamic motion might be a component of the 
ClpS-induced rate increase for N-end-rule substrate degradation.   
Furthermore, because ClpS can bind at up to six copies per ClpA hexamer, it is 
unclear how this stoichiometry affects the role of the adaptor.  The work in this thesis 
demonstrates that titrating ClpS levels did not cause a linear effect on the inhibition of 
ssrA or the stimulation of N-end-rule degradation rates.  For N-end-rule substrates, for 
example, the degradation rate enhancement maximizes at approximately 3-4 molecules of 
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ClpS per ClpA hexamer, even though up to six molecules of ClpS can bind.  Does this 
substoichiometric rate maximization suggest that only 3-4 ClpS molecules loaded with an 
N-end-rule substrate can bind ClpA at any time, perhaps due to steric clashing at the 
pore?  Or, is ClpA’s ability to process N-end-rule substrates the rate-limiting step, in 
which more ClpS molecules bound does not increase the observed rate? 
 The N-degron binding pocket is another region of the ClpS molecule that is of 
immense interest in understanding the role of the adaptor.  The recent crystal structure of 
an N-degron bound to ClpS greatly enhances our understanding of substrate recognition 
(Wang et al. 2008b).  Future research needs to be dedicated to understanding if there is an 
active mechanism for ClpS to dissociate the N-degron from this binding pocket or if the 
natural on and off movements of the substrate allow it to be transferred over to ClpA for 
degradation. 
 
ClpA mechanism 
 Although the majority of this thesis is focused on the role and mechanism of the 
adaptor ClpS, the protease ClpAP is also of great interest.  Understanding the operational 
rules for ClpAP will aid in the understanding of ClpS and vice versa.  The ClpA hexamer 
is a large molecule of over 500 kilodaltons in which each monomer is comprised of an N-
domain and two ATPase domains.  The N-terminal domains have been reported to be a 
site of substrate contact as well as the docking site for ClpS (Ishikawa et al. 2004; Xia et 
al. 2004; Erbse et al. 2008).  Although ClpA lacking its N-terminal domain has shown to 
be impaired in recognizing model substrates, its role in substrate recognition is still 
unclear (Lo et al. 2001; Hinnerwisch et al. 2005b).  With regards to the ATPase domains, 
it is also unclear why some AAA+ proteins have two AAA+ rings and some only have 
one.  Some differing roles have been attributed to the two ATP-domains of ClpA, but it is 
not understood why some AAA+ enzymes, such as ClpX, can accomplish similar and 
specific proteolytic tasks with one.   
 Because I propose that ClpS induces a conformational change in ClpA, a future 
direction could be to identify what features of the ClpA hexamer change upon adaptor 
binding.  Preliminary studies monitoring tryptophan fluorescence, bis-ANS binding, and 
protease sensitivity have been attempted but with inconclusive results.  The ClpA 
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hexamer is a large molecule in which subtle changes may be difficult to detect.  
Therefore, more sensitive assays will be required to probe these changes such as small 
angle x-ray scattering or crystallography, if possible.     
As mentioned in Chapter Three, we have narrowed down a putative region of 
interaction on ClpA where the ClpS N-terminal extension interacts.  Cross-linking studies 
to achieve the same goal were conducted, but with ambiguous results.  However, 
different techniques with different probes can be explored to triangulate the results 
gathered with the FeBABE reagent.  Once a sharper picture of the interaction zone is 
created, more ClpA mutants can be generated with higher confidence of success.  The 
discovery of a unique point of contact on ClpA will be a milestone for understanding the 
role of ClpS in the modulation in substrate selection.   
 
In vivo roles and regulation 
 As described above, little information is known about the physiological role and 
regulation of ClpAP and ClpS.  Therefore it will be important to understand why these 
proteins are conserved in cells and how they are regulated. 
 The immediate future directions I propose are a continuation on the proteomic-
based work described in this thesis.  We have generated a list of putative ClpAP 
substrates that are affected by ClpS.  Because validation has been inconsistent, I propose 
validating substrates by looking at their endogenous levels as opposed to validation upon 
overexpression or purification.  The principle reason for this strategy is that many 
putative substrates, particularly those enhanced for degradation in the presence of ClpS, 
may be processed prior to ClpAP recognition.  Furthermore, we cannot rule out that the 
effect on substrate degradation by ClpS may be indirect, that is, requiring other factors in 
the cell.  Fis is one protein described herein that may be a substrate for ClpAP.  
Immediate future work monitoring Fis levels in vivo with an improved antibody will 
greatly assist in this validation.   
 Moreover, the assay for ClpS pull-downs (described in Appendix) in which we 
searched for novel ClpS-binding proteins, particularly N-degron-bearing proteins, can be 
further refined.  These pull-downs are a straightforward method to directly look for 
naturally occurring N-degrons in the cell that can be recognized by ClpS.  If ClpS-
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binding proteins are found, they can be tested for degradation by ClpAP to determine if 
they are also proteolytic substrates.  No physiological N-end-rule protein has been well-
characterized in E. coli to date, but a very recent study suggests that the DNA protection 
protein Dps and Putrescine-Aminotransferase are being recognized as N-end-rule 
substrates (Schmidt et al. 2009).  Although the N-end rule may be part of a general 
quality control mechanism in bacteria, there are likely to be proteins that are processed 
more frequently.  The degradation of some proteins by the N-end-rule pathway may be 
part of regulatory strategies in the cell. 
 Both the comparative ClpPTrap and pull-down assays can be further conducted 
under a variety of environmental conditions.  For example, ClpXP has a reported role in 
degrading specific proteins under DNA-damaging conditions (Neher et al. 2006).  ClpAP 
and ClpS may also have undiscovered roles in a particular stress response that is 
undetectable under normal conditions.   
 Similarly, the field does not have an understanding on the regulation of ClpAP 
and ClpS at the transcriptional level.  ClpS and ClpA lie in the same operon (Dougan et 
al. 2002).  However, it was shown that ClpA levels rose from exponential to stationary 
phase while ClpS levels remained constant in the cell (Farrell et al. 2005).  The reasons 
why ClpA levels rise are nebulous, although we speculate that ClpAP may degrade a 
different profile of substrates when its levels are raised above saturating ClpS levels.  It is 
also unknown what factors cause this increase in ClpA production.  Likewise, the role of 
ClpA autodegradation, if it exists robustly in vivo, is unclear.  Thus, understanding how 
components of this proteolytic machine are themselves regulated will assist in the 
understanding of how ClpAP and ClpS affect the cellular proteome under different 
growth conditions and environmental states.   
 
 In this thesis, I have described the multi-faceted role of ClpS in ClpAP substrate 
selection.  With time, the field has adopted a greater understanding of the diverse make-
up of AAA+ enzymes and adaptor proteins.  ClpS represents a new class of adaptor that 
does not function like the canonical molecule.  Different stoichiometries of ClpS can bind 
to a ClpA hexamer, offering one level of substrate regulation.  Secondly, distinct parts of 
the adaptor are responsible for affecting different types of substrates.  We provide a 
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deeper examination of the function of the N-terminal extension of ClpS, showing that the 
length and chemical characteristics are important, despite its lack of conversation 
between ClpS orthologs.  Furthermore, I have focused the area of interaction of the ClpS 
N-terminal extension to the pore of ClpA, which will facilitate the understanding of how 
ClpA is affected by adaptor binding.  Finally, we have generated a list of putative ClpAP 
substrates that are stimulated or inhibited by the presence of ClpS in the cell.  Hopefully 
these discoveries will encourage further work on ClpAP and ClpS. 
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APPENDIX 
Preliminary search for ClpS-interacting proteins 
 
 
 
 
 
 
 
 
 
 
 
 
 
The cross-linking part of this work was done in collaboration with K. Wang. 
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INTRODUCTION 
 Little is known about the physiological role of ClpS in the cell.  ClpS’s role in 
delivering N-end-rule substrates to ClpAP has not been verified in vivo, and it is unclear 
if ClpS only binds to ClpA and potential N-degron-bearing substrates in the cell.   Thus, 
we decided to explore the ClpS interactome through several co-precipitation experiments.  
We expected that the proteins pulled-down, if any, by ClpS may yield novel ClpS-
dependent substrates or other currently identified binding partners.  This project is 
unfinished, and future directions and considerations are described below. 
 
RESULTS AND DISCUSSION 
 To investigate potential binding partners of ClpS, we implemented pull-down 
experiments.  Two different methods of attachment of ClpS to a solid support were 
initially used: covalent linkage of ClpS primary amines to N-hydroxysuccinimide esters 
on an Affigel-15 matrix and non-covalent linkage of ClpS with a C-terminal His-tag to 
Ni-NTA resin.  The advantage of the primary amine linkage is that ClpS can presumably 
bind to the solid support in multiple orientations via its nine lysines and N-terminus, thus 
not systematically eliminating a possible protein binding interaction through steric 
occlusion.  Conversely, the advantage of C-terminal linkage to a column is that the point 
of linkage is known.  The C-terminal His-tag did not appear to inhibit the folding and 
function of ClpS-H6 in inhibiting GFP-ssrA degradation by ClpAP (Fig. A.1).   
 
Figure A.1.  Testing of ClpS-H6. 
The degradation of GFP-ssrA by ClpAP was monitored with wild-type ClpS or ClpS-H6.  
At the two adaptor concentrations tested, the His-tagged ClpS behaves similarly to wild-
type ClpS.   
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Figure A.2.  Initial ClpS co-precipitation experiments. 
(a) Coomassie-stained polyacrylamide gels showing isolation of putative ClpS-binding 
proteins from ClpS-H6 column.  FT = flow through; W1 and W2  = washes with 10 mM 
imidazole buffer; W3 and W4 = washes with 20 mM imidazole buffer; E1, E2, and E3 = 
elution fractions with 500 mM imidazole buffer.  ClpS-H6 partially emerged in the 
washes and was eluted from the matrix along with co-purifying proteins from the ClpS 
column.  (b) Coomassie-stained polyacrylamide gels showing isolation of putative ClpS-
binding proteins from ClpS-Affigel column.  Free ClpS was used to elute bound proteins, 
and only the three elution fractions from the ClpS and beads-only column are shown.  (c) 
Anti-ClpA western showing the emergence of ClpA from the ClpS-H6 or beads-only 
column in a pull-down experiment.  See (a) for lane labels.   
 
 
 
 127
In both experiments, E. coli cellular lysates were applied to a solid support matrix 
bound with ClpS followed by washing and elution.  Elution samples were precipitated 
with trichloroacetic acid prior to loading on the gel (Fig. A.2a,b).  Protein indeed eluted 
from the ClpS columns, but the beads-only column also yielded eluted proteins.  These 
contaminating proteins in the beads-only column persisted in the washing steps, and a 
more stringent washing might reduce these levels. 
We considered the possibility that extensive washing might remove potential 
binding proteins that are transiently bound to ClpS.  Therefore, we monitored the binding 
of ClpA as a control between the ClpS column and a beads-only column.  Figure A.2c 
shows the presence of ClpA in wash and elution fractions from the ClpS and beads-only 
columns.  As expected, most of the ClpA is present in the lysate flow-through and first 
wash fraction in the beads-only column.  In the ClpS column, ClpA is bound to the 
column and co-eluted in the first elution fraction.  However, a substantial amount of 
ClpA is removed from the column in the flow-though as well as the wash fractions.  
Therefore, instead of more stringent washing, we decided to identify the proteins eluted 
in the beads-only column and label them as contaminants. 
Elution fractions from both the ClpS column and the beads-only were run on 
SDS-PAGE, and the gel slices contained eluted protein were excised for trypsinization 
and mass spectrometric analysis.  Many proteins that eluted from all columns were 
ribosomal proteins.  Even though ribosomal proteins may bind specifically to ClpS, we 
decided to disregard these proteins as contaminants due to their sheer abundance in the 
beads-only elutions.  Not unexpectedly, proteins with consecutive histidines were eluted 
from both the ClpS and beads-only Ni-NTA columns.  These histidine-rich proteins were 
also dismissed as contaminants. 
The proteins AphA, ClpA, MreB, and MutM were identified in the ClpS column 
and not the beads-only column for both matrices.  All of these proteins were identified in 
the SDS-PAGE gel slice that approximately corresponds to their full molecular weight, 
indicating that these proteins were not substantially cleaved prior to being recognized for 
binding by ClpS.  As described in Chapter Four, identification of multiple unique 
peptides by mass spectrometry increases the confidence that the identification is not 
erroneous, keeping into consideration that proteins of higher mass will yield more 
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peptides.  ClpA was identified by 12 unique peptides in a ClpS-H6 column and 10 unique 
peptides in the covalently-linked ClpS column.  AphA was identified by 1 and 3 peptides, 
MreB was identified by 2 peptides each, and MutM was identified by 1 unique peptide in 
the Ni-NTA and Affigel columns, respectively.  With many peptides identified, ClpA 
serves as a good positive control for the ClpS column, showing that a binding partner can 
recognize ClpS tethered to a solid support.  Conversely, AphA, MreB, and MutM were 
identified by few peptides.  Because the vast majority of the proteins identified by mass 
spectrometry were either identified in the beads-only column or were not seen in a second 
mass spectrometry experiment, we sought a more specific way to isolate ClpS-binding 
proteins before protein-specific validation.   
Due to the role of ClpS as an adaptor, we assumed that most proteins that may 
potentially bind to ClpS, with the exception of ClpA, are transiently bound.  An isolated 
N-degron bound to E. coli ClpS with a KD of ~6-7 µM (Chapter Three).  It would 
therefore be difficult to specifically identify these proteins amongst potential 
contaminants under wash and purification conditions that did not perturb true binding 
interactions.  Therefore, a cross-linking approach was used with the intention of 
covalently linking interacting proteins to ClpS followed by a more extensive purification 
of ClpS.  Although we were interested in any new interacting protein, we focused 
specifically on seeking novel N-end-rule substrates.  We used non-site-specific cross-
linkers in conjunction with ClpS-H6.  To ensure that the isolated proteins are N-degron 
substrates, we duplicated each experiment with ClpS-H6 D35G D35A (“GA”), a mutant 
that does not bind N-degrons (Erbse et al. 2006).  Proteins pulled-down by wild-type 
ClpS and not the GA mutants would be considered for further validation. 
A control experiment was carried out testing the ability of ClpS-H6 and ClpS-H6 
GA to pull down a purified N-end-rule substrate added to cellular lysates with several 
cross-linkers.  YLFVR-GFP was enriched by wild-type ClpS but not by the GA mutant 
(Fig. A.3a).  Furthermore, both ClpS and GFP were detected at higher molecular weights, 
indicating that ClpS and GFP cross-linked to form higher order complexes.  This control 
shows that ClpS-H6 attached to Ni-NTA beads can bind an N-end-rule protein and that 
the GA mutant prevents this interaction.   
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Figure A.3. ClpS co-precipitation using cross-linkers. 
(a) Control experiment showing the preferential binding of YLFVR-GFP to wild-type 
ClpS and not ClpS GA.  WT = wild-type ClpS-H6, GA = ClpS-H6 D35G D36A.  
YLFVR-GFP was cross-linked to wild-type ClpS and formed higher molecular weight 
complexes, as determined by the YA4-GPF-only lane on the right-hand side of the blots.  
YA4-GPF did not cross-react with the anti-ClpS antibody.  Most of the ClpS did not 
cross-link with YLFVR-GFP as shown by migration of a monomeric ClpS band.  
Insufficient boiling prior to electrophoresis may have resulted in ClpS dimer formation 
on the gel.  (b) Elution fractions from a sulfo-SIAB cross-linking experiment using ClpS-
H6 and ClpS-H6 GA expressed from a plasmid in vivo.  E = exponential phase cell 
lysates, S = stationary phase cell lysates.  Insufficient boiling prior to electrophoresis may 
have resulted in ClpS dimer formation on the gel.  Peptides from this gel were extracted 
and analyzed by mass spectrometry. 
 
Unclear differences between wild-type ClpS and ClpS GA column elutions were 
seen in several experiments attempting to pull-down potential binding partners from 
cellular lysate.  We therefore, decided to express ClpS-H6 in vivo to maximize binding.  
Cross-linker was added to the cell lysates prior to isolation of ClpS-H6 and bound 
proteins, and ClpS was purified under denaturing conditions to remove as many 
contaminants as possible.  The differences between wild-type ClpS and ClpS GA are still 
unclear, but we surmised that potential binding partners might be few and undetectable 
by eye (Fig. A.3b).  We analyzed some of the eluted proteins by mass spectrometry and 
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generated a list of potential proteins to test.  Some proteins that were found in wild-type 
elutions and not GA elutions that were also detected by more than one peptide included: 
AceA, AhpC, DsbC, GlmU, GsaE/HemL, HldE/RfaE, IscR/YfhP, MprA, NagD, PtsI, and 
YdaO.  We cloned these genes into a vector encoding an N-terminal His6 and a C-
terminal FLAG tag.  If these genes were processed in vivo by a cleavage reaction, each 
end of the protein would still bear an epitope tag for detection.  We aimed to conduct 
ClpS far-western experiments to determine if ClpS could bind to the proteins of interest, 
and if so, if ClpS could bind a proteolytically processed form that might bear an N-
degron.  These experiments were put on hold due to technical problems and should be 
addressed in the future.   
Because these studies have not been completed, there is still ample possibility of 
detecting and identifying ClpS binding proteins.  For instance, a more stringent protocol 
for isolating ClpS-H6 cross-linked to proteins would assist in the specific identification of 
N-end-rule substrates.  The cross-linking concentration and time can be adjusted to 
reduce the cross-linking of contaminants to ClpS, and the wash procedure can be made 
harsher to lower the level of contaminant binding.   
Validation of potential binding partners identified by mass spectrometry is more 
complex.  ClpS has been shown to bind to N-degrons by far-western blots (Erbse et al. 
2006), but the overexpression of our candidate proteins might not permit sufficient 
processing in vivo for N-degron exposure.  Solution-based assays may also be required to 
test for binding.  Additional challenges to validation may include low cellular abundance 
of N-degrons for detection and the lack of knowledge of potential upstream processing 
steps.   
 
MATERIALS AND METHODS 
Proteins 
 The clpS gene was amplified and cloned into a pET23b overexpression vector 
(Novagen).  Protein was overexpressed with 0.4 mM IPTG for 2 hours after which the 
cells were harvested.  The cell lysate was cleared with 35% saturated ammonium sulfate 
followed by resuspension of the spun pellet into S1 buffer (50 mM sodium phosphate pH 
8, 300 mM NaCl, 5 mM imidazole, 10% glycerol).  The sample was then purified over 
 131
Ni-NTA resin (Qiagen), washed, and eluted in high imidazole buffer (S1 with 500 mM 
imidazole).   
 ClpS-H6 D35G D36A was generated from ClpS-H6 by QuikChange mutagenesis 
(Stratagene) and purified similarly. 
 
Protein degradation 
 ClpS-H6 was tested for ability to degrade GFP-ssrA with 0.1 µM ClpA6, 0.27 µM 
ClpP14, 1 µM GFP-ssrA, 0.2 or 0.6 µM ClpS protein, 4 mM ATP, and an ATP 
regeneration system (0.05 mg/mL creatine kinase and 2.5 mM creatine phosphate).  Loss 
of fluorescence was measured on a Photon Technology International fluorimeter.   
 
Initial pull-downs 
 For ClpS-H6 binding assays, E. coli cell cultures grown to either exponential or 
stationary phase were harvested and lysed.  About 0.2 µmol of ClpS-H6 was bound to 250 
µL Ni-NTA beads (Qiagen).  The cell lysates were added to the ClpS-H6 column and a 
beads-only column, and the samples were washed with S1 buffer containing 10 mM or 20 
mM imidazole, and eluted in high imidazole buffer. 
 For ClpS-Affigel binding assays, 2.4 mg ClpS was bound to washed Affigel-15 
beads (Bio-Rad) overnight.  The next morning, unreacted ClpS was removed and the 
remaining reactive groups were quenched with ethanolamine pH. 8.  E. coli cultures at 
exponential or stationary phase were harvested after which the spun and filtered lysate 
was applied to the washed ClpS column.  After binding, the column was washed and 
eluted with excess competitor ClpS. 
 For both co-precipitation experiments, the elutions were TCA-precipitated, 
samples run on SDS-PAGE, bands excised, proteins trypsinized, and peptides analyzed 
by mass spectrometry. 
 
Cross-linking pull-downs 
 For the YLFVR-GFP cross-linking experiment, 2.5 nmol of ClpS-H6 or ClpS-H6 
GA was added to 100 µL lysates from exponentially-grown E. coli to a total of 200 µL.  
~0.1 mg BS3 (Bis(sulfosuccinimidyl)suberate, homo-bifunctional amine-reactive), sulfo-
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MBS (m-Maleimidobenzoyl-N-hydroxysulfosuccinimide ester, heterobifunctional amine- 
and sulfhydryl-reactive), or sulfo-SIAB (N-Sulfosuccinimidyl[4-
iodoacetyl]aminobenzoate, heterobifunctional amine- and sulfhydryl-reactive) cross-
linker was added to the lysate at 4 ºC for 1 hour after which the sample was added to Ni-
NTA resin.  The slurry was pipetted into a spin column (Bio-Rad) and washed and eluted 
by centrifugation.  Elutions from all samples were run on SDS-PAGE followed by an 
anti-ClpS or anti-GFP western to detect the formation of higher molecular weight 
complexes.  Purified YA -GFP was loaded onto the gel as a GFP size standard.    4
 For “in vivo” cross-linking experiments, ClpS-H6 and ClpS-H6 GA were 
expressed from a pTrc99a plasmid with 0.2 mM IPTG in W3110 clpA::kan cells grown 
to either exponential or stationary phase.  Sulfo-SIAB was added to the lysate after which 
the ClpS proteins were purified by binding to Ni-NTA and washed and eluted under 8 M 
urea denaturing conditions.  After running the samples on SDS-PAGE, gel bands were 
excised, and the proteins were trypsinized and analyzed by tandem mass spectrometry for 
identification.   
 
ClpS far westerns 
 The genes for putative ClpS-binding proteins were amplified and cloned into 
pTrc99a vectors with an N-terminal His6 tag and a C-terminal FLAG tag.  These 
plasmids were then transformed into W3110 clpA::kan and induced for expression.  Cell 
samples were taken, run on SDS-PAGE, and probed with 50 nM ClpS-H6 followed by an 
anti-His or anti-ClpS antibody.   
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